data_2mli_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mli _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.554 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.4 tt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.313 0.578 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.7 t -59.85 -50.3 80.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.799 -1.188 . . . . 0.0 110.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -51.87 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.56 -1.338 . . . . 0.0 110.928 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.73 -41.04 89.99 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 111.884 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.33 -46.0 10.7 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.033 -1.042 . . . . 0.0 112.129 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.5 t -82.97 -53.0 6.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.723 -1.236 . . . . 0.0 111.039 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -70.85 -28.71 64.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.734 -1.229 . . . . 0.0 108.884 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.8 m -135.27 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.74 129.23 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.62 -1.3 . . . . 0.0 109.1 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.68 -173.06 3.23 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.219 1.009 . . . . 0.0 109.868 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.21 154.85 50.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.21 -60.54 1.85 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 122.325 1.059 . . . . 0.0 109.364 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.33 -45.1 17.32 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.87 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.584 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.7 mt-30 -64.86 -32.51 74.25 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.63 -34.87 65.2 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.179 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 20.1 mt-10 -64.96 -37.75 88.69 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.107 0.956 . . . . 0.0 110.324 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.88 -37.15 18.81 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.901 0.857 . . . . 0.0 110.103 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.584 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.2 m-85 -87.92 3.04 50.07 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.428 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 59.9 m -74.84 75.77 2.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.749 -1.844 . . . . 0.0 109.961 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.434 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 3.6 t-20 . . . . . 0 C--N 1.293 -1.87 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -147.98 165.89 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.0 109.837 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.488 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 14.1 m120 -122.9 71.2 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.05 169.87 9.81 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.78 0.8 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.16 92.63 8.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.94 141.04 31.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.405 -0.81 . . . . 0.0 110.551 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.7 m -142.53 124.28 15.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.76 -107.59 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.415 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.5 m -38.59 -60.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.386 -1.067 . . . . 0.0 111.45 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.2 m-20 -64.23 -43.39 95.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.922 -1.111 . . . . 0.0 109.665 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.8 tp -67.51 -63.25 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.68 -57.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.97 0.891 . . . . 0.0 108.644 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -53.83 -38.86 65.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -60.18 -35.87 76.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' B' ' 40' ' ' CYS . 50.4 mt -75.06 -57.08 4.12 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.506 -1.371 . . . . 0.0 108.748 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.22 -31.11 2.28 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.3 tt -74.8 -48.13 26.99 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.7 t -74.19 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.766 0.794 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' B' ' 36' ' ' LEU . 30.1 m -68.25 -47.12 68.6 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.775 -0.578 . . . . 0.0 112.101 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.56 -121.14 19.36 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.496 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 9.7 tp10 -62.35 -44.0 97.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.265 -1.138 . . . . 0.0 111.036 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.02 -17.33 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.064 -1.022 . . . . 0.0 110.594 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.94 -175.4 41.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.404 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.7 p90 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.174 -1.78 . . . . 0.0 110.952 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.55 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.6 tt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.337 0.589 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 7' ' ' CYS . 89.9 t -59.34 -50.43 79.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.874 -1.141 . . . . 0.0 110.849 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -50.96 -62.16 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.669 -1.27 . . . . 0.0 111.14 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.7 mp0 -61.32 -39.89 92.19 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.9 -1.125 . . . . 0.0 111.948 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -46.02 10.6 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.014 -1.053 . . . . 0.0 112.106 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.78 -52.94 6.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.85 -1.156 . . . . 0.0 111.043 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.17 -28.31 64.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.178 . . . . 0.0 108.927 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.5 m -135.86 174.09 11.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.06 129.32 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.601 -1.312 . . . . 0.0 109.01 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.17 -173.16 3.35 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.195 0.997 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.51 151.65 48.65 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -42.16 -60.41 1.46 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 122.255 1.026 . . . . 0.0 109.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.73 -45.41 19.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.779 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.7 mt-30 -64.15 -32.55 74.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.69 -35.64 65.19 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.246 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 24.6 mt-10 -64.03 -37.66 88.24 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.152 0.977 . . . . 0.0 110.467 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.76 -37.13 18.12 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.917 0.865 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.4 m-85 -88.19 3.28 49.93 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 21' ' ' ASN . 62.1 m -75.18 74.06 2.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 119.826 -1.796 . . . . 0.0 110.027 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 20' ' ' CYS . 21.9 t-20 . . . . . 0 C--N 1.294 -1.839 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.752 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.96 165.94 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.026 -1.046 . . . . 0.0 109.84 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.486 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 14.2 m120 -122.68 71.07 1.01 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -120.27 169.91 9.83 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.861 0.839 . . . . 0.0 110.063 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -91.01 92.29 8.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.73 139.71 32.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 110.671 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 51.2 m -140.89 124.17 16.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 109.727 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.82 -111.4 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.407 ' C ' ' O ' ' B' ' 29' ' ' GLY . 38.8 t -38.62 -54.18 1.56 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.405 -1.056 . . . . 0.0 111.473 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.91 -31.7 70.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.886 -1.133 . . . . 0.0 109.666 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 35' ' ' ALA . 20.7 tp -82.1 -61.51 1.88 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.658 -0.651 . . . . 0.0 109.554 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' B' ' 29' ' ' GLY . 29.2 t -40.8 -56.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 108.585 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -53.51 -39.47 64.65 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.47 -36.34 75.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' B' ' 40' ' ' CYS . 48.9 mt -74.67 -56.06 5.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.622 -1.299 . . . . 0.0 108.603 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -46.69 -31.12 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.87 -47.75 24.2 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 t -73.79 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.745 0.783 . . . . 0.0 109.785 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.34 -47.45 67.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.74 -0.6 . . . . 0.0 112.025 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.48 -117.75 11.88 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.796 -1.193 . . . . 0.0 110.71 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.31 -43.18 95.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -1.103 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -48.41 -19.35 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.904 -1.123 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.69 44.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.417 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 27.2 p90 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.125 -1.809 . . . . 0.0 111.288 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.546 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.2 tt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.332 0.587 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.7 t -59.32 -50.12 81.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.797 -1.189 . . . . 0.0 110.743 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -51.47 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.644 -1.285 . . . . 0.0 111.047 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.9 mp0 -60.71 -40.18 91.33 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 111.929 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.39 -46.18 10.5 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.031 -1.043 . . . . 0.0 112.076 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.72 -52.86 6.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.804 -1.185 . . . . 0.0 111.023 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -71.15 -28.68 64.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.241 . . . . 0.0 108.971 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.3 m -135.45 174.36 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.29 130.22 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.584 -1.322 . . . . 0.0 109.086 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.48 -173.01 3.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.184 0.992 . . . . 0.0 109.92 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.1 152.32 48.65 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.8 tp -42.53 -60.63 1.46 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 122.338 1.066 . . . . 0.0 109.599 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.7 -44.87 19.06 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.794 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.581 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -65.0 -32.38 74.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -34.99 65.23 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.126 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.84 -37.77 88.73 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.117 0.961 . . . . 0.0 110.374 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -36.84 18.11 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.899 0.857 . . . . 0.0 110.079 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.8 m-85 -88.1 3.25 49.76 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -74.82 74.64 2.11 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 119.735 -1.853 . . . . 0.0 110.043 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.416 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 12.4 t-20 . . . . . 0 C--N 1.294 -1.835 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.56 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.3 p -148.81 165.68 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.045 . . . . 0.0 109.922 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.49 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 14.1 m120 -122.55 71.58 1.03 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -120.51 169.94 9.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.814 0.816 . . . . 0.0 110.215 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -91.36 92.49 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.98 140.82 31.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 110.581 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 m -142.15 124.21 15.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 109.915 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -107.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 29' ' ' GLY . 8.7 t -38.58 -59.41 0.93 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -1.049 . . . . 0.0 111.398 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.06 -42.78 93.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 109.629 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.7 tp -68.21 -63.29 1.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.64 . . . . 0.0 109.82 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.56 -57.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.073 0.94 . . . . 0.0 108.614 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -54.05 -39.65 66.43 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.29 -36.13 75.02 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.9 mt -74.8 -57.52 3.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.46 -1.4 . . . . 0.0 108.732 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.5 t80 -46.07 -30.77 2.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -75.24 -47.51 27.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.88 -61.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.778 0.799 . . . . 0.0 109.832 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.1 m -68.3 -47.13 68.44 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.757 -0.589 . . . . 0.0 112.068 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -121.61 22.67 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.473 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' B' ' 44' ' ' GLY . 12.0 tp10 -61.33 -44.05 97.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -1.096 . . . . 0.0 111.111 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.02 -18.28 0.07 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.99 -1.069 . . . . 0.0 110.696 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.25 43.87 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.416 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.8 p90 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.19 -1.77 . . . . 0.0 111.265 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.551 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.5 tt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' CYS . 75.8 t -59.27 -50.88 78.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.816 -1.177 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -51.02 -62.43 1.62 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.571 -1.33 . . . . 0.0 110.993 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.47 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.9 mp0 -60.33 -40.56 91.05 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.977 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.22 -45.69 11.07 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.067 -1.021 . . . . 0.0 111.974 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.65 -52.91 6.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.795 -1.191 . . . . 0.0 110.995 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.47 -28.11 63.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.73 -1.231 . . . . 0.0 109.014 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' CYS . 70.9 m -135.72 174.19 10.88 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.43 129.02 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.542 -1.349 . . . . 0.0 108.961 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.79 -173.12 3.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.157 0.979 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.24 155.49 49.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.64 -60.54 1.95 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 122.407 1.098 . . . . 0.0 109.242 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.35 -45.09 17.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.936 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.8 mt-30 -64.94 -32.61 74.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.85 -34.18 64.41 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.11 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.6 mt-10 -65.63 -37.68 87.24 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.196 0.998 . . . . 0.0 110.324 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.93 -37.04 18.78 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.966 0.889 . . . . 0.0 110.101 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.0 m-85 -87.85 2.87 50.36 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 59.7 m -74.91 76.23 2.16 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.801 -1.812 . . . . 0.0 109.915 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.435 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 24.5 t-20 . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.677 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.3 p -150.52 165.96 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.999 -1.063 . . . . 0.0 109.887 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.484 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 13.6 m120 -123.08 71.53 1.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.69 170.15 9.72 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.799 0.809 . . . . 0.0 110.167 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -91.28 92.57 8.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.81 140.57 31.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.11 124.0 16.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 109.798 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.0 -110.03 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -38.73 -55.7 1.44 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.058 . . . . 0.0 111.444 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -34.86 78.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 109.621 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' B' ' 35' ' ' ALA . 20.9 tp -78.23 -61.78 1.89 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.582 . . . . 0.0 109.769 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 29' ' ' GLY . 24.8 t -40.84 -56.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 122.056 0.932 . . . . 0.0 108.567 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.84 -39.74 65.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.36 74.06 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' B' ' 40' ' ' CYS . 47.9 mt -75.25 -56.71 4.45 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.511 -1.368 . . . . 0.0 108.692 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -46.76 -30.64 2.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.57 -45.43 45.44 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.2 t -77.81 -61.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.765 0.793 . . . . 0.0 109.886 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.39 -47.17 68.04 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.721 -0.612 . . . . 0.0 111.867 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.46 -118.83 13.54 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.628 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 44' ' ' GLY . 18.1 tp10 -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -1.08 . . . . 0.0 111.058 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.58 -17.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 110.406 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.21 -176.54 40.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.8 p90 . . . . . 0 C--N 1.302 -1.495 0 O-C-N 120.215 -1.756 . . . . 0.0 110.972 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.55 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.4 tt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.346 0.593 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.5 t -60.93 -51.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.799 -1.188 . . . . 0.0 110.705 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.61 -62.17 1.79 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.526 -1.359 . . . . 0.0 110.85 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.83 -41.33 91.08 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.0 111.913 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.7 m -86.41 -45.62 11.0 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.109 -0.994 . . . . 0.0 112.189 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.8 t -82.57 -53.02 6.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.711 -1.243 . . . . 0.0 110.962 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -71.57 -28.05 63.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.806 -1.184 . . . . 0.0 108.985 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.8 m -135.72 174.35 10.71 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mt -86.83 134.13 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.618 -1.301 . . . . 0.0 109.151 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -99.95 -172.96 2.33 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.141 0.972 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -138.23 156.12 47.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.67 -60.42 2.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.345 1.069 . . . . 0.0 109.285 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -46.31 -44.83 17.0 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.2 mt-30 -65.41 -32.44 74.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.61 -34.62 65.14 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.881 -1.127 . . . . 0.0 108.063 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.4 mt-10 -65.15 -37.89 88.86 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.157 0.98 . . . . 0.0 110.329 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.29 19.39 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.977 0.894 . . . . 0.0 110.047 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.5 m-85 -87.79 3.21 49.06 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.17 73.55 2.3 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 119.853 -1.779 . . . . 0.0 109.819 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' OXT' ' A' ' 21' ' ' ASN . 51.2 t-20 . . . . . 0 C--N 1.292 -1.903 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.459 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.2 p -151.02 165.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.073 . . . . 0.0 109.992 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.5 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 1.7 m120 -122.91 72.32 1.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -120.57 169.09 10.68 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.738 0.78 . . . . 0.0 109.85 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -90.67 91.69 8.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.57 140.05 33.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.614 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 45.3 m -140.92 123.99 16.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.697 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -110.43 0.13 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 32.0 m -38.66 -55.57 1.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.408 -1.054 . . . . 0.0 111.527 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.15 -31.49 71.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.915 -1.115 . . . . 0.0 109.808 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 35' ' ' ALA . 20.3 tp -82.36 -61.51 1.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 109.644 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' B' ' 29' ' ' GLY . 32.4 t -40.67 -57.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.005 0.907 . . . . 0.0 108.554 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -53.51 -39.76 64.86 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.23 -35.82 74.32 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 40' ' ' CYS . 48.7 mt -75.01 -56.99 4.19 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.494 -1.379 . . . . 0.0 108.749 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.2 t80 -46.5 -30.7 2.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 tt -75.4 -47.15 28.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.29 -61.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.817 0.817 . . . . 0.0 109.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.8 m -68.05 -47.25 68.88 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.71 -0.619 . . . . 0.0 111.989 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.62 -117.92 11.53 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.681 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.3 tt0 -64.98 -43.04 93.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.325 -1.103 . . . . 0.0 111.317 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -48.2 -17.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.866 -1.146 . . . . 0.0 110.46 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.09 -175.51 42.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.4 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.3 p90 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 120.063 -1.845 . . . . 0.0 111.367 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.549 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.6 tt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.358 0.599 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 80.3 t -59.06 -50.23 80.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.898 -1.126 . . . . 0.0 110.866 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -51.35 -62.65 1.49 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.65 -1.281 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.0 mp0 -60.5 -39.94 89.53 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.925 -1.109 . . . . 0.0 111.914 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.45 -46.21 10.42 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.986 -1.071 . . . . 0.0 112.034 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.77 -52.98 6.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.198 . . . . 0.0 110.942 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -70.88 -28.17 64.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.752 -1.217 . . . . 0.0 108.945 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.3 m -136.14 174.03 11.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.28 127.35 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.639 -1.288 . . . . 0.0 108.944 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -89.44 -173.19 3.89 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.262 1.03 . . . . 0.0 109.942 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.09 151.4 48.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -42.09 -60.48 1.42 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.259 1.028 . . . . 0.0 109.516 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.82 -45.22 19.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.77 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.8 mt-30 -64.49 -32.41 74.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.66 -35.32 65.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.132 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.36 -37.73 88.52 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 122.096 0.95 . . . . 0.0 110.398 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.88 -36.89 18.13 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.858 0.837 . . . . 0.0 110.02 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.0 m-85 -88.54 3.76 49.16 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.8 m -75.55 73.22 2.57 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.8 -1.813 . . . . 0.0 110.007 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 13.9 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.186 -0.911 . . . . 0.0 109.452 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.88 166.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.046 -1.033 . . . . 0.0 109.823 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.497 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 14.6 m120 -123.42 71.49 1.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -120.87 169.9 10.0 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.798 0.809 . . . . 0.0 110.242 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -90.69 92.89 9.02 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 mt -84.73 140.96 30.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -142.24 124.28 15.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.74 -107.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.473 ' HG ' ' H ' ' B' ' 31' ' ' ASP . 12.4 p -38.55 -60.28 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -1.012 . . . . 0.0 111.342 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.473 ' H ' ' HG ' ' B' ' 30' ' ' SER . 3.4 m-20 -64.4 -43.5 94.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 109.617 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.9 tp -66.74 -63.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.841 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.3 t -40.47 -57.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 108.708 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.27 -39.15 66.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.57 -35.45 74.29 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.0 mt -75.63 -56.62 4.52 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.464 -1.398 . . . . 0.0 108.693 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.6 t80 -46.52 -30.38 2.2 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.09 -47.4 28.95 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 t -75.42 -61.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.796 0.807 . . . . 0.0 109.775 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.9 m -67.93 -47.19 69.39 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.745 -0.597 . . . . 0.0 111.808 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.15 -117.65 11.82 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.632 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.03 -43.08 96.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.435 -1.038 . . . . 0.0 111.438 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -49.06 -18.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.0 110.628 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.6 -177.41 43.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.407 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.071 -1.84 . . . . 0.0 111.478 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.543 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.1 tt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.323 0.582 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.6 t -59.82 -50.65 79.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.892 -1.13 . . . . 0.0 110.836 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -51.34 -62.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.583 -1.323 . . . . 0.0 110.988 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.486 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 3.2 mp0 -59.95 -40.96 90.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.928 -1.108 . . . . 0.0 111.883 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.31 -46.06 10.66 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.087 -1.008 . . . . 0.0 112.142 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.8 t -82.26 -52.72 6.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.797 -1.189 . . . . 0.0 110.886 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.38 -30.09 65.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.798 -1.188 . . . . 0.0 108.961 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -133.43 174.19 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.08 129.17 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.662 -1.274 . . . . 0.0 108.795 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.72 -173.15 3.25 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.23 1.014 . . . . 0.0 109.845 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.81 155.02 49.45 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -44.24 -60.54 1.86 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.338 1.066 . . . . 0.0 109.352 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.32 -45.11 17.28 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.957 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.1 mt-30 -64.97 -32.44 74.16 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.66 -34.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.065 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.2 mt-10 -65.05 -37.86 88.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.149 0.976 . . . . 0.0 110.365 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.9 -37.42 19.7 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.907 0.86 . . . . 0.0 110.085 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.2 m-85 -87.66 2.72 50.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.5 m -74.43 73.09 1.88 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 119.806 -1.809 . . . . 0.0 109.961 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 55.1 t-20 . . . . . 0 C--N 1.292 -1.923 0 CA-C-O 118.182 -0.914 . . . . 0.0 109.528 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 5.3 p -122.15 164.63 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.488 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 10.0 m120 -122.54 71.05 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -122.02 169.49 10.78 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.8 0.809 . . . . 0.0 110.166 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.55 91.57 8.74 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.7 mt -81.79 138.76 35.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 110.73 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 44.0 m -139.53 123.74 17.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.409 -0.807 . . . . 0.0 109.54 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -110.63 0.13 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.455 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 19.7 m -38.68 -54.22 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -1.015 . . . . 0.0 111.515 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -69.19 -30.84 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.644 -1.285 . . . . 0.0 109.644 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' B' ' 35' ' ' ALA . 21.0 tp -82.95 -61.37 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.716 -0.615 . . . . 0.0 110.077 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 31.3 t -40.0 -60.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.04 0.924 . . . . 0.0 108.752 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 2.9 mp0 -50.51 -40.74 52.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -57.8 -36.2 71.88 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' B' ' 40' ' ' CYS . 46.5 mt -75.26 -56.73 4.43 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.575 -1.328 . . . . 0.0 108.724 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -46.11 -31.47 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 tt -74.48 -47.93 30.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.0 t -74.57 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.743 0.782 . . . . 0.0 109.97 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.6 m -67.94 -47.13 69.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.752 -0.592 . . . . 0.0 111.977 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.3 -117.72 11.92 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -64.5 -43.01 95.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -1.133 . . . . 0.0 111.386 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -48.81 -18.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.856 -1.153 . . . . 0.0 110.425 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.85 -177.32 41.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 26.3 p90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.174 -1.78 . . . . 0.0 111.211 -179.268 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.553 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.7 tt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.293 0.568 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.9 t -60.02 -49.58 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.818 -1.176 . . . . 0.0 110.875 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.95 -62.49 1.6 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.698 -1.251 . . . . 0.0 111.198 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.484 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.1 mp0 -61.61 -39.31 90.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 111.882 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.59 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.46 -46.32 10.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.038 -1.039 . . . . 0.0 112.121 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.6 t -83.01 -53.1 6.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.701 -1.25 . . . . 0.0 110.921 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -70.27 -28.55 65.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.793 -1.192 . . . . 0.0 108.909 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.9 m -136.13 174.31 10.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.01 131.43 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.583 -1.323 . . . . 0.0 109.106 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -95.4 -173.02 2.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.22 1.009 . . . . 0.0 109.924 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.1 154.9 50.19 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.27 -60.46 1.9 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.321 1.058 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.31 -45.07 17.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.937 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.3 mt-30 -64.66 -32.67 74.44 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.64 -35.0 65.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.223 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.3 mt-10 -64.7 -37.79 88.79 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.167 0.984 . . . . 0.0 110.433 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.26 19.25 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.085 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.1 m-85 -87.73 2.85 50.1 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.429 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -74.49 74.09 1.93 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 119.797 -1.815 . . . . 0.0 109.938 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 21' ' ' ASN . 36.7 t30 . . . . . 0 C--N 1.293 -1.858 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.592 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.88 166.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.01 -1.056 . . . . 0.0 109.909 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.499 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 6.9 m120 -123.27 71.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.27 170.25 9.51 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -90.83 91.96 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.61 140.67 32.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.465 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.1 m -142.58 124.15 14.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.903 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.98 -107.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 29.8 m -38.64 -61.08 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.33 -1.1 . . . . 0.0 111.526 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -42.13 98.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 109.783 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.0 tp -68.77 -63.13 1.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.657 -0.652 . . . . 0.0 109.813 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' B' ' 29' ' ' GLY . 34.5 t -40.59 -57.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 122.027 0.917 . . . . 0.0 108.679 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -54.17 -39.15 66.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.75 -35.99 75.72 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.3 mt -74.77 -57.39 3.95 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.583 -1.323 . . . . 0.0 108.842 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.2 -30.53 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 tt -75.73 -46.91 28.41 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.3 t -75.22 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.75 0.786 . . . . 0.0 109.777 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 29.5 m -68.01 -47.13 69.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.769 -0.582 . . . . 0.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.88 11.71 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.718 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.9 tt0 -64.88 -43.12 93.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -1.075 . . . . 0.0 111.333 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -48.3 -18.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.17 . . . . 0.0 110.358 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.81 43.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.407 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.2 p90 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.186 -1.773 . . . . 0.0 111.047 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.545 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.1 tt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.273 0.559 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 7' ' ' CYS . 94.5 t -59.5 -49.97 81.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.913 -1.117 . . . . 0.0 110.738 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -51.73 -62.54 1.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.609 -1.307 . . . . 0.0 111.022 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.9 mp0 -59.83 -40.63 89.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.936 -1.103 . . . . 0.0 111.878 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.44 -46.21 10.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.045 -1.035 . . . . 0.0 112.125 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.7 t -82.74 -53.05 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.774 -1.204 . . . . 0.0 111.079 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -70.82 -28.43 64.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.772 -1.205 . . . . 0.0 108.948 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.6 m -135.77 174.16 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.05 129.14 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 108.846 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.63 -173.1 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.238 1.018 . . . . 0.0 109.99 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.21 151.65 48.99 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.68 -60.53 1.53 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.298 1.047 . . . . 0.0 109.611 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -46.8 -45.05 19.75 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.828 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.6 mt-30 -64.7 -32.22 73.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.98 -35.51 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.207 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.9 mt-10 -64.07 -37.78 88.68 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.112 0.958 . . . . 0.0 110.369 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.03 -37.65 21.35 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.941 0.877 . . . . 0.0 110.049 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.583 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.6 m-85 -87.37 2.61 49.86 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.72 73.35 2.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.831 -1.793 . . . . 0.0 109.899 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.405 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 45.3 t-20 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.269 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 4.9 p -137.03 165.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.35 -0.844 . . . . 0.0 109.766 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.479 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 13.4 m120 -123.15 71.18 1.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -120.75 170.37 9.52 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.819 0.818 . . . . 0.0 109.992 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.93 92.3 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.19 139.82 32.92 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.32 -0.862 . . . . 0.0 110.667 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 m -141.83 124.25 15.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.254 -0.904 . . . . 0.0 109.927 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.87 -107.75 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 55.8 m -38.49 -59.74 0.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.393 -1.063 . . . . 0.0 111.464 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -43.5 93.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.928 -1.107 . . . . 0.0 109.674 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.6 tp -67.2 -63.41 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.618 -0.676 . . . . 0.0 109.603 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.33 -56.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.934 0.873 . . . . 0.0 108.737 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -54.35 -40.62 68.23 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.15 -36.59 73.23 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.3 mt -74.87 -56.43 4.78 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 120.59 -1.319 . . . . 0.0 108.779 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -46.11 -31.42 2.35 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.17 0.985 . . . . 0.0 108.365 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 9.3 tt -75.3 -48.59 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 t -73.01 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.746 0.784 . . . . 0.0 109.889 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.6 m -68.6 -47.49 66.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.707 -0.621 . . . . 0.0 111.971 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.52 -117.82 11.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.627 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -42.78 92.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -1.061 . . . . 0.0 111.432 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.31 -18.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.815 -1.178 . . . . 0.0 110.329 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.49 -176.59 44.91 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.405 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.084 -1.833 . . . . 0.0 111.372 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.556 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.2 tt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.313 0.577 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 7' ' ' CYS . 88.5 t -59.99 -50.38 80.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.826 -1.171 . . . . 0.0 110.974 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.16 -62.34 1.7 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.576 -1.328 . . . . 0.0 110.927 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.53 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -59.34 -40.92 87.91 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.971 -1.081 . . . . 0.0 111.872 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -45.99 10.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.053 -1.029 . . . . 0.0 112.126 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.467 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.4 t -82.82 -52.86 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.792 -1.192 . . . . 0.0 110.99 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 m -71.18 -28.0 63.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.5 m -136.1 174.04 11.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.39 128.92 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.646 -1.284 . . . . 0.0 109.01 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.18 -173.06 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.167 0.984 . . . . 0.0 109.867 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -136.84 154.44 50.51 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.17 -60.66 1.79 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.322 1.058 . . . . 0.0 109.327 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.26 -45.22 17.05 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.878 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.4 mt-30 -64.76 -32.64 74.42 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.63 -34.7 65.13 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.807 -1.157 . . . . 0.0 108.156 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.0 mt-10 -65.19 -37.77 88.39 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.146 0.974 . . . . 0.0 110.385 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.78 -36.89 17.61 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.916 0.865 . . . . 0.0 110.054 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.5 m-85 -88.14 3.01 50.76 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 21' ' ' ASN . 59.7 m -74.66 75.42 2.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 119.809 -1.807 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.492 ' OXT' ' ND2' ' A' ' 21' ' ' ASN . 2.5 t-20 . . . . . 0 C--N 1.293 -1.88 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.6 p -150.12 165.82 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.994 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.494 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 12.9 m120 -123.46 71.64 1.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -121.2 170.58 9.44 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.813 0.816 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -91.0 91.98 8.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.92 141.32 31.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 110.568 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 43.6 m -142.66 124.31 14.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.026 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.64 -107.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.406 ' C ' ' O ' ' B' ' 29' ' ' GLY . 39.2 m -38.61 -59.56 0.91 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -1.04 . . . . 0.0 111.328 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.73 -44.42 90.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 109.572 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.8 tp -66.24 -63.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.628 -0.67 . . . . 0.0 109.72 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.9 t -40.58 -57.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 122.061 0.934 . . . . 0.0 108.724 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -54.16 -39.35 66.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.49 74.32 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.1 mt -75.37 -57.36 3.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.575 -1.328 . . . . 0.0 108.798 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -46.41 -30.19 2.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.9 -47.09 31.75 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.63 -61.15 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.834 0.826 . . . . 0.0 109.873 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.9 m -68.03 -47.19 69.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.766 -0.584 . . . . 0.0 111.992 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.05 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.545 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.6 tt0 -63.42 -43.08 98.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -1.064 . . . . 0.0 110.997 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.51 -18.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 110.372 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -176.42 42.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.581 -2.207 . . . . 0.0 107.581 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.432 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.202 -1.764 . . . . 0.0 111.082 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.548 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.7 tt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.41 0.624 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 7' ' ' CYS . 74.7 t -61.65 -50.12 81.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.804 -1.185 . . . . 0.0 110.763 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.56 -62.45 1.62 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.642 -1.287 . . . . 0.0 111.073 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.7 mp0 -61.83 -39.92 93.49 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 111.866 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.8 m -86.07 -45.73 11.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.051 -1.031 . . . . 0.0 112.241 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' VAL . 41.5 t -83.23 -52.91 6.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.671 -1.268 . . . . 0.0 110.957 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 m -70.65 -28.01 64.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.795 -1.191 . . . . 0.0 108.935 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.4 m -136.04 174.03 11.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.52 135.78 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.566 -1.334 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -101.09 -172.9 2.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.1 0.953 . . . . 0.0 109.659 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.51 156.35 48.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.7 -60.48 1.99 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 109.327 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.3 -45.21 17.25 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.892 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.9 mt-30 -64.76 -32.57 74.31 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.77 -34.59 64.74 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.117 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 13.3 mt-10 -65.32 -37.71 87.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.131 0.967 . . . . 0.0 110.327 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.9 -36.96 18.39 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.889 0.852 . . . . 0.0 109.94 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.6 m-85 -88.42 4.01 47.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -76.29 73.58 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.773 -1.829 . . . . 0.0 110.05 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.5 t30 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.46 179.361 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.6 p -151.27 165.85 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.957 -1.09 . . . . 0.0 110.084 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 11.0 m120 -123.16 71.27 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -120.44 170.49 9.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.826 0.822 . . . . 0.0 110.139 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -90.87 92.05 8.61 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.68 140.74 31.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.421 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -142.67 124.2 14.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.12 -107.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.8 m -38.44 -59.75 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -1.059 . . . . 0.0 111.368 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.23 -44.4 88.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.988 -1.07 . . . . 0.0 109.609 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' B' ' 35' ' ' ALA . 25.4 tp -66.22 -63.33 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.693 -0.63 . . . . 0.0 109.873 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' GLY . 42.5 t -40.47 -57.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.043 0.925 . . . . 0.0 108.75 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -54.24 -39.09 66.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.71 -35.45 74.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.8 mt -75.46 -57.29 3.98 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.452 -1.405 . . . . 0.0 108.741 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -46.12 -30.61 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.53 -45.93 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.0 t -77.38 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.716 0.77 . . . . 0.0 109.949 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.63 -47.3 66.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.788 -0.57 . . . . 0.0 111.897 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 -117.91 10.65 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.642 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' B' ' 44' ' ' GLY . 41.5 tt0 -66.14 -41.31 90.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.321 -1.105 . . . . 0.0 111.233 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -49.38 -16.27 0.18 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.48 -173.79 43.02 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.193 -2.363 . . . . 0.0 107.193 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 22.0 p90 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 119.996 -1.885 . . . . 0.0 111.434 -179.488 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.548 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.5 tt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.301 0.572 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 7' ' ' CYS . 64.0 t -59.63 -51.52 71.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.861 -1.15 . . . . 0.0 110.736 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -50.92 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.593 -1.317 . . . . 0.0 110.907 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.528 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.7 mp0 -59.68 -41.36 90.51 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.045 -1.034 . . . . 0.0 111.975 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.2 -45.56 11.2 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 0.0 112.047 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.69 -53.18 6.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.837 -1.165 . . . . 0.0 111.053 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 m -71.43 -27.62 63.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.187 . . . . 0.0 108.945 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.5 m -136.14 173.96 11.14 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.21 130.04 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.61 -1.306 . . . . 0.0 108.851 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.31 -173.08 3.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.212 1.006 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.89 151.85 48.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.15 -60.52 1.42 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.286 1.041 . . . . 0.0 109.622 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.71 -45.22 19.38 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.84 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.5 mt-30 -64.4 -32.61 74.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.51 -35.25 65.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.167 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.6 mt-10 -64.68 -37.59 88.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.124 0.964 . . . . 0.0 110.367 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -48.86 -36.85 17.92 Favored 'General case' 0 C--N 1.286 -2.196 0 CA-C-O 121.982 0.896 . . . . 0.0 109.982 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.4 m-85 -88.53 4.33 47.14 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 21' ' ' ASN . 62.0 m -76.55 74.27 3.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.787 -1.821 . . . . 0.0 109.824 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 20' ' ' CYS . 18.7 t30 . . . . . 0 C--N 1.294 -1.826 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.547 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.4 p -147.81 165.58 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.496 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 8.2 m120 -122.69 71.27 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -120.37 169.56 10.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.802 0.811 . . . . 0.0 110.166 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -90.53 92.69 8.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.06 138.82 32.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.677 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' GLY . 56.4 m -140.15 124.04 17.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.363 -0.836 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -108.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' ' 29' ' ' GLY . 10.0 t -39.08 -56.29 1.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.433 -1.039 . . . . 0.0 111.403 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -27.49 65.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.113 . . . . 0.0 110.022 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' B' ' 35' ' ' ALA . 19.8 tp -84.23 -61.57 1.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.78 . . . . 0.0 109.272 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' B' ' 29' ' ' GLY . 43.2 t -40.97 -57.68 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.828 0.823 . . . . 0.0 109.028 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.08 -36.71 63.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -61.24 -36.33 79.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' B' ' 40' ' ' CYS . 52.1 mt -75.06 -56.52 4.66 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.568 -1.333 . . . . 0.0 108.654 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.67 -30.72 2.49 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.76 -47.9 23.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.98 -60.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.707 0.765 . . . . 0.0 109.819 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' B' ' 36' ' ' LEU . 23.7 m -69.38 -47.29 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.699 -0.626 . . . . 0.0 112.096 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.26 -118.15 11.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.564 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 4.7 tp10 -63.83 -43.77 95.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -1.098 . . . . 0.0 111.123 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -49.22 -14.69 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.854 -1.153 . . . . 0.0 110.637 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.21 -173.15 39.91 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.7 p90 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.026 -1.867 . . . . 0.0 111.471 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.546 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.0 tt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.336 0.589 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' CYS . 84.4 t -59.34 -50.43 79.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.893 -1.129 . . . . 0.0 110.909 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -51.1 -62.49 1.58 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.62 -1.3 . . . . 0.0 111.088 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.4 mp0 -60.5 -40.25 90.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 111.945 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.43 -46.03 10.61 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.014 -1.054 . . . . 0.0 112.081 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.9 t -82.7 -53.05 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.855 -1.153 . . . . 0.0 111.057 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.01 -28.51 64.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.793 -1.192 . . . . 0.0 108.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.8 m -135.8 174.18 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.63 131.05 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.611 -1.306 . . . . 0.0 108.763 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -93.69 -173.07 3.06 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.26 1.029 . . . . 0.0 109.927 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -138.11 152.19 48.52 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -42.55 -60.76 1.42 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.267 1.032 . . . . 0.0 109.49 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.52 -45.3 18.43 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.845 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.573 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.7 mt-30 -64.61 -32.47 74.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.72 -34.98 65.05 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.166 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.66 -37.74 88.62 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 122.147 0.975 . . . . 0.0 110.387 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.01 18.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.983 0.897 . . . . 0.0 110.086 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.3 m-85 -88.21 3.42 49.45 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 62.0 m -75.61 74.95 2.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 119.803 -1.811 . . . . 0.0 109.785 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.435 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 12.0 t-20 . . . . . 0 C--N 1.295 -1.785 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.534 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 5.0 p -120.92 164.97 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.384 -0.822 . . . . 0.0 109.995 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.483 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 8.5 m120 -123.56 71.55 1.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -121.61 170.51 9.63 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.853 0.835 . . . . 0.0 110.058 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -89.33 91.72 8.86 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.96 138.23 33.88 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.638 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.8 m -139.62 124.09 18.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.604 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.83 -108.99 0.09 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 29' ' ' GLY . 58.5 m -38.85 -58.14 1.13 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.37 -1.076 . . . . 0.0 111.642 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 -27.02 66.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 110.11 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' B' ' 35' ' ' ALA . 19.7 tp -84.15 -61.44 1.81 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.442 -0.786 . . . . 0.0 109.262 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.5 t -41.28 -57.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 121.773 0.797 . . . . 0.0 109.001 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -54.14 -35.95 62.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -61.98 -36.09 80.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' B' ' 40' ' ' CYS . 50.2 mt -74.75 -57.77 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.886 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.3 t80 -45.58 -31.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -74.91 -47.07 31.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.95 -60.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.725 0.774 . . . . 0.0 109.818 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.2 m -68.69 -47.18 67.11 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.773 -0.579 . . . . 0.0 112.055 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.23 -117.86 11.66 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.465 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' B' ' 44' ' ' GLY . 15.8 tp10 -63.46 -43.92 95.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -1.095 . . . . 0.0 111.221 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -49.72 -15.49 0.18 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.869 -1.144 . . . . 0.0 110.631 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.43 -174.88 37.62 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.9 p90 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.116 -1.814 . . . . 0.0 111.194 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.56 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.2 tt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.283 0.563 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.0 t -60.26 -51.68 70.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.742 -1.224 . . . . 0.0 110.673 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -50.83 -62.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.62 -1.3 . . . . 0.0 110.888 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.522 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -60.09 -41.15 91.86 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.956 -1.09 . . . . 0.0 112.028 -177.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.583 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.21 -45.51 11.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.032 -1.043 . . . . 0.0 111.975 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 38.3 t -82.67 -53.1 6.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.795 -1.191 . . . . 0.0 111.056 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 m -71.47 -27.87 63.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.742 -1.224 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.2 m -135.76 174.12 10.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.61 130.28 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.651 -1.28 . . . . 0.0 109.039 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.22 -172.97 2.95 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.152 0.977 . . . . 0.0 109.855 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -137.5 154.31 49.9 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -43.83 -60.57 1.76 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.4 1.095 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -46.43 -44.96 17.73 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.4 mt-30 -64.99 -32.41 74.12 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.59 -34.86 65.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.909 -1.117 . . . . 0.0 108.128 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.9 mt-10 -65.03 -37.75 88.64 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.122 0.963 . . . . 0.0 110.398 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.09 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.907 0.86 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.0 m-85 -87.77 3.12 49.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 21' ' ' ASN . 60.0 m -75.42 75.79 2.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 119.702 -1.874 . . . . 0.0 109.993 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' CYS . 26.6 t30 . . . . . 0 C--N 1.295 -1.804 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.646 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.4 p -148.23 165.59 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 109.937 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.49 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 13.0 m120 -121.85 71.11 0.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -119.49 169.65 9.86 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.824 0.821 . . . . 0.0 110.196 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.69 92.02 8.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -83.75 139.71 32.55 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.43 -0.794 . . . . 0.0 110.734 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 m -140.28 124.11 17.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.339 -0.851 . . . . 0.0 109.745 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -109.98 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 41.5 t -38.82 -54.84 1.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.378 -1.072 . . . . 0.0 111.464 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.5 OUTLIER -70.49 -27.8 64.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.98 -1.075 . . . . 0.0 109.889 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' B' ' 35' ' ' ALA . 19.6 tp -84.23 -61.5 1.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.457 -0.777 . . . . 0.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.3 t -41.15 -57.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.836 0.827 . . . . 0.0 108.948 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.31 -36.48 63.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -61.37 -36.08 79.24 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 40' ' ' CYS . 50.8 mt -75.02 -57.24 4.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.644 -1.285 . . . . 0.0 108.765 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -46.2 -31.29 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -74.65 -48.22 27.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -73.93 -60.68 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.789 0.804 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.7 m -68.69 -47.22 66.99 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 112.166 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.67 -120.76 17.96 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.572 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.4 tt0 -63.58 -43.18 97.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.337 -1.096 . . . . 0.0 111.121 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.77 -18.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.982 -1.074 . . . . 0.0 110.448 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.04 -176.07 41.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.422 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 120.164 -1.786 . . . . 0.0 111.201 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.551 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.0 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.278 0.561 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -59.36 -49.7 82.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.881 -1.137 . . . . 0.0 110.821 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -52.2 -62.5 1.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.668 -1.27 . . . . 0.0 111.055 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.1 mp0 -60.59 -39.88 89.72 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.936 -1.103 . . . . 0.0 111.836 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.49 -46.22 10.39 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.068 -1.02 . . . . 0.0 112.164 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.1 t -82.84 -52.88 6.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.77 -1.206 . . . . 0.0 110.897 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -70.34 -30.61 67.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.758 -1.214 . . . . 0.0 108.849 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.7 m -133.41 174.22 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.73 129.57 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.627 -1.295 . . . . 0.0 109.077 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.33 -173.07 3.12 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.191 0.996 . . . . 0.0 109.838 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -137.38 155.46 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.26 -60.56 1.86 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.355 1.074 . . . . 0.0 109.363 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.39 -45.05 17.61 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.889 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.0 mt-30 -64.86 -32.52 74.27 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.67 -35.17 65.18 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.156 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 31.3 mt-10 -64.6 -37.81 88.84 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.154 0.978 . . . . 0.0 110.39 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.0 -37.02 19.05 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.913 0.863 . . . . 0.0 110.136 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.6 m-85 -88.2 2.8 51.41 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 61.6 m -75.01 73.56 2.19 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 119.848 -1.783 . . . . 0.0 110.111 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 38.7 t-20 . . . . . 0 C--N 1.293 -1.878 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.28 165.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.993 -1.067 . . . . 0.0 109.985 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.48 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 9.9 m120 -121.66 70.99 0.96 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -119.39 169.19 10.23 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.05 92.29 8.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -83.7 141.2 31.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.387 -0.82 . . . . 0.0 110.6 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.5 m -142.5 124.25 15.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 109.954 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.5 -107.45 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 13.1 t -38.65 -59.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.343 -1.092 . . . . 0.0 111.447 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -42.73 93.25 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.4 tp -68.03 -63.23 1.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.724 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.569 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.8 t -40.52 -56.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 122.018 0.913 . . . . 0.0 108.655 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.39 -40.05 67.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.9 -36.03 74.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.5 mt -74.95 -57.48 3.88 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.518 -1.364 . . . . 0.0 108.736 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -46.09 -30.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.92 -47.33 25.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.71 -60.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.24 -47.3 68.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.727 -0.608 . . . . 0.0 112.091 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.1 -117.91 10.41 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.4 tt0 -65.89 -41.88 90.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 111.354 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -49.45 -15.78 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.868 -1.145 . . . . 0.0 110.327 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.16 -172.77 40.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 21.8 p90 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 120.112 -1.817 . . . . 0.0 110.936 -179.35 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.574 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 9.4 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -68.47 -50.71 54.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.561 -1.337 . . . . 0.0 110.641 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -50.89 -62.58 1.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.58 -1.325 . . . . 0.0 111.097 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 1.9 mp0 -62.69 -40.05 95.9 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.896 -1.127 . . . . 0.0 111.948 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 4.3 m -85.81 -44.96 12.03 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.06 -1.025 . . . . 0.0 112.222 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 3' ' ' VAL . 49.0 t -83.14 -53.07 6.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.536 -1.353 . . . . 0.0 110.906 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -69.9 -31.47 69.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.822 -1.174 . . . . 0.0 108.807 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.9 m -132.09 174.01 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.81 136.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.598 -1.314 . . . . 0.0 108.975 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -102.71 -172.92 2.21 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.127 0.965 . . . . 0.0 109.668 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.45 157.08 47.35 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -44.34 -60.26 2.01 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.296 1.046 . . . . 0.0 109.452 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.27 -45.13 17.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.948 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -64.7 -32.55 74.28 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.87 -35.35 64.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.28 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 21.8 mt-10 -64.34 -37.73 88.55 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.12 0.962 . . . . 0.0 110.464 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.83 -37.17 18.59 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.94 0.876 . . . . 0.0 110.173 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.9 m-85 -87.71 2.73 50.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 21' ' ' ASN . 60.5 m -74.12 74.29 1.75 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 119.806 -1.809 . . . . 0.0 110.045 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 20' ' ' CYS . 32.3 t30 . . . . . 0 C--N 1.293 -1.861 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.74 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 4.0 p -149.16 166.06 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.083 . . . . 0.0 109.801 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.486 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 13.0 m120 -123.47 69.73 1.03 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -118.63 168.24 10.89 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.789 0.804 . . . . 0.0 109.957 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -88.8 91.85 8.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.43 138.91 33.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.432 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.4 m -140.29 124.04 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.18 -109.43 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.5 m -38.92 -58.18 1.14 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -1.094 . . . . 0.0 111.674 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.73 -27.27 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.917 -1.114 . . . . 0.0 110.057 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' B' ' 35' ' ' ALA . 18.9 tp -84.16 -61.47 1.8 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.324 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 33.1 t -41.28 -57.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.771 0.796 . . . . 0.0 108.992 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.07 -36.17 62.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -61.58 -36.32 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' B' ' 40' ' ' CYS . 48.9 mt -74.44 -57.84 3.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.617 -1.302 . . . . 0.0 108.876 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.7 t80 -45.94 -30.02 1.62 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -76.73 -46.03 27.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.0 t -75.88 -60.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.757 0.789 . . . . 0.0 109.677 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.3 m -68.17 -47.06 69.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.704 -0.623 . . . . 0.0 111.942 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -118.4 12.23 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.755 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.7 tt0 -64.75 -43.14 94.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -1.076 . . . . 0.0 111.351 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -48.24 -17.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.912 -1.118 . . . . 0.0 110.415 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -175.51 44.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -178.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.412 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.6 p90 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.203 -1.763 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.551 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.4 tt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.275 0.56 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.7 t -59.17 -50.1 81.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.813 -1.179 . . . . 0.0 110.814 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.65 -62.45 1.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.596 -1.315 . . . . 0.0 111.032 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -60.24 -40.25 89.58 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.954 -1.091 . . . . 0.0 111.949 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.49 -46.16 10.44 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.038 -1.039 . . . . 0.0 112.008 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.93 -52.95 6.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.797 -1.19 . . . . 0.0 111.023 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.87 -28.32 64.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.731 -1.231 . . . . 0.0 108.889 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.9 m -135.97 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.22 128.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.616 -1.302 . . . . 0.0 108.981 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.32 -173.05 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.259 1.028 . . . . 0.0 109.974 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.11 151.61 49.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.35 -60.56 1.45 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.237 1.017 . . . . 0.0 109.572 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.66 -45.13 19.07 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.823 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.5 mt-30 -64.35 -32.59 74.25 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.82 -35.37 64.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.268 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.2 mt-10 -64.43 -37.61 88.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.088 0.947 . . . . 0.0 110.43 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.79 -37.13 18.28 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.929 0.871 . . . . 0.0 110.088 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.9 m-85 -88.29 3.81 48.28 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.433 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 62.2 m -76.04 75.0 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 119.83 -1.794 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 14.1 t-20 . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.576 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.6 p -147.81 165.47 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.018 -1.051 . . . . 0.0 109.847 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.498 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 15.0 m120 -122.93 71.7 1.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -120.94 170.75 9.19 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.804 0.812 . . . . 0.0 110.09 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -90.89 92.63 8.86 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.96 140.25 32.04 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.366 -0.833 . . . . 0.0 110.572 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' B' ' 29' ' ' GLY . 54.4 m -142.38 124.36 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 67.1 m -38.53 -60.56 0.79 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.391 -1.064 . . . . 0.0 111.391 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.91 -45.46 89.21 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.014 -1.054 . . . . 0.0 109.636 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 35' ' ' ALA . 25.3 tp -64.84 -63.71 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.663 . . . . 0.0 109.638 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.9 t -40.85 -57.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -53.97 -39.66 66.17 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.56 -36.65 76.61 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' B' ' 40' ' ' CYS . 52.1 mt -74.29 -57.1 4.17 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.505 -1.372 . . . . 0.0 108.844 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.8 t80 -46.66 -30.57 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -75.96 -47.49 24.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.78 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.747 0.784 . . . . 0.0 109.669 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.7 m -67.94 -47.24 69.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.777 -0.577 . . . . 0.0 112.037 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.76 -117.84 10.56 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.696 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -39.59 90.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -1.059 . . . . 0.0 111.403 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -52.56 -15.68 0.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.78 -173.87 40.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.412 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.8 p90 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 120.083 -1.834 . . . . 0.0 111.273 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.547 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.8 tt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.372 0.606 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.0 t -58.98 -49.46 83.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.831 -1.168 . . . . 0.0 110.838 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -52.57 -62.37 1.69 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.591 -1.318 . . . . 0.0 111.042 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.9 mp0 -59.82 -40.48 88.59 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.879 -1.138 . . . . 0.0 111.82 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.3 -46.13 10.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.084 -1.01 . . . . 0.0 112.111 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.2 t -82.98 -53.04 6.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.719 -1.238 . . . . 0.0 110.953 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.67 -28.07 64.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.763 -1.211 . . . . 0.0 108.883 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.1 m -136.31 174.22 10.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.63 127.65 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.625 -1.297 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -90.31 -173.08 3.68 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.209 1.005 . . . . 0.0 109.959 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.44 152.51 49.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.59 -60.59 1.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 122.369 1.08 . . . . 0.0 109.651 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -46.52 -45.19 18.39 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.874 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.3 mt-30 -64.26 -32.53 74.15 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -74.03 -35.1 64.33 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.256 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 18.5 mt-10 -64.37 -37.74 88.57 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.126 0.965 . . . . 0.0 110.393 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -49.04 -37.36 20.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.972 0.892 . . . . 0.0 110.217 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.5 m-85 -87.7 2.66 50.49 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.3 m -75.71 75.03 2.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 119.886 -1.759 . . . . 0.0 110.069 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 27.1 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.053 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.7 p -148.38 165.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.076 -1.015 . . . . 0.0 109.817 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.496 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 8.5 m120 -123.18 71.22 1.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -119.87 170.06 9.59 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.752 0.787 . . . . 0.0 109.994 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -90.9 94.22 9.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -85.48 140.78 30.41 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.488 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.412 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.0 m -142.53 124.25 15.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.32 -107.17 0.06 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 29' ' ' GLY . 11.1 t -38.58 -59.98 0.86 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -1.109 . . . . 0.0 111.344 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.77 -43.63 92.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.977 -1.077 . . . . 0.0 109.689 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 35' ' ' ALA . 23.9 tp -66.9 -63.26 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 109.642 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.7 t -40.6 -57.16 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.021 0.915 . . . . 0.0 108.709 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -53.86 -39.65 65.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.43 -36.21 75.46 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.1 mt -74.68 -57.33 3.99 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.527 -1.358 . . . . 0.0 108.825 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.41 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.4 t80 -46.04 -31.23 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 tt -74.76 -47.82 28.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.3 t -74.16 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.71 0.767 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 22.2 m -67.98 -47.19 69.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.748 -0.595 . . . . 0.0 112.058 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.7 11.6 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.539 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' B' ' 44' ' ' GLY . 52.2 tp10 -62.58 -44.07 97.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.318 -1.107 . . . . 0.0 111.446 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -50.72 -14.0 0.17 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.918 -1.114 . . . . 0.0 110.667 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 68.53 -173.44 33.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 24.7 p90 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 120.138 -1.801 . . . . 0.0 110.841 -179.284 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.549 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.0 tt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.344 0.593 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 7' ' ' CYS . 85.0 t -59.84 -50.3 80.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.889 -1.132 . . . . 0.0 110.809 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.32 -62.44 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.7 -1.25 . . . . 0.0 111.041 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.0 mp0 -60.76 -40.36 92.18 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 111.889 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.29 -46.03 10.7 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.047 -1.033 . . . . 0.0 112.164 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.8 t -82.83 -52.97 6.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.719 -1.238 . . . . 0.0 111.027 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -70.99 -28.25 64.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.793 -1.192 . . . . 0.0 108.919 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -135.99 174.17 10.9 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mt -87.09 130.86 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.587 -1.321 . . . . 0.0 109.051 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.67 -173.19 2.94 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.223 1.011 . . . . 0.0 109.845 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -136.96 155.43 49.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.7 tp -44.97 -60.69 1.94 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.303 1.049 . . . . 0.0 109.239 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.2 -45.07 16.66 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.847 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.586 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.6 mt-30 -64.86 -32.73 74.57 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.6 -35.19 65.34 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.159 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 29.2 mt-10 -64.59 -37.76 88.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.134 0.969 . . . . 0.0 110.37 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.92 -36.99 18.55 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 121.871 0.843 . . . . 0.0 110.066 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.586 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.4 m-85 -88.29 2.93 51.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 21' ' ' ASN . 61.8 m -74.32 74.41 1.85 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.8 -1.812 . . . . 0.0 109.892 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 20' ' ' CYS . 21.4 t-20 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.668 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.6 p -149.72 165.53 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.054 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.486 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 11.8 m120 -121.31 71.27 0.95 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -120.22 169.84 9.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.832 0.825 . . . . 0.0 110.179 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -91.13 92.75 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.36 140.65 31.44 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 110.514 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -142.05 124.26 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.66 -107.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.8 m -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.381 -1.07 . . . . 0.0 111.358 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -42.9 95.99 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.962 -1.086 . . . . 0.0 109.695 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 35' ' ' ALA . 25.2 tp -68.17 -63.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.81 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.66 -57.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -53.79 -39.29 65.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.68 -36.46 76.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' B' ' 40' ' ' CYS . 50.7 mt -74.49 -56.74 4.5 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.55 -1.344 . . . . 0.0 108.703 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -46.45 -30.71 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.98 -46.52 29.18 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.03 -61.17 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.82 0.819 . . . . 0.0 109.73 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.5 m -68.05 -47.23 68.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.772 -0.58 . . . . 0.0 111.993 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.22 -117.87 11.02 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.665 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.37 -42.46 92.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -1.06 . . . . 0.0 111.309 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.99 -17.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.853 -1.155 . . . . 0.0 110.506 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.7 -175.03 44.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.418 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.3 p90 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.088 -1.831 . . . . 0.0 111.174 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.559 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.8 tt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.33 0.586 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.2 t -61.75 -49.34 84.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.78 -1.2 . . . . 0.0 111.01 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -51.95 -62.54 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.24 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mp0 -62.38 -38.8 90.99 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.845 -1.159 . . . . 0.0 111.872 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 3.8 m -86.33 -46.13 10.58 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.976 -1.078 . . . . 0.0 112.101 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.502 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.0 t -83.31 -53.0 6.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.649 -1.282 . . . . 0.0 110.945 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -69.91 -29.73 66.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.725 -1.234 . . . . 0.0 108.857 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.3 m -134.83 174.19 10.86 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -86.41 134.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.587 -1.321 . . . . 0.0 108.951 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -98.82 -172.96 2.4 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.203 1.001 . . . . 0.0 109.838 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.28 152.46 49.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.16 -60.32 1.49 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.229 1.014 . . . . 0.0 109.617 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.91 -45.24 20.45 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.824 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 25.8 mt-30 -64.19 -32.56 74.18 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -35.72 65.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.267 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 25.8 mt-10 -64.2 -37.64 88.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.128 0.965 . . . . 0.0 110.462 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.78 -37.21 18.46 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.885 0.85 . . . . 0.0 110.063 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.4 m-85 -88.01 2.81 50.9 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 21' ' ' ASN . 60.4 m -75.41 74.51 2.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 119.84 -1.788 . . . . 0.0 110.189 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' CYS . 37.2 t-20 . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.988 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.4 p -150.21 165.91 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 109.841 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.491 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 7.5 m120 -123.49 71.69 1.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -120.42 169.74 10.03 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.752 0.786 . . . . 0.0 110.057 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -90.06 92.02 8.8 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.54 141.26 31.73 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.3 m -143.17 124.33 14.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.956 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 29' ' ' GLY . 26.4 t -38.73 -60.75 0.79 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -1.085 . . . . 0.0 111.46 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.8 OUTLIER -63.82 -43.57 95.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.934 -1.104 . . . . 0.0 109.72 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.4 tp -67.24 -63.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 0.0 109.732 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.1 t -40.62 -57.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.033 0.92 . . . . 0.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -53.65 -39.53 65.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.46 -36.63 76.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.8 mt -74.44 -56.67 4.59 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.553 -1.342 . . . . 0.0 108.722 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -46.33 -30.67 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -76.39 -48.23 20.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.83 -60.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.828 0.823 . . . . 0.0 109.687 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.38 -47.17 68.07 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.802 -0.561 . . . . 0.0 112.152 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -121.72 22.44 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.353 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' B' ' 44' ' ' GLY . 8.3 tp10 -61.26 -44.14 97.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -1.096 . . . . 0.0 110.979 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -16.68 0.07 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.999 -1.063 . . . . 0.0 110.622 -177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.45 -174.62 38.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 25.1 p90 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 120.185 -1.773 . . . . 0.0 110.917 -179.35 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.451 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.947 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.554 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.4 tt -49.63 -30.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.7 t -59.85 -50.3 80.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.799 -1.188 . . . . 0.0 110.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -51.87 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.56 -1.338 . . . . 0.0 110.928 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.73 -41.04 89.99 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 111.884 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.33 -46.0 10.7 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.033 -1.042 . . . . 0.0 112.129 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.5 t -82.97 -53.0 6.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.723 -1.236 . . . . 0.0 111.039 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -70.85 -28.71 64.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.734 -1.229 . . . . 0.0 108.884 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.8 m -135.27 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.74 129.23 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.62 -1.3 . . . . 0.0 109.1 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.68 -173.06 3.23 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.219 1.009 . . . . 0.0 109.868 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.21 154.85 50.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.21 -60.54 1.85 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 122.325 1.059 . . . . 0.0 109.364 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.33 -45.1 17.32 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.87 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.584 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.7 mt-30 -64.86 -32.51 74.25 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.63 -34.87 65.2 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.179 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 20.1 mt-10 -64.96 -37.75 88.69 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.107 0.956 . . . . 0.0 110.324 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.88 -37.15 18.81 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.901 0.857 . . . . 0.0 110.103 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.584 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.2 m-85 -87.92 3.04 50.07 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.428 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 59.9 m -74.84 75.77 2.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.749 -1.844 . . . . 0.0 109.961 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.434 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 3.6 t-20 . . . . . 0 C--N 1.293 -1.87 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -147.98 165.89 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.0 109.837 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.488 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 14.1 m120 -122.9 71.2 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.05 169.87 9.81 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.78 0.8 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.16 92.63 8.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.94 141.04 31.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.405 -0.81 . . . . 0.0 110.551 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.7 m -142.53 124.28 15.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.76 -107.59 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.415 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.5 m -38.59 -60.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.386 -1.067 . . . . 0.0 111.45 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.2 m-20 -64.23 -43.39 95.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.922 -1.111 . . . . 0.0 109.665 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.8 tp -67.51 -63.25 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.68 -57.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.97 0.891 . . . . 0.0 108.644 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -53.83 -38.86 65.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -60.18 -35.87 76.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' B' ' 40' ' ' CYS . 50.4 mt -75.06 -57.08 4.12 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.506 -1.371 . . . . 0.0 108.748 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.22 -31.11 2.28 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.3 tt -74.8 -48.13 26.99 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.7 t -74.19 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.766 0.794 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' B' ' 36' ' ' LEU . 30.1 m -68.25 -47.12 68.6 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.775 -0.578 . . . . 0.0 112.101 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.56 -121.14 19.36 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.496 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 9.7 tp10 -62.35 -44.0 97.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.265 -1.138 . . . . 0.0 111.036 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.02 -17.33 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.064 -1.022 . . . . 0.0 110.594 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.94 -175.4 41.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.404 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.7 p90 -168.34 169.62 10.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.174 -1.78 . . . . 0.0 110.952 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.458 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.97 -83.52 0.0 OUTLIER 'General case' 0 C--N 1.401 2.823 0 O-C-N 119.712 -1.867 . . . . 0.0 108.119 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.07 106.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.486 ' H ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -74.64 168.58 25.72 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -51.28 -72.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.431 1.421 . . . . 0.0 110.432 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.407 ' OXT' ' OG1' ' B' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.446 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.524 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.98 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.55 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.6 tt -65.53 -30.0 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.554 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 7' ' ' CYS . 89.9 t -59.34 -50.43 79.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.874 -1.141 . . . . 0.0 110.849 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -50.96 -62.16 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.669 -1.27 . . . . 0.0 111.14 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.7 mp0 -61.32 -39.89 92.19 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.9 -1.125 . . . . 0.0 111.948 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -46.02 10.6 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.014 -1.053 . . . . 0.0 112.106 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.78 -52.94 6.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.85 -1.156 . . . . 0.0 111.043 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.17 -28.31 64.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.178 . . . . 0.0 108.927 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.5 m -135.86 174.09 11.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.06 129.32 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.601 -1.312 . . . . 0.0 109.01 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.17 -173.16 3.35 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.195 0.997 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.51 151.65 48.65 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -42.16 -60.41 1.46 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 122.255 1.026 . . . . 0.0 109.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.73 -45.41 19.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.779 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.7 mt-30 -64.15 -32.55 74.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.69 -35.64 65.19 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.246 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 24.6 mt-10 -64.03 -37.66 88.24 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.152 0.977 . . . . 0.0 110.467 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.76 -37.13 18.12 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.917 0.865 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.4 m-85 -88.19 3.28 49.93 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 21' ' ' ASN . 62.1 m -75.18 74.06 2.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 119.826 -1.796 . . . . 0.0 110.027 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 20' ' ' CYS . 21.9 t-20 . . . . . 0 C--N 1.294 -1.839 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.752 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.96 165.94 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.026 -1.046 . . . . 0.0 109.84 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.486 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 14.2 m120 -122.68 71.07 1.01 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -120.27 169.91 9.83 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.861 0.839 . . . . 0.0 110.063 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -91.01 92.29 8.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.73 139.71 32.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 110.671 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 51.2 m -140.89 124.17 16.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 109.727 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.82 -111.4 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.407 ' C ' ' O ' ' B' ' 29' ' ' GLY . 38.8 t -38.62 -54.18 1.56 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.405 -1.056 . . . . 0.0 111.473 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.91 -31.7 70.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.886 -1.133 . . . . 0.0 109.666 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 35' ' ' ALA . 20.7 tp -82.1 -61.51 1.88 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.658 -0.651 . . . . 0.0 109.554 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' B' ' 29' ' ' GLY . 29.2 t -40.8 -56.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 108.585 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -53.51 -39.47 64.65 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.47 -36.34 75.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' B' ' 40' ' ' CYS . 48.9 mt -74.67 -56.06 5.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.622 -1.299 . . . . 0.0 108.603 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -46.69 -31.12 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.87 -47.75 24.2 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 t -73.79 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.745 0.783 . . . . 0.0 109.785 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.34 -47.45 67.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.74 -0.6 . . . . 0.0 112.025 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.48 -117.75 11.88 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.796 -1.193 . . . . 0.0 110.71 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.31 -43.18 95.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -1.103 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -48.41 -19.35 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.904 -1.123 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.69 44.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.417 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 27.2 p90 -166.16 170.8 12.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.125 -1.809 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.457 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.82 118.67 0.1 Allowed 'General case' 0 C--N 1.402 2.858 0 O-C-N 119.47 -2.019 . . . . 0.0 108.815 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.523 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.3 t -89.93 -132.12 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.286 -0.884 . . . . 0.0 108.804 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' N ' ' OG1' ' B' ' 48' ' ' THR . 8.2 ptpp? -86.91 151.65 52.45 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.02 -1.05 . . . . 0.0 108.891 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -49.04 -64.05 0.25 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 120.678 0.919 . . . . 0.0 110.496 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.478 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.994 0 N-CA-C 119.647 2.619 . . . . 0.0 119.647 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.546 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.2 tt -55.26 -30.91 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.656 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.7 t -59.32 -50.12 81.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.797 -1.189 . . . . 0.0 110.743 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -51.47 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.644 -1.285 . . . . 0.0 111.047 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -60.71 -40.18 91.33 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 111.929 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.39 -46.18 10.5 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.031 -1.043 . . . . 0.0 112.076 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.72 -52.86 6.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.804 -1.185 . . . . 0.0 111.023 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -71.15 -28.68 64.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.241 . . . . 0.0 108.971 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.3 m -135.45 174.36 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.29 130.22 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.584 -1.322 . . . . 0.0 109.086 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.48 -173.01 3.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.184 0.992 . . . . 0.0 109.92 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.1 152.32 48.65 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.8 tp -42.53 -60.63 1.46 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 122.338 1.066 . . . . 0.0 109.599 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.7 -44.87 19.06 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.794 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.581 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -65.0 -32.38 74.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -34.99 65.23 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.126 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.84 -37.77 88.73 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.117 0.961 . . . . 0.0 110.374 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -36.84 18.11 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.899 0.857 . . . . 0.0 110.079 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.8 m-85 -88.1 3.25 49.76 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -74.82 74.64 2.11 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 119.735 -1.853 . . . . 0.0 110.043 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.416 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 12.4 t-20 . . . . . 0 C--N 1.294 -1.835 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.56 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.3 p -148.81 165.68 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.045 . . . . 0.0 109.922 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.49 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 14.1 m120 -122.55 71.58 1.03 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -120.51 169.94 9.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.814 0.816 . . . . 0.0 110.215 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -91.36 92.49 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.98 140.82 31.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 110.581 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 m -142.15 124.21 15.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 109.915 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -107.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 29' ' ' GLY . 8.7 t -38.58 -59.41 0.93 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -1.049 . . . . 0.0 111.398 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.06 -42.78 93.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 109.629 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.7 tp -68.21 -63.29 1.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.64 . . . . 0.0 109.82 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.56 -57.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.073 0.94 . . . . 0.0 108.614 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -54.05 -39.65 66.43 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.29 -36.13 75.02 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.9 mt -74.8 -57.52 3.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.46 -1.4 . . . . 0.0 108.732 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.5 t80 -46.07 -30.77 2.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -75.24 -47.51 27.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.88 -61.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.778 0.799 . . . . 0.0 109.832 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.1 m -68.3 -47.13 68.44 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.757 -0.589 . . . . 0.0 112.068 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -121.61 22.67 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.473 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' B' ' 44' ' ' GLY . 12.0 tp10 -61.33 -44.05 97.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -1.096 . . . . 0.0 111.111 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.02 -18.28 0.07 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.99 -1.069 . . . . 0.0 110.696 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.25 43.87 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.416 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.8 p90 -168.02 170.03 10.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.19 -1.77 . . . . 0.0 111.265 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.456 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.65 103.93 0.06 Allowed 'General case' 0 C--N 1.4 2.804 0 O-C-N 119.779 -1.826 . . . . 0.0 107.959 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -144.25 112.24 6.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 5.8 mttt -78.22 -42.87 2.13 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.993 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 19.5 Cg_exo -54.34 -57.11 1.98 Allowed 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.964 1.109 . . . . 0.0 110.501 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.32 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 5.024 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.551 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.5 tt -55.17 -30.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -1.147 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' CYS . 75.8 t -59.27 -50.88 78.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.816 -1.177 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -51.02 -62.43 1.62 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.571 -1.33 . . . . 0.0 110.993 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -60.33 -40.56 91.05 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.977 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.22 -45.69 11.07 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.067 -1.021 . . . . 0.0 111.974 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.65 -52.91 6.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.795 -1.191 . . . . 0.0 110.995 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.47 -28.11 63.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.73 -1.231 . . . . 0.0 109.014 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' CYS . 70.9 m -135.72 174.19 10.88 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.43 129.02 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.542 -1.349 . . . . 0.0 108.961 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.79 -173.12 3.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.157 0.979 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.24 155.49 49.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.64 -60.54 1.95 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 122.407 1.098 . . . . 0.0 109.242 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.35 -45.09 17.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.936 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.8 mt-30 -64.94 -32.61 74.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.85 -34.18 64.41 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.11 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.6 mt-10 -65.63 -37.68 87.24 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.196 0.998 . . . . 0.0 110.324 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.93 -37.04 18.78 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.966 0.889 . . . . 0.0 110.101 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.0 m-85 -87.85 2.87 50.36 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 59.7 m -74.91 76.23 2.16 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.801 -1.812 . . . . 0.0 109.915 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.435 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 24.5 t-20 . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.677 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.3 p -150.52 165.96 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.999 -1.063 . . . . 0.0 109.887 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.484 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 13.6 m120 -123.08 71.53 1.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.69 170.15 9.72 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.799 0.809 . . . . 0.0 110.167 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -91.28 92.57 8.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.81 140.57 31.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.11 124.0 16.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 109.798 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.0 -110.03 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -38.73 -55.7 1.44 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.058 . . . . 0.0 111.444 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -34.86 78.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 109.621 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' B' ' 35' ' ' ALA . 20.9 tp -78.23 -61.78 1.89 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.582 . . . . 0.0 109.769 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 29' ' ' GLY . 24.8 t -40.84 -56.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 122.056 0.932 . . . . 0.0 108.567 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.84 -39.74 65.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.36 74.06 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' B' ' 40' ' ' CYS . 47.9 mt -75.25 -56.71 4.45 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.511 -1.368 . . . . 0.0 108.692 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -46.76 -30.64 2.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.57 -45.43 45.44 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.2 t -77.81 -61.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.765 0.793 . . . . 0.0 109.886 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.39 -47.17 68.04 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.721 -0.612 . . . . 0.0 111.867 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.46 -118.83 13.54 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.628 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 44' ' ' GLY . 18.1 tp10 -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -1.08 . . . . 0.0 111.058 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.58 -17.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 110.406 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.21 -176.54 40.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.8 p90 -168.08 169.27 11.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.215 -1.756 . . . . 0.0 110.972 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.459 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -179.95 -87.92 0.0 OUTLIER 'General case' 0 C--N 1.399 2.737 0 O-C-N 120.038 -1.664 . . . . 0.0 107.301 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.464 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 6.7 p 40.54 -134.97 0.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.567 -0.708 . . . . 0.0 110.929 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.464 ' N ' ' OG1' ' B' ' 48' ' ' THR . 7.5 pttp -149.82 91.63 4.29 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.517 -0.739 . . . . 0.0 109.249 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -56.17 -75.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 120.736 0.957 . . . . 0.0 110.616 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.428 179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.514 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.97 0 N-CA-C 119.686 2.634 . . . . 0.0 119.686 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.55 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.4 tt -49.04 -30.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.5 t -60.93 -51.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.799 -1.188 . . . . 0.0 110.705 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.61 -62.17 1.79 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.526 -1.359 . . . . 0.0 110.85 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.83 -41.33 91.08 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.0 111.913 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.7 m -86.41 -45.62 11.0 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.109 -0.994 . . . . 0.0 112.189 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.8 t -82.57 -53.02 6.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.711 -1.243 . . . . 0.0 110.962 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -71.57 -28.05 63.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.806 -1.184 . . . . 0.0 108.985 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.8 m -135.72 174.35 10.71 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mt -86.83 134.13 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.618 -1.301 . . . . 0.0 109.151 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -99.95 -172.96 2.33 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.141 0.972 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -138.23 156.12 47.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.67 -60.42 2.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.345 1.069 . . . . 0.0 109.285 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -46.31 -44.83 17.0 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.2 mt-30 -65.41 -32.44 74.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.61 -34.62 65.14 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.881 -1.127 . . . . 0.0 108.063 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.4 mt-10 -65.15 -37.89 88.86 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.157 0.98 . . . . 0.0 110.329 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.29 19.39 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.977 0.894 . . . . 0.0 110.047 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.5 m-85 -87.79 3.21 49.06 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.17 73.55 2.3 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 119.853 -1.779 . . . . 0.0 109.819 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' OXT' ' A' ' 21' ' ' ASN . 51.2 t-20 . . . . . 0 C--N 1.292 -1.903 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.459 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.2 p -151.02 165.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.073 . . . . 0.0 109.992 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.5 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 1.7 m120 -122.91 72.32 1.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -120.57 169.09 10.68 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.738 0.78 . . . . 0.0 109.85 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -90.67 91.69 8.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.57 140.05 33.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.614 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 45.3 m -140.92 123.99 16.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.697 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -110.43 0.13 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 32.0 m -38.66 -55.57 1.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.408 -1.054 . . . . 0.0 111.527 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.15 -31.49 71.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.915 -1.115 . . . . 0.0 109.808 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 35' ' ' ALA . 20.3 tp -82.36 -61.51 1.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 109.644 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' B' ' 29' ' ' GLY . 32.4 t -40.67 -57.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.005 0.907 . . . . 0.0 108.554 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -53.51 -39.76 64.86 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.23 -35.82 74.32 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 40' ' ' CYS . 48.7 mt -75.01 -56.99 4.19 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.494 -1.379 . . . . 0.0 108.749 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.2 t80 -46.5 -30.7 2.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 tt -75.4 -47.15 28.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.29 -61.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.817 0.817 . . . . 0.0 109.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.8 m -68.05 -47.25 68.88 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.71 -0.619 . . . . 0.0 111.989 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.62 -117.92 11.53 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.681 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.3 tt0 -64.98 -43.04 93.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.325 -1.103 . . . . 0.0 111.317 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -48.2 -17.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.866 -1.146 . . . . 0.0 110.46 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.09 -175.51 42.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.4 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.3 p90 -168.1 169.96 10.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.063 -1.845 . . . . 0.0 111.367 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.454 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.76 82.59 0.02 OUTLIER 'General case' 0 C--N 1.398 2.717 0 O-C-N 119.894 -1.754 . . . . 0.0 107.686 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 80.0 p -86.76 -166.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.698 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -71.94 -58.39 3.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.951 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -44.27 -63.87 0.3 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.834 1.023 . . . . 0.0 110.643 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.495 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.944 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.549 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.6 tt -66.55 -30.09 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.137 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 80.3 t -59.06 -50.23 80.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.898 -1.126 . . . . 0.0 110.866 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -51.35 -62.65 1.49 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.65 -1.281 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.0 mp0 -60.5 -39.94 89.53 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.925 -1.109 . . . . 0.0 111.914 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.45 -46.21 10.42 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.986 -1.071 . . . . 0.0 112.034 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.77 -52.98 6.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.198 . . . . 0.0 110.942 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -70.88 -28.17 64.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.752 -1.217 . . . . 0.0 108.945 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.3 m -136.14 174.03 11.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.28 127.35 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.639 -1.288 . . . . 0.0 108.944 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -89.44 -173.19 3.89 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.262 1.03 . . . . 0.0 109.942 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.09 151.4 48.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -42.09 -60.48 1.42 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.259 1.028 . . . . 0.0 109.516 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.82 -45.22 19.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.77 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.8 mt-30 -64.49 -32.41 74.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.66 -35.32 65.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.132 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.36 -37.73 88.52 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 122.096 0.95 . . . . 0.0 110.398 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.88 -36.89 18.13 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.858 0.837 . . . . 0.0 110.02 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.0 m-85 -88.54 3.76 49.16 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.8 m -75.55 73.22 2.57 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.8 -1.813 . . . . 0.0 110.007 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 13.9 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.186 -0.911 . . . . 0.0 109.452 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.88 166.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.046 -1.033 . . . . 0.0 109.823 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.497 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 14.6 m120 -123.42 71.49 1.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -120.87 169.9 10.0 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.798 0.809 . . . . 0.0 110.242 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -90.69 92.89 9.02 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 mt -84.73 140.96 30.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -142.24 124.28 15.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.74 -107.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.473 ' HG ' ' H ' ' B' ' 31' ' ' ASP . 12.4 p -38.55 -60.28 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -1.012 . . . . 0.0 111.342 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.473 ' H ' ' HG ' ' B' ' 30' ' ' SER . 3.4 m-20 -64.4 -43.5 94.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 109.617 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.9 tp -66.74 -63.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.841 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.3 t -40.47 -57.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 108.708 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.27 -39.15 66.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.57 -35.45 74.29 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.0 mt -75.63 -56.62 4.52 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.464 -1.398 . . . . 0.0 108.693 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.6 t80 -46.52 -30.38 2.2 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.09 -47.4 28.95 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 t -75.42 -61.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.796 0.807 . . . . 0.0 109.775 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.9 m -67.93 -47.19 69.39 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.745 -0.597 . . . . 0.0 111.808 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.15 -117.65 11.82 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.632 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.03 -43.08 96.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.435 -1.038 . . . . 0.0 111.438 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -49.06 -18.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.0 110.628 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.6 -177.41 43.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.407 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 -166.56 171.1 12.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.071 -1.84 . . . . 0.0 111.478 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.451 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.49 94.82 0.05 OUTLIER 'General case' 0 C--N 1.402 2.85 0 O-C-N 119.615 -1.928 . . . . 0.0 108.37 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 39.2 p -153.27 112.29 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttp 47.09 71.14 1.69 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.887 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.64 -56.64 1.84 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.702 1.601 . . . . 0.0 110.481 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.488 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.929 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.543 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.1 tt -54.92 -30.12 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.24 -1.153 . . . . 0.0 109.508 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.6 t -59.82 -50.65 79.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.892 -1.13 . . . . 0.0 110.836 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -51.34 -62.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.583 -1.323 . . . . 0.0 110.988 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.2 mp0 -59.95 -40.96 90.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.928 -1.108 . . . . 0.0 111.883 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.31 -46.06 10.66 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.087 -1.008 . . . . 0.0 112.142 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.8 t -82.26 -52.72 6.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.797 -1.189 . . . . 0.0 110.886 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.38 -30.09 65.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.798 -1.188 . . . . 0.0 108.961 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -133.43 174.19 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.08 129.17 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.662 -1.274 . . . . 0.0 108.795 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.72 -173.15 3.25 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.23 1.014 . . . . 0.0 109.845 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.81 155.02 49.45 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -44.24 -60.54 1.86 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.338 1.066 . . . . 0.0 109.352 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.32 -45.11 17.28 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.957 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.1 mt-30 -64.97 -32.44 74.16 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.66 -34.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.065 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.2 mt-10 -65.05 -37.86 88.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.149 0.976 . . . . 0.0 110.365 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.9 -37.42 19.7 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.907 0.86 . . . . 0.0 110.085 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.2 m-85 -87.66 2.72 50.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.5 m -74.43 73.09 1.88 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 119.806 -1.809 . . . . 0.0 109.961 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 55.1 t-20 . . . . . 0 C--N 1.292 -1.923 0 CA-C-O 118.182 -0.914 . . . . 0.0 109.528 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 5.3 p -122.15 164.63 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.488 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 10.0 m120 -122.54 71.05 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -122.02 169.49 10.78 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.8 0.809 . . . . 0.0 110.166 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.55 91.57 8.74 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.7 mt -81.79 138.76 35.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 110.73 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 44.0 m -139.53 123.74 17.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.409 -0.807 . . . . 0.0 109.54 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -110.63 0.13 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.455 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 19.7 m -38.68 -54.22 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -1.015 . . . . 0.0 111.515 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -69.19 -30.84 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.644 -1.285 . . . . 0.0 109.644 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' B' ' 35' ' ' ALA . 21.0 tp -82.95 -61.37 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.716 -0.615 . . . . 0.0 110.077 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 31.3 t -40.0 -60.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.04 0.924 . . . . 0.0 108.752 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 2.9 mp0 -50.51 -40.74 52.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -57.8 -36.2 71.88 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' B' ' 40' ' ' CYS . 46.5 mt -75.26 -56.73 4.43 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.575 -1.328 . . . . 0.0 108.724 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -46.11 -31.47 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 tt -74.48 -47.93 30.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.0 t -74.57 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.743 0.782 . . . . 0.0 109.97 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.6 m -67.94 -47.13 69.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.752 -0.592 . . . . 0.0 111.977 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.3 -117.72 11.92 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -64.5 -43.01 95.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -1.133 . . . . 0.0 111.386 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -48.81 -18.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.856 -1.153 . . . . 0.0 110.425 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.85 -177.32 41.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -166.79 171.24 11.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.174 -1.78 . . . . 0.0 111.211 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.46 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -179.33 91.2 0.02 OUTLIER 'General case' 0 C--N 1.4 2.787 0 O-C-N 119.777 -1.827 . . . . 0.0 108.082 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.46 -28.2 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 109.67 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -139.79 71.7 36.03 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -56.65 -68.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.636 1.557 . . . . 0.0 110.399 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.492 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.985 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.553 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.7 tt -57.96 -30.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.119 . . . . 0.0 109.673 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.612 ' CG2' ' HH ' ' B' ' 47' ' ' TYR . 95.9 t -60.02 -49.58 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.818 -1.176 . . . . 0.0 110.875 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.95 -62.49 1.6 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.698 -1.251 . . . . 0.0 111.198 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.1 mp0 -61.61 -39.31 90.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 111.882 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.59 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.46 -46.32 10.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.038 -1.039 . . . . 0.0 112.121 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.6 t -83.01 -53.1 6.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.701 -1.25 . . . . 0.0 110.921 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -70.27 -28.55 65.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.793 -1.192 . . . . 0.0 108.909 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.9 m -136.13 174.31 10.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.01 131.43 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.583 -1.323 . . . . 0.0 109.106 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -95.4 -173.02 2.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.22 1.009 . . . . 0.0 109.924 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.1 154.9 50.19 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.27 -60.46 1.9 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.321 1.058 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.31 -45.07 17.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.937 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.3 mt-30 -64.66 -32.67 74.44 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.64 -35.0 65.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.223 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.3 mt-10 -64.7 -37.79 88.79 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.167 0.984 . . . . 0.0 110.433 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.26 19.25 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.085 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.1 m-85 -87.73 2.85 50.1 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.429 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -74.49 74.09 1.93 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 119.797 -1.815 . . . . 0.0 109.938 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.7 t30 . . . . . 0 C--N 1.293 -1.858 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.592 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.88 166.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.01 -1.056 . . . . 0.0 109.909 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.499 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 6.9 m120 -123.27 71.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.27 170.25 9.51 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -90.83 91.96 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.61 140.67 32.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.465 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.1 m -142.58 124.15 14.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.903 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.98 -107.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 29.8 m -38.64 -61.08 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.33 -1.1 . . . . 0.0 111.526 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -42.13 98.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 109.783 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.0 tp -68.77 -63.13 1.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.657 -0.652 . . . . 0.0 109.813 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' B' ' 29' ' ' GLY . 34.5 t -40.59 -57.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 122.027 0.917 . . . . 0.0 108.679 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -54.17 -39.15 66.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.75 -35.99 75.72 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.3 mt -74.77 -57.39 3.95 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.583 -1.323 . . . . 0.0 108.842 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.2 -30.53 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 tt -75.73 -46.91 28.41 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.3 t -75.22 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.75 0.786 . . . . 0.0 109.777 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 29.5 m -68.01 -47.13 69.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.769 -0.582 . . . . 0.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.88 11.71 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.718 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.9 tt0 -64.88 -43.12 93.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -1.075 . . . . 0.0 111.333 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -48.3 -18.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.17 . . . . 0.0 110.358 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.81 43.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.407 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.2 p90 -166.91 170.53 12.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.186 -1.773 . . . . 0.0 111.047 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.462 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.612 ' HH ' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -179.54 101.63 0.03 OUTLIER 'General case' 0 C--N 1.401 2.825 0 O-C-N 119.732 -1.855 . . . . 0.0 108.22 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' B' ' 47' ' ' TYR . 3.3 m -166.37 -60.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 0.0 109.681 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -146.2 71.98 13.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.267 -0.896 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.424 ' O ' ' OG1' ' B' ' 51' ' ' THR . 16.4 Cg_exo -56.23 -66.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.703 1.602 . . . . 0.0 110.559 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 35.1 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.651 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.995 0 N-CA-C 119.595 2.598 . . . . 0.0 119.595 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.545 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.1 tt -68.97 -29.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -1.164 . . . . 0.0 109.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 7' ' ' CYS . 94.5 t -59.5 -49.97 81.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.913 -1.117 . . . . 0.0 110.738 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -51.73 -62.54 1.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.609 -1.307 . . . . 0.0 111.022 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -59.83 -40.63 89.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.936 -1.103 . . . . 0.0 111.878 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.44 -46.21 10.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.045 -1.035 . . . . 0.0 112.125 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.7 t -82.74 -53.05 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.774 -1.204 . . . . 0.0 111.079 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -70.82 -28.43 64.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.772 -1.205 . . . . 0.0 108.948 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.6 m -135.77 174.16 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.05 129.14 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 108.846 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.63 -173.1 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.238 1.018 . . . . 0.0 109.99 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.21 151.65 48.99 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.68 -60.53 1.53 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.298 1.047 . . . . 0.0 109.611 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -46.8 -45.05 19.75 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.828 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.6 mt-30 -64.7 -32.22 73.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.98 -35.51 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.207 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.9 mt-10 -64.07 -37.78 88.68 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.112 0.958 . . . . 0.0 110.369 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.03 -37.65 21.35 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.941 0.877 . . . . 0.0 110.049 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.583 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.6 m-85 -87.37 2.61 49.86 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.72 73.35 2.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.831 -1.793 . . . . 0.0 109.899 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.405 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 45.3 t-20 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.269 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 4.9 p -137.03 165.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.35 -0.844 . . . . 0.0 109.766 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.479 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 13.4 m120 -123.15 71.18 1.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -120.75 170.37 9.52 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.819 0.818 . . . . 0.0 109.992 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.93 92.3 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.19 139.82 32.92 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.32 -0.862 . . . . 0.0 110.667 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 m -141.83 124.25 15.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.254 -0.904 . . . . 0.0 109.927 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.87 -107.75 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 55.8 m -38.49 -59.74 0.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.393 -1.063 . . . . 0.0 111.464 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -43.5 93.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.928 -1.107 . . . . 0.0 109.674 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.6 tp -67.2 -63.41 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.618 -0.676 . . . . 0.0 109.603 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.33 -56.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.934 0.873 . . . . 0.0 108.737 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -54.35 -40.62 68.23 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.15 -36.59 73.23 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.3 mt -74.87 -56.43 4.78 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 120.59 -1.319 . . . . 0.0 108.779 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -46.11 -31.42 2.35 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.17 0.985 . . . . 0.0 108.365 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 9.3 tt -75.3 -48.59 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 t -73.01 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.746 0.784 . . . . 0.0 109.889 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.6 m -68.6 -47.49 66.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.707 -0.621 . . . . 0.0 111.971 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.52 -117.82 11.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.627 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -42.78 92.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -1.061 . . . . 0.0 111.432 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.31 -18.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.815 -1.178 . . . . 0.0 110.329 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.49 -176.59 44.91 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.405 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 -166.94 171.05 11.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.084 -1.833 . . . . 0.0 111.372 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.45 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.5 135.97 0.25 Allowed 'General case' 0 C--N 1.4 2.791 0 O-C-N 119.762 -1.836 . . . . 0.0 108.058 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 121.4 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.975 . . . . 0.0 109.642 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.644 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 44.6 mtpt -89.66 -32.92 0.38 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 111.78 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 17.4 Cg_exo -56.06 -72.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.718 0.946 . . . . 0.0 110.514 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.53 -179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.438 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.971 0 N-CA-C 119.791 2.676 . . . . 0.0 119.791 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.556 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.2 tt -48.56 -29.96 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -1.16 . . . . 0.0 109.608 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 7' ' ' CYS . 88.5 t -59.99 -50.38 80.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.826 -1.171 . . . . 0.0 110.974 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.16 -62.34 1.7 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.576 -1.328 . . . . 0.0 110.927 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.53 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -59.34 -40.92 87.91 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.971 -1.081 . . . . 0.0 111.872 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -45.99 10.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.053 -1.029 . . . . 0.0 112.126 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.467 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.4 t -82.82 -52.86 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.792 -1.192 . . . . 0.0 110.99 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 m -71.18 -28.0 63.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.5 m -136.1 174.04 11.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.39 128.92 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.646 -1.284 . . . . 0.0 109.01 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.18 -173.06 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.167 0.984 . . . . 0.0 109.867 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -136.84 154.44 50.51 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.17 -60.66 1.79 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.322 1.058 . . . . 0.0 109.327 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.26 -45.22 17.05 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.878 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.4 mt-30 -64.76 -32.64 74.42 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.63 -34.7 65.13 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.807 -1.157 . . . . 0.0 108.156 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.0 mt-10 -65.19 -37.77 88.39 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.146 0.974 . . . . 0.0 110.385 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.78 -36.89 17.61 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.916 0.865 . . . . 0.0 110.054 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.5 m-85 -88.14 3.01 50.76 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 21' ' ' ASN . 59.7 m -74.66 75.42 2.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 119.809 -1.807 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.492 ' OXT' ' ND2' ' A' ' 21' ' ' ASN . 2.5 t-20 . . . . . 0 C--N 1.293 -1.88 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.6 p -150.12 165.82 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.994 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.494 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 12.9 m120 -123.46 71.64 1.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -121.2 170.58 9.44 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.813 0.816 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -91.0 91.98 8.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.92 141.32 31.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 110.568 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 43.6 m -142.66 124.31 14.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.026 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.64 -107.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.406 ' C ' ' O ' ' B' ' 29' ' ' GLY . 39.2 m -38.61 -59.56 0.91 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -1.04 . . . . 0.0 111.328 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.73 -44.42 90.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 109.572 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.8 tp -66.24 -63.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.628 -0.67 . . . . 0.0 109.72 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.9 t -40.58 -57.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 122.061 0.934 . . . . 0.0 108.724 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -54.16 -39.35 66.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.49 74.32 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.1 mt -75.37 -57.36 3.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.575 -1.328 . . . . 0.0 108.798 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -46.41 -30.19 2.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.9 -47.09 31.75 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.63 -61.15 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.834 0.826 . . . . 0.0 109.873 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.9 m -68.03 -47.19 69.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.766 -0.584 . . . . 0.0 111.992 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.05 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.545 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.6 tt0 -63.42 -43.08 98.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -1.064 . . . . 0.0 110.997 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.51 -18.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 110.372 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -176.42 42.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.581 -2.207 . . . . 0.0 107.581 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.432 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 -167.59 170.72 10.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.202 -1.764 . . . . 0.0 111.082 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.458 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.86 104.19 0.06 Allowed 'General case' 0 C--N 1.403 2.908 0 O-C-N 119.568 -1.957 . . . . 0.0 108.656 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 47.3 p -96.57 11.14 36.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.884 . . . . 0.0 109.253 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 45.88 72.27 1.29 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 109.742 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.18 -70.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.589 1.526 . . . . 0.0 110.32 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.511 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.917 0 N-CA-C 119.754 2.661 . . . . 0.0 119.754 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.548 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.7 tt -65.08 -29.11 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.294 -1.121 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 7' ' ' CYS . 74.7 t -61.65 -50.12 81.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.804 -1.185 . . . . 0.0 110.763 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.56 -62.45 1.62 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.642 -1.287 . . . . 0.0 111.073 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.7 mp0 -61.83 -39.92 93.49 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 111.866 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.8 m -86.07 -45.73 11.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.051 -1.031 . . . . 0.0 112.241 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' VAL . 41.5 t -83.23 -52.91 6.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.671 -1.268 . . . . 0.0 110.957 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 m -70.65 -28.01 64.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.795 -1.191 . . . . 0.0 108.935 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.4 m -136.04 174.03 11.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.52 135.78 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.566 -1.334 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -101.09 -172.9 2.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.1 0.953 . . . . 0.0 109.659 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.51 156.35 48.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.7 -60.48 1.99 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 109.327 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.3 -45.21 17.25 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.892 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.9 mt-30 -64.76 -32.57 74.31 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.77 -34.59 64.74 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.117 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 13.3 mt-10 -65.32 -37.71 87.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.131 0.967 . . . . 0.0 110.327 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.9 -36.96 18.39 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.889 0.852 . . . . 0.0 109.94 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.6 m-85 -88.42 4.01 47.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -76.29 73.58 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.773 -1.829 . . . . 0.0 110.05 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.5 t30 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.46 179.361 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.6 p -151.27 165.85 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.957 -1.09 . . . . 0.0 110.084 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 11.0 m120 -123.16 71.27 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -120.44 170.49 9.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.826 0.822 . . . . 0.0 110.139 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -90.87 92.05 8.61 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.68 140.74 31.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.421 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -142.67 124.2 14.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.12 -107.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.8 m -38.44 -59.75 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -1.059 . . . . 0.0 111.368 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.23 -44.4 88.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.988 -1.07 . . . . 0.0 109.609 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' B' ' 35' ' ' ALA . 25.4 tp -66.22 -63.33 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.693 -0.63 . . . . 0.0 109.873 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' GLY . 42.5 t -40.47 -57.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.043 0.925 . . . . 0.0 108.75 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -54.24 -39.09 66.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.71 -35.45 74.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.8 mt -75.46 -57.29 3.98 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.452 -1.405 . . . . 0.0 108.741 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -46.12 -30.61 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.53 -45.93 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.0 t -77.38 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.716 0.77 . . . . 0.0 109.949 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.63 -47.3 66.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.788 -0.57 . . . . 0.0 111.897 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 -117.91 10.65 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.642 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' B' ' 44' ' ' GLY . 41.5 tt0 -66.14 -41.31 90.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.321 -1.105 . . . . 0.0 111.233 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -49.38 -16.27 0.18 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.48 -173.79 43.02 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.193 -2.363 . . . . 0.0 107.193 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -169.04 169.59 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 119.996 -1.885 . . . . 0.0 111.434 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.457 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.552 ' O ' ' CB ' ' B' ' 48' ' ' THR . 0.2 OUTLIER -169.92 -64.39 0.02 OUTLIER 'General case' 0 C--N 1.405 2.991 0 O-C-N 119.376 -2.077 . . . . 0.0 109.239 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.552 ' CB ' ' O ' ' B' ' 47' ' ' TYR . 2.7 m 97.0 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 2.5 mtmt -70.38 -43.16 16.87 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.475 -0.765 . . . . 0.0 110.898 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 21.7 Cg_exo -53.53 -63.03 0.25 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.942 1.094 . . . . 0.0 110.537 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.54 179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.954 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.548 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.5 tt -49.04 -31.03 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.518 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 7' ' ' CYS . 64.0 t -59.63 -51.52 71.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.861 -1.15 . . . . 0.0 110.736 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -50.92 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.593 -1.317 . . . . 0.0 110.907 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.528 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.7 mp0 -59.68 -41.36 90.51 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.045 -1.034 . . . . 0.0 111.975 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.2 -45.56 11.2 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 0.0 112.047 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.69 -53.18 6.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.837 -1.165 . . . . 0.0 111.053 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 m -71.43 -27.62 63.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.187 . . . . 0.0 108.945 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.5 m -136.14 173.96 11.14 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.21 130.04 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.61 -1.306 . . . . 0.0 108.851 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.31 -173.08 3.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.212 1.006 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.89 151.85 48.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.15 -60.52 1.42 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.286 1.041 . . . . 0.0 109.622 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.71 -45.22 19.38 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.84 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.5 mt-30 -64.4 -32.61 74.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.51 -35.25 65.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.167 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.6 mt-10 -64.68 -37.59 88.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.124 0.964 . . . . 0.0 110.367 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -48.86 -36.85 17.92 Favored 'General case' 0 C--N 1.286 -2.196 0 CA-C-O 121.982 0.896 . . . . 0.0 109.982 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.4 m-85 -88.53 4.33 47.14 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 21' ' ' ASN . 62.0 m -76.55 74.27 3.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.787 -1.821 . . . . 0.0 109.824 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 20' ' ' CYS . 18.7 t30 . . . . . 0 C--N 1.294 -1.826 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.547 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.4 p -147.81 165.58 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.496 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 8.2 m120 -122.69 71.27 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -120.37 169.56 10.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.802 0.811 . . . . 0.0 110.166 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -90.53 92.69 8.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.06 138.82 32.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.677 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' GLY . 56.4 m -140.15 124.04 17.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.363 -0.836 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -108.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' ' 29' ' ' GLY . 10.0 t -39.08 -56.29 1.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.433 -1.039 . . . . 0.0 111.403 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -27.49 65.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.113 . . . . 0.0 110.022 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' B' ' 35' ' ' ALA . 19.8 tp -84.23 -61.57 1.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.78 . . . . 0.0 109.272 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' B' ' 29' ' ' GLY . 43.2 t -40.97 -57.68 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.828 0.823 . . . . 0.0 109.028 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.08 -36.71 63.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -61.24 -36.33 79.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' B' ' 40' ' ' CYS . 52.1 mt -75.06 -56.52 4.66 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.568 -1.333 . . . . 0.0 108.654 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.67 -30.72 2.49 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.76 -47.9 23.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.98 -60.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.707 0.765 . . . . 0.0 109.819 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' B' ' 36' ' ' LEU . 23.7 m -69.38 -47.29 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.699 -0.626 . . . . 0.0 112.096 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.26 -118.15 11.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.564 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 4.7 tp10 -63.83 -43.77 95.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -1.098 . . . . 0.0 111.123 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -49.22 -14.69 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.854 -1.153 . . . . 0.0 110.637 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.21 -173.15 39.91 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.7 p90 -169.31 169.79 8.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.026 -1.867 . . . . 0.0 111.471 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.454 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.58 97.78 0.24 Allowed 'General case' 0 C--N 1.403 2.928 0 O-C-N 119.637 -1.914 . . . . 0.0 108.404 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -64.25 107.93 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.475 -0.766 . . . . 0.0 109.643 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -65.23 116.64 32.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -53.19 -55.09 3.99 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 CA-C-N 119.102 0.715 . . . . 0.0 110.359 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.49 179.961 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.515 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.974 0 N-CA-C 119.767 2.667 . . . . 0.0 119.767 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.546 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.0 tt -62.35 -29.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -1.128 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' CYS . 84.4 t -59.34 -50.43 79.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.893 -1.129 . . . . 0.0 110.909 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -51.1 -62.49 1.58 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.62 -1.3 . . . . 0.0 111.088 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.4 mp0 -60.5 -40.25 90.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 111.945 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.43 -46.03 10.61 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.014 -1.054 . . . . 0.0 112.081 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.9 t -82.7 -53.05 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.855 -1.153 . . . . 0.0 111.057 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.01 -28.51 64.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.793 -1.192 . . . . 0.0 108.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.8 m -135.8 174.18 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.63 131.05 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.611 -1.306 . . . . 0.0 108.763 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -93.69 -173.07 3.06 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.26 1.029 . . . . 0.0 109.927 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -138.11 152.19 48.52 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -42.55 -60.76 1.42 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.267 1.032 . . . . 0.0 109.49 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.52 -45.3 18.43 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.845 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.573 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.7 mt-30 -64.61 -32.47 74.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.72 -34.98 65.05 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.166 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.66 -37.74 88.62 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 122.147 0.975 . . . . 0.0 110.387 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.01 18.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.983 0.897 . . . . 0.0 110.086 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.3 m-85 -88.21 3.42 49.45 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 62.0 m -75.61 74.95 2.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 119.803 -1.811 . . . . 0.0 109.785 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.435 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 12.0 t-20 . . . . . 0 C--N 1.295 -1.785 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.534 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 5.0 p -120.92 164.97 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.384 -0.822 . . . . 0.0 109.995 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.483 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 8.5 m120 -123.56 71.55 1.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -121.61 170.51 9.63 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.853 0.835 . . . . 0.0 110.058 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -89.33 91.72 8.86 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.96 138.23 33.88 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.638 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.8 m -139.62 124.09 18.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.604 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.83 -108.99 0.09 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 29' ' ' GLY . 58.5 m -38.85 -58.14 1.13 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.37 -1.076 . . . . 0.0 111.642 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 -27.02 66.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 110.11 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' B' ' 35' ' ' ALA . 19.7 tp -84.15 -61.44 1.81 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.442 -0.786 . . . . 0.0 109.262 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.5 t -41.28 -57.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 121.773 0.797 . . . . 0.0 109.001 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -54.14 -35.95 62.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -61.98 -36.09 80.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' B' ' 40' ' ' CYS . 50.2 mt -74.75 -57.77 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.886 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.3 t80 -45.58 -31.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -74.91 -47.07 31.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.95 -60.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.725 0.774 . . . . 0.0 109.818 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.2 m -68.69 -47.18 67.11 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.773 -0.579 . . . . 0.0 112.055 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.23 -117.86 11.66 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.465 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' B' ' 44' ' ' GLY . 15.8 tp10 -63.46 -43.92 95.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -1.095 . . . . 0.0 111.221 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -49.72 -15.49 0.18 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.869 -1.144 . . . . 0.0 110.631 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.43 -174.88 37.62 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.9 p90 -167.95 170.69 10.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.116 -1.814 . . . . 0.0 111.194 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.462 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -175.86 84.11 0.03 OUTLIER 'General case' 0 C--N 1.402 2.86 0 O-C-N 119.68 -1.887 . . . . 0.0 108.11 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.454 ' O ' ' O ' ' B' ' 49' ' ' LYS . 26.3 p -147.55 -144.92 0.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.985 . . . . 0.0 109.229 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' B' ' 48' ' ' THR . 10.1 mtmt 58.27 158.0 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -51.75 -59.21 1.2 Allowed 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 120.624 0.883 . . . . 0.0 110.393 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.477 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.951 0 N-CA-C 119.757 2.663 . . . . 0.0 119.757 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.56 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.2 tt -48.76 -30.28 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.515 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.0 t -60.26 -51.68 70.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.742 -1.224 . . . . 0.0 110.673 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -50.83 -62.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.62 -1.3 . . . . 0.0 110.888 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.522 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -60.09 -41.15 91.86 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.956 -1.09 . . . . 0.0 112.028 -177.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.583 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.21 -45.51 11.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.032 -1.043 . . . . 0.0 111.975 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 38.3 t -82.67 -53.1 6.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.795 -1.191 . . . . 0.0 111.056 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 m -71.47 -27.87 63.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.742 -1.224 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.2 m -135.76 174.12 10.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.61 130.28 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.651 -1.28 . . . . 0.0 109.039 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.22 -172.97 2.95 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.152 0.977 . . . . 0.0 109.855 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -137.5 154.31 49.9 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -43.83 -60.57 1.76 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.4 1.095 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -46.43 -44.96 17.73 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.4 mt-30 -64.99 -32.41 74.12 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.59 -34.86 65.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.909 -1.117 . . . . 0.0 108.128 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.9 mt-10 -65.03 -37.75 88.64 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.122 0.963 . . . . 0.0 110.398 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.09 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.907 0.86 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.0 m-85 -87.77 3.12 49.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 21' ' ' ASN . 60.0 m -75.42 75.79 2.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 119.702 -1.874 . . . . 0.0 109.993 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' CYS . 26.6 t30 . . . . . 0 C--N 1.295 -1.804 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.646 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.4 p -148.23 165.59 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 109.937 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.49 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 13.0 m120 -121.85 71.11 0.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -119.49 169.65 9.86 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.824 0.821 . . . . 0.0 110.196 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.69 92.02 8.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -83.75 139.71 32.55 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.43 -0.794 . . . . 0.0 110.734 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 m -140.28 124.11 17.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.339 -0.851 . . . . 0.0 109.745 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -109.98 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 41.5 t -38.82 -54.84 1.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.378 -1.072 . . . . 0.0 111.464 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.5 OUTLIER -70.49 -27.8 64.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.98 -1.075 . . . . 0.0 109.889 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' B' ' 35' ' ' ALA . 19.6 tp -84.23 -61.5 1.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.457 -0.777 . . . . 0.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.3 t -41.15 -57.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.836 0.827 . . . . 0.0 108.948 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.31 -36.48 63.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -61.37 -36.08 79.24 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 40' ' ' CYS . 50.8 mt -75.02 -57.24 4.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.644 -1.285 . . . . 0.0 108.765 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -46.2 -31.29 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -74.65 -48.22 27.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -73.93 -60.68 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.789 0.804 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.7 m -68.69 -47.22 66.99 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 112.166 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.67 -120.76 17.96 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.572 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.4 tt0 -63.58 -43.18 97.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.337 -1.096 . . . . 0.0 111.121 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.77 -18.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.982 -1.074 . . . . 0.0 110.448 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.04 -176.07 41.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.422 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 -167.6 170.11 11.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.164 -1.786 . . . . 0.0 111.201 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.459 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -175.91 92.12 0.05 Allowed 'General case' 0 C--N 1.401 2.843 0 O-C-N 119.581 -1.949 . . . . 0.0 108.639 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.7 OUTLIER -80.95 -117.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 108.843 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.525 ' N ' ' OG1' ' B' ' 48' ' ' THR . 0.3 OUTLIER -93.3 169.49 10.2 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -50.31 -67.22 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.289 1.326 . . . . 0.0 110.497 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.421 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.999 0 N-CA-C 119.719 2.647 . . . . 0.0 119.719 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.551 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.0 tt -59.52 -30.95 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -1.142 . . . . 0.0 109.564 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -59.36 -49.7 82.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.881 -1.137 . . . . 0.0 110.821 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -52.2 -62.5 1.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.668 -1.27 . . . . 0.0 111.055 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.1 mp0 -60.59 -39.88 89.72 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.936 -1.103 . . . . 0.0 111.836 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.49 -46.22 10.39 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.068 -1.02 . . . . 0.0 112.164 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.1 t -82.84 -52.88 6.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.77 -1.206 . . . . 0.0 110.897 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -70.34 -30.61 67.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.758 -1.214 . . . . 0.0 108.849 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.7 m -133.41 174.22 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.73 129.57 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.627 -1.295 . . . . 0.0 109.077 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.33 -173.07 3.12 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.191 0.996 . . . . 0.0 109.838 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -137.38 155.46 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.26 -60.56 1.86 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.355 1.074 . . . . 0.0 109.363 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.39 -45.05 17.61 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.889 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.0 mt-30 -64.86 -32.52 74.27 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.67 -35.17 65.18 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.156 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 31.3 mt-10 -64.6 -37.81 88.84 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.154 0.978 . . . . 0.0 110.39 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.0 -37.02 19.05 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.913 0.863 . . . . 0.0 110.136 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.6 m-85 -88.2 2.8 51.41 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 61.6 m -75.01 73.56 2.19 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 119.848 -1.783 . . . . 0.0 110.111 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 38.7 t-20 . . . . . 0 C--N 1.293 -1.878 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.28 165.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.993 -1.067 . . . . 0.0 109.985 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.48 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 9.9 m120 -121.66 70.99 0.96 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -119.39 169.19 10.23 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.05 92.29 8.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -83.7 141.2 31.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.387 -0.82 . . . . 0.0 110.6 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.5 m -142.5 124.25 15.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 109.954 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.5 -107.45 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 13.1 t -38.65 -59.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.343 -1.092 . . . . 0.0 111.447 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -42.73 93.25 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.4 tp -68.03 -63.23 1.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.724 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.569 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.8 t -40.52 -56.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 122.018 0.913 . . . . 0.0 108.655 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.39 -40.05 67.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.9 -36.03 74.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.5 mt -74.95 -57.48 3.88 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.518 -1.364 . . . . 0.0 108.736 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -46.09 -30.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.92 -47.33 25.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.71 -60.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.24 -47.3 68.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.727 -0.608 . . . . 0.0 112.091 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.1 -117.91 10.41 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.4 tt0 -65.89 -41.88 90.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 111.354 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -49.45 -15.78 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.868 -1.145 . . . . 0.0 110.327 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.16 -172.77 40.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -169.76 170.14 8.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.112 -1.817 . . . . 0.0 110.936 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.45 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.39 -84.88 0.0 OUTLIER 'General case' 0 C--N 1.401 2.821 0 O-C-N 119.815 -1.803 . . . . 0.0 107.797 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m 43.67 -140.37 0.22 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.246 -0.909 . . . . 0.0 110.048 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 50.1 mttm 46.82 72.42 1.26 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 109.874 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -57.2 -54.13 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.736 1.624 . . . . 0.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.327 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.938 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.574 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 9.4 tt -53.06 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.604 ' CG2' ' HH ' ' B' ' 47' ' ' TYR . 93.6 t -68.47 -50.71 54.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.561 -1.337 . . . . 0.0 110.641 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -50.89 -62.58 1.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.58 -1.325 . . . . 0.0 111.097 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 1.9 mp0 -62.69 -40.05 95.9 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.896 -1.127 . . . . 0.0 111.948 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 4.3 m -85.81 -44.96 12.03 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.06 -1.025 . . . . 0.0 112.222 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 3' ' ' VAL . 49.0 t -83.14 -53.07 6.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.536 -1.353 . . . . 0.0 110.906 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -69.9 -31.47 69.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.822 -1.174 . . . . 0.0 108.807 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.9 m -132.09 174.01 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.81 136.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.598 -1.314 . . . . 0.0 108.975 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -102.71 -172.92 2.21 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.127 0.965 . . . . 0.0 109.668 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.45 157.08 47.35 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -44.34 -60.26 2.01 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.296 1.046 . . . . 0.0 109.452 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.27 -45.13 17.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.948 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -64.7 -32.55 74.28 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.87 -35.35 64.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.28 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 21.8 mt-10 -64.34 -37.73 88.55 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.12 0.962 . . . . 0.0 110.464 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.83 -37.17 18.59 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.94 0.876 . . . . 0.0 110.173 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.9 m-85 -87.71 2.73 50.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 21' ' ' ASN . 60.5 m -74.12 74.29 1.75 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 119.806 -1.809 . . . . 0.0 110.045 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 20' ' ' CYS . 32.3 t30 . . . . . 0 C--N 1.293 -1.861 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.74 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 4.0 p -149.16 166.06 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.083 . . . . 0.0 109.801 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.486 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 13.0 m120 -123.47 69.73 1.03 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -118.63 168.24 10.89 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.789 0.804 . . . . 0.0 109.957 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -88.8 91.85 8.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.43 138.91 33.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.432 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.4 m -140.29 124.04 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.18 -109.43 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.5 m -38.92 -58.18 1.14 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -1.094 . . . . 0.0 111.674 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.73 -27.27 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.917 -1.114 . . . . 0.0 110.057 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' B' ' 35' ' ' ALA . 18.9 tp -84.16 -61.47 1.8 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.324 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 33.1 t -41.28 -57.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.771 0.796 . . . . 0.0 108.992 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.07 -36.17 62.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -61.58 -36.32 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' B' ' 40' ' ' CYS . 48.9 mt -74.44 -57.84 3.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.617 -1.302 . . . . 0.0 108.876 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.7 t80 -45.94 -30.02 1.62 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -76.73 -46.03 27.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.0 t -75.88 -60.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.757 0.789 . . . . 0.0 109.677 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.3 m -68.17 -47.06 69.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.704 -0.623 . . . . 0.0 111.942 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -118.4 12.23 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.755 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.7 tt0 -64.75 -43.14 94.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -1.076 . . . . 0.0 111.351 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -48.24 -17.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.912 -1.118 . . . . 0.0 110.415 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -175.51 44.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -178.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.412 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.6 p90 -168.13 170.93 9.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.203 -1.763 . . . . 0.0 110.905 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.462 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.604 ' HH ' ' CG2' ' A' ' 3' ' ' VAL . 0.2 OUTLIER 179.48 134.06 0.1 Allowed 'General case' 0 C--N 1.401 2.808 0 O-C-N 119.811 -1.806 . . . . 0.0 108.236 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.509 ' HG1' ' H ' ' B' ' 49' ' ' LYS . 8.9 t -82.17 171.28 14.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.22 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.509 ' H ' ' HG1' ' B' ' 48' ' ' THR . 11.0 mttp -50.65 151.97 3.75 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.139 -0.976 . . . . 0.0 108.709 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -50.38 -71.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 120.514 0.809 . . . . 0.0 110.478 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.124 -179.751 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.98 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.551 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.4 tt -54.21 -30.95 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -1.148 . . . . 0.0 109.618 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.7 t -59.17 -50.1 81.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.813 -1.179 . . . . 0.0 110.814 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.65 -62.45 1.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.596 -1.315 . . . . 0.0 111.032 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -60.24 -40.25 89.58 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.954 -1.091 . . . . 0.0 111.949 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.49 -46.16 10.44 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.038 -1.039 . . . . 0.0 112.008 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.93 -52.95 6.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.797 -1.19 . . . . 0.0 111.023 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.87 -28.32 64.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.731 -1.231 . . . . 0.0 108.889 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.9 m -135.97 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.22 128.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.616 -1.302 . . . . 0.0 108.981 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.32 -173.05 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.259 1.028 . . . . 0.0 109.974 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.11 151.61 49.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.35 -60.56 1.45 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.237 1.017 . . . . 0.0 109.572 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.66 -45.13 19.07 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.823 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.5 mt-30 -64.35 -32.59 74.25 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.82 -35.37 64.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.268 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.2 mt-10 -64.43 -37.61 88.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.088 0.947 . . . . 0.0 110.43 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.79 -37.13 18.28 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.929 0.871 . . . . 0.0 110.088 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.9 m-85 -88.29 3.81 48.28 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.433 ' O ' ' OXT' ' A' ' 21' ' ' ASN . 62.2 m -76.04 75.0 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 119.83 -1.794 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 14.1 t-20 . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.576 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.6 p -147.81 165.47 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.018 -1.051 . . . . 0.0 109.847 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.498 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 15.0 m120 -122.93 71.7 1.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -120.94 170.75 9.19 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.804 0.812 . . . . 0.0 110.09 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -90.89 92.63 8.86 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.96 140.25 32.04 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.366 -0.833 . . . . 0.0 110.572 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' B' ' 29' ' ' GLY . 54.4 m -142.38 124.36 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 67.1 m -38.53 -60.56 0.79 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.391 -1.064 . . . . 0.0 111.391 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.91 -45.46 89.21 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.014 -1.054 . . . . 0.0 109.636 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 35' ' ' ALA . 25.3 tp -64.84 -63.71 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.663 . . . . 0.0 109.638 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.9 t -40.85 -57.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -53.97 -39.66 66.17 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.56 -36.65 76.61 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' B' ' 40' ' ' CYS . 52.1 mt -74.29 -57.1 4.17 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.505 -1.372 . . . . 0.0 108.844 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.8 t80 -46.66 -30.57 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -75.96 -47.49 24.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.78 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.747 0.784 . . . . 0.0 109.669 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.7 m -67.94 -47.24 69.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.777 -0.577 . . . . 0.0 112.037 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.76 -117.84 10.56 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.696 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -39.59 90.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -1.059 . . . . 0.0 111.403 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -52.56 -15.68 0.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.78 -173.87 40.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.412 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.8 p90 -168.31 170.57 9.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.083 -1.834 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.468 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' B' ' 48' ' ' THR . 0.2 OUTLIER -172.69 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.403 2.924 0 O-C-N 119.461 -2.024 . . . . 0.0 108.984 178.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 47' ' ' TYR . 60.8 p -41.02 143.63 0.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 110.246 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 53.09 71.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.857 . . . . 0.0 109.35 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -57.7 -71.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.819 1.679 . . . . 0.0 110.52 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.495 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.515 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.948 0 N-CA-C 119.916 2.727 . . . . 0.0 119.916 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.547 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.8 tt -68.32 -30.8 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.0 t -58.98 -49.46 83.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.831 -1.168 . . . . 0.0 110.838 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -52.57 -62.37 1.69 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.591 -1.318 . . . . 0.0 111.042 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -59.82 -40.48 88.59 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.879 -1.138 . . . . 0.0 111.82 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.3 -46.13 10.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.084 -1.01 . . . . 0.0 112.111 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.2 t -82.98 -53.04 6.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.719 -1.238 . . . . 0.0 110.953 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.67 -28.07 64.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.763 -1.211 . . . . 0.0 108.883 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.1 m -136.31 174.22 10.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.63 127.65 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.625 -1.297 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -90.31 -173.08 3.68 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.209 1.005 . . . . 0.0 109.959 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.44 152.51 49.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.59 -60.59 1.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 122.369 1.08 . . . . 0.0 109.651 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -46.52 -45.19 18.39 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.874 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.3 mt-30 -64.26 -32.53 74.15 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -74.03 -35.1 64.33 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.256 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 18.5 mt-10 -64.37 -37.74 88.57 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.126 0.965 . . . . 0.0 110.393 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -49.04 -37.36 20.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.972 0.892 . . . . 0.0 110.217 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.5 m-85 -87.7 2.66 50.49 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.3 m -75.71 75.03 2.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 119.886 -1.759 . . . . 0.0 110.069 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 27.1 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.053 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.7 p -148.38 165.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.076 -1.015 . . . . 0.0 109.817 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.496 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 8.5 m120 -123.18 71.22 1.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -119.87 170.06 9.59 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.752 0.787 . . . . 0.0 109.994 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -90.9 94.22 9.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -85.48 140.78 30.41 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.488 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.412 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.0 m -142.53 124.25 15.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.32 -107.17 0.06 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 29' ' ' GLY . 11.1 t -38.58 -59.98 0.86 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -1.109 . . . . 0.0 111.344 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.77 -43.63 92.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.977 -1.077 . . . . 0.0 109.689 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 35' ' ' ALA . 23.9 tp -66.9 -63.26 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 109.642 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.7 t -40.6 -57.16 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.021 0.915 . . . . 0.0 108.709 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -53.86 -39.65 65.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.43 -36.21 75.46 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.1 mt -74.68 -57.33 3.99 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.527 -1.358 . . . . 0.0 108.825 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.41 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.4 t80 -46.04 -31.23 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 tt -74.76 -47.82 28.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.3 t -74.16 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.71 0.767 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 22.2 m -67.98 -47.19 69.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.748 -0.595 . . . . 0.0 112.058 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.7 11.6 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.539 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' B' ' 44' ' ' GLY . 52.2 tp10 -62.58 -44.07 97.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.318 -1.107 . . . . 0.0 111.446 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -50.72 -14.0 0.17 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.918 -1.114 . . . . 0.0 110.667 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 68.53 -173.44 33.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -169.38 169.48 8.99 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.138 -1.801 . . . . 0.0 110.841 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.467 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' B' ' 48' ' ' THR . 0.1 OUTLIER -178.6 140.74 0.2 Allowed 'General case' 0 C--N 1.401 2.807 0 O-C-N 119.689 -1.882 . . . . 0.0 108.534 178.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.43 ' O ' ' O ' ' B' ' 47' ' ' TYR . 16.9 m 52.98 101.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -0.818 . . . . 0.0 109.861 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' H ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -82.25 160.5 62.45 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -49.75 -72.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.407 1.405 . . . . 0.0 110.695 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.457 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.999 0 N-CA-C 119.817 2.687 . . . . 0.0 119.817 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.549 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.0 tt -65.54 -29.81 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.502 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 7' ' ' CYS . 85.0 t -59.84 -50.3 80.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.889 -1.132 . . . . 0.0 110.809 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.32 -62.44 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.7 -1.25 . . . . 0.0 111.041 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.0 mp0 -60.76 -40.36 92.18 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 111.889 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.29 -46.03 10.7 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.047 -1.033 . . . . 0.0 112.164 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.8 t -82.83 -52.97 6.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.719 -1.238 . . . . 0.0 111.027 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -70.99 -28.25 64.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.793 -1.192 . . . . 0.0 108.919 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -135.99 174.17 10.9 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mt -87.09 130.86 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.587 -1.321 . . . . 0.0 109.051 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.67 -173.19 2.94 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.223 1.011 . . . . 0.0 109.845 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -136.96 155.43 49.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.7 tp -44.97 -60.69 1.94 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.303 1.049 . . . . 0.0 109.239 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.2 -45.07 16.66 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.847 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.586 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.6 mt-30 -64.86 -32.73 74.57 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.6 -35.19 65.34 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.159 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 29.2 mt-10 -64.59 -37.76 88.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.134 0.969 . . . . 0.0 110.37 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.92 -36.99 18.55 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 121.871 0.843 . . . . 0.0 110.066 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.586 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 29.4 m-85 -88.29 2.93 51.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 21' ' ' ASN . 61.8 m -74.32 74.41 1.85 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.8 -1.812 . . . . 0.0 109.892 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 20' ' ' CYS . 21.4 t-20 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.668 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.6 p -149.72 165.53 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.054 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.486 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 11.8 m120 -121.31 71.27 0.95 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -120.22 169.84 9.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.832 0.825 . . . . 0.0 110.179 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -91.13 92.75 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.36 140.65 31.44 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 110.514 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -142.05 124.26 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.66 -107.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.8 m -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.381 -1.07 . . . . 0.0 111.358 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -42.9 95.99 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.962 -1.086 . . . . 0.0 109.695 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 35' ' ' ALA . 25.2 tp -68.17 -63.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.81 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.66 -57.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -53.79 -39.29 65.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.68 -36.46 76.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' B' ' 40' ' ' CYS . 50.7 mt -74.49 -56.74 4.5 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.55 -1.344 . . . . 0.0 108.703 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -46.45 -30.71 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.98 -46.52 29.18 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.03 -61.17 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.82 0.819 . . . . 0.0 109.73 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.5 m -68.05 -47.23 68.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.772 -0.58 . . . . 0.0 111.993 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.22 -117.87 11.02 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.665 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.37 -42.46 92.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -1.06 . . . . 0.0 111.309 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.99 -17.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.853 -1.155 . . . . 0.0 110.506 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.7 -175.03 44.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.418 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.3 p90 -167.98 170.66 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.088 -1.831 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.449 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 87.79 0.03 OUTLIER 'General case' 0 C--N 1.4 2.779 0 O-C-N 119.826 -1.796 . . . . 0.0 107.654 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -86.78 -19.31 29.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.17 -0.956 . . . . 0.0 110.204 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.45 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 7.6 mtmp? 53.42 75.8 0.59 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.08 -1.013 . . . . 0.0 109.436 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -55.6 -72.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.494 1.463 . . . . 0.0 110.555 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.565 179.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.95 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.559 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 8.8 tt -62.32 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -1.118 . . . . 0.0 109.716 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.2 t -61.75 -49.34 84.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.78 -1.2 . . . . 0.0 111.01 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -51.95 -62.54 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.24 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.6 mp0 -62.38 -38.8 90.99 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.845 -1.159 . . . . 0.0 111.872 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 3.8 m -86.33 -46.13 10.58 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.976 -1.078 . . . . 0.0 112.101 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.502 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.0 t -83.31 -53.0 6.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.649 -1.282 . . . . 0.0 110.945 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -69.91 -29.73 66.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.725 -1.234 . . . . 0.0 108.857 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.3 m -134.83 174.19 10.86 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -86.41 134.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.587 -1.321 . . . . 0.0 108.951 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -98.82 -172.96 2.4 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.203 1.001 . . . . 0.0 109.838 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -137.28 152.46 49.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.16 -60.32 1.49 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.229 1.014 . . . . 0.0 109.617 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.91 -45.24 20.45 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.824 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 25.8 mt-30 -64.19 -32.56 74.18 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -35.72 65.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.267 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 25.8 mt-10 -64.2 -37.64 88.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.128 0.965 . . . . 0.0 110.462 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.78 -37.21 18.46 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.885 0.85 . . . . 0.0 110.063 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 15' ' ' GLN . 30.4 m-85 -88.01 2.81 50.9 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 21' ' ' ASN . 60.4 m -75.41 74.51 2.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 119.84 -1.788 . . . . 0.0 110.189 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' CYS . 37.2 t-20 . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.988 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' B' ' 24' ' ' ASN . 3.4 p -150.21 165.91 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 109.841 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.491 ' N ' ' CG2' ' B' ' 23' ' ' VAL . 7.5 m120 -123.49 71.69 1.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -120.42 169.74 10.03 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.752 0.786 . . . . 0.0 110.057 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -90.06 92.02 8.8 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.54 141.26 31.73 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.3 m -143.17 124.33 14.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.956 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 29' ' ' GLY . 26.4 t -38.73 -60.75 0.79 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -1.085 . . . . 0.0 111.46 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.8 OUTLIER -63.82 -43.57 95.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.934 -1.104 . . . . 0.0 109.72 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 35' ' ' ALA . 24.4 tp -67.24 -63.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 0.0 109.732 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.1 t -40.62 -57.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.033 0.92 . . . . 0.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -53.65 -39.53 65.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.46 -36.63 76.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' B' ' 40' ' ' CYS . 49.8 mt -74.44 -56.67 4.59 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.553 -1.342 . . . . 0.0 108.722 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -46.33 -30.67 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -76.39 -48.23 20.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.83 -60.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.828 0.823 . . . . 0.0 109.687 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.38 -47.17 68.07 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.802 -0.561 . . . . 0.0 112.152 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -121.72 22.44 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.353 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' B' ' 44' ' ' GLY . 8.3 tp10 -61.26 -44.14 97.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -1.096 . . . . 0.0 110.979 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -16.68 0.07 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.999 -1.063 . . . . 0.0 110.622 -177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.45 -174.62 38.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -169.24 169.92 8.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.185 -1.773 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' 23F . . . . . 0.458 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.11 114.31 0.08 Allowed 'General case' 0 C--N 1.402 2.861 0 O-C-N 119.573 -1.954 . . . . 0.0 108.535 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.3 t -89.02 -173.07 3.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.269 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -149.45 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.309 -0.87 . . . . 0.0 109.677 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' B' ' 49' ' ' LYS . 24.7 Cg_exo -41.59 -54.42 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.995 1.13 . . . . 0.0 110.769 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.768 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.313 0.578 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.7 t -59.85 -50.3 80.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.799 -1.188 . . . . 0.0 110.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -51.87 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.56 -1.338 . . . . 0.0 110.928 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.73 -41.04 89.99 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 111.884 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.33 -46.0 10.7 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.033 -1.042 . . . . 0.0 112.129 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.5 t -82.97 -53.0 6.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.723 -1.236 . . . . 0.0 111.039 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -70.85 -28.71 64.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.734 -1.229 . . . . 0.0 108.884 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.8 m -135.27 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.74 129.23 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.62 -1.3 . . . . 0.0 109.1 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.68 -173.06 3.23 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.219 1.009 . . . . 0.0 109.868 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.21 154.85 50.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.21 -60.54 1.85 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 122.325 1.059 . . . . 0.0 109.364 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.33 -45.1 17.32 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.87 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.584 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.8 mt-30 -64.86 -32.51 74.25 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.63 -34.87 65.2 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.179 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 20.1 mt-10 -64.96 -37.75 88.69 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.107 0.956 . . . . 0.0 110.324 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.88 -37.15 18.81 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.901 0.857 . . . . 0.0 110.103 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.2 m-85 -87.92 3.04 50.07 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.9 m -74.84 75.77 2.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.749 -1.844 . . . . 0.0 109.961 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 23.9 t30 . . . . . 0 C--N 1.293 -1.87 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.57 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -147.98 165.89 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.0 109.837 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.57 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.1 m120 -122.9 71.2 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -120.05 169.87 9.81 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.78 0.8 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.16 92.63 8.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.94 141.04 31.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.405 -0.81 . . . . 0.0 110.551 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.7 m -142.53 124.28 15.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.76 -107.59 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.415 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.5 m -38.59 -60.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.386 -1.067 . . . . 0.0 111.45 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.2 m-20 -64.23 -43.39 95.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.922 -1.111 . . . . 0.0 109.665 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.82 HD11 HD11 ' A' ' 2' ' ' ILE . 24.8 tp -67.51 -63.25 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.68 -57.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.97 0.891 . . . . 0.0 108.644 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -53.83 -38.86 65.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -60.18 -35.87 76.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.82 HD11 HD13 ' A' ' 2' ' ' ILE . 50.4 mt -75.06 -57.08 4.12 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.506 -1.371 . . . . 0.0 108.748 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.22 -31.11 2.28 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.3 tt -74.8 -48.13 26.99 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.7 t -74.19 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.766 0.794 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' B' ' 36' ' ' LEU . 30.1 m -68.25 -47.12 68.6 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.775 -0.578 . . . . 0.0 112.101 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.56 -121.14 19.36 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.496 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 9.7 tp10 -62.35 -44.0 97.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.265 -1.138 . . . . 0.0 111.036 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.447 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -47.02 -17.33 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.064 -1.022 . . . . 0.0 110.594 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.94 -175.4 41.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.7 p90 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.174 -1.78 . . . . 0.0 110.952 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 32' ' ' LEU . 7.6 tt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.337 0.589 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 7' ' ' CYS . 89.9 t -59.34 -50.43 79.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.874 -1.141 . . . . 0.0 110.849 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -50.96 -62.16 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.669 -1.27 . . . . 0.0 111.14 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.7 mp0 -61.32 -39.89 92.19 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.9 -1.125 . . . . 0.0 111.948 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -46.02 10.6 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.014 -1.053 . . . . 0.0 112.106 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.78 -52.94 6.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.85 -1.156 . . . . 0.0 111.043 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.17 -28.31 64.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.178 . . . . 0.0 108.927 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.5 m -135.86 174.09 11.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.06 129.32 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.601 -1.312 . . . . 0.0 109.01 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.17 -173.16 3.35 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.195 0.997 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.51 151.65 48.65 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -42.16 -60.41 1.46 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 122.255 1.026 . . . . 0.0 109.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.73 -45.41 19.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.779 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.6 mt-30 -64.15 -32.55 74.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.69 -35.64 65.19 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.246 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 24.6 mt-10 -64.03 -37.66 88.24 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.152 0.977 . . . . 0.0 110.467 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.76 -37.13 18.12 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.917 0.865 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.19 3.28 49.93 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.1 m -75.18 74.06 2.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 119.826 -1.796 . . . . 0.0 110.027 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.441 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 21.9 t-20 . . . . . 0 C--N 1.294 -1.839 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.752 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.575 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.96 165.94 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.026 -1.046 . . . . 0.0 109.84 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.575 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.2 m120 -122.68 71.07 1.01 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -120.27 169.91 9.83 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.861 0.839 . . . . 0.0 110.063 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -91.01 92.29 8.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.73 139.71 32.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 110.671 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 51.2 m -140.89 124.17 16.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 109.727 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.82 -111.4 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.407 ' C ' ' O ' ' B' ' 29' ' ' GLY . 38.8 t -38.62 -54.18 1.56 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.405 -1.056 . . . . 0.0 111.473 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.91 -31.7 70.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.886 -1.133 . . . . 0.0 109.666 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 2' ' ' ILE . 20.7 tp -82.1 -61.51 1.88 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.658 -0.651 . . . . 0.0 109.554 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' B' ' 29' ' ' GLY . 29.2 t -40.8 -56.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 108.585 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -53.51 -39.47 64.65 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.47 -36.34 75.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.799 HD11 HD13 ' A' ' 2' ' ' ILE . 48.9 mt -74.67 -56.06 5.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.622 -1.299 . . . . 0.0 108.603 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -46.69 -31.12 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.568 ' C ' HD23 ' B' ' 38' ' ' LEU . 8.1 tt -75.87 -47.75 24.2 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 t -73.79 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.745 0.783 . . . . 0.0 109.785 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.34 -47.45 67.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.74 -0.6 . . . . 0.0 112.025 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.48 -117.75 11.88 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.796 -1.193 . . . . 0.0 110.71 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.31 -43.18 95.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -1.103 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -48.41 -19.35 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.904 -1.123 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.69 44.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.441 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 27.2 p90 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.125 -1.809 . . . . 0.0 111.288 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.797 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.332 0.587 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.7 t -59.32 -50.12 81.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.797 -1.189 . . . . 0.0 110.743 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -51.47 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.644 -1.285 . . . . 0.0 111.047 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.516 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.9 mp0 -60.71 -40.18 91.33 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 111.929 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.39 -46.18 10.5 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.031 -1.043 . . . . 0.0 112.076 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.72 -52.86 6.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.804 -1.185 . . . . 0.0 111.023 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -71.15 -28.68 64.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.241 . . . . 0.0 108.971 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.3 m -135.45 174.36 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.29 130.22 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.584 -1.322 . . . . 0.0 109.086 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.48 -173.01 3.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.184 0.992 . . . . 0.0 109.92 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -138.1 152.32 48.65 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.8 tp -42.53 -60.63 1.46 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 122.338 1.066 . . . . 0.0 109.599 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.7 -44.87 19.06 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.794 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.581 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -65.0 -32.38 74.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -34.99 65.23 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.126 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.84 -37.77 88.73 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.117 0.961 . . . . 0.0 110.374 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -48.9 -36.84 18.11 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.899 0.857 . . . . 0.0 110.079 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.8 m-85 -88.1 3.25 49.76 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -74.82 74.64 2.11 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 119.735 -1.853 . . . . 0.0 110.043 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.438 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 12.4 t-20 . . . . . 0 C--N 1.294 -1.835 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.56 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.3 p -148.81 165.68 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.045 . . . . 0.0 109.922 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.563 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.1 m120 -122.55 71.58 1.03 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -120.51 169.94 9.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.814 0.816 . . . . 0.0 110.215 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -91.36 92.49 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.98 140.82 31.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 110.581 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 m -142.15 124.21 15.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 109.915 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -107.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 29' ' ' GLY . 8.7 t -38.58 -59.41 0.93 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -1.049 . . . . 0.0 111.398 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.06 -42.78 93.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 109.629 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 2' ' ' ILE . 24.7 tp -68.21 -63.29 1.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.64 . . . . 0.0 109.82 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.56 -57.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.073 0.94 . . . . 0.0 108.614 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -54.05 -39.65 66.43 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.29 -36.13 75.02 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.788 HD11 HD13 ' A' ' 2' ' ' ILE . 49.9 mt -74.8 -57.52 3.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.46 -1.4 . . . . 0.0 108.732 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.5 t80 -46.07 -30.77 2.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.4 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.4 tt -75.24 -47.51 27.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.88 -61.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.778 0.799 . . . . 0.0 109.832 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.1 m -68.3 -47.13 68.44 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.757 -0.589 . . . . 0.0 112.068 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -121.61 22.67 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.473 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' B' ' 44' ' ' GLY . 12.0 tp10 -61.33 -44.05 97.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -1.096 . . . . 0.0 111.111 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -47.02 -18.28 0.07 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.99 -1.069 . . . . 0.0 110.696 -178.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.25 43.87 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.438 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.8 p90 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.19 -1.77 . . . . 0.0 111.265 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.829 HD11 HD11 ' B' ' 32' ' ' LEU . 7.5 tt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' CYS . 75.8 t -59.27 -50.88 78.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.816 -1.177 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -51.02 -62.43 1.62 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.571 -1.33 . . . . 0.0 110.993 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.529 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.9 mp0 -60.33 -40.56 91.05 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.977 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.22 -45.69 11.07 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.067 -1.021 . . . . 0.0 111.974 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.65 -52.91 6.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.795 -1.191 . . . . 0.0 110.995 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.47 -28.11 63.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.73 -1.231 . . . . 0.0 109.014 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' CYS . 70.9 m -135.72 174.19 10.88 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.43 129.02 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.542 -1.349 . . . . 0.0 108.961 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.79 -173.12 3.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.157 0.979 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.451 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -137.24 155.49 49.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.354 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.64 -60.54 1.95 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 122.407 1.098 . . . . 0.0 109.242 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.35 -45.09 17.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.936 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 64.4 mt-30 -64.94 -32.61 74.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.85 -34.18 64.41 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.11 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.6 mt-10 -65.63 -37.68 87.24 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.196 0.998 . . . . 0.0 110.324 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.93 -37.04 18.78 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.966 0.889 . . . . 0.0 110.101 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.0 m-85 -87.85 2.87 50.36 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 m -74.91 76.23 2.16 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.801 -1.812 . . . . 0.0 109.915 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.436 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 24.5 t-20 . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.677 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.586 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.3 p -150.52 165.96 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.999 -1.063 . . . . 0.0 109.887 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.586 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.6 m120 -123.08 71.53 1.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -120.69 170.15 9.72 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.799 0.809 . . . . 0.0 110.167 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -91.28 92.57 8.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.81 140.57 31.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.11 124.0 16.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 109.798 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.0 -110.03 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -38.73 -55.7 1.44 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.058 . . . . 0.0 111.444 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -34.86 78.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 109.621 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 2' ' ' ILE . 20.9 tp -78.23 -61.78 1.89 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.582 . . . . 0.0 109.769 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 24.8 t -40.84 -56.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 122.056 0.932 . . . . 0.0 108.567 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.84 -39.74 65.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.36 74.06 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.794 HD11 HD13 ' A' ' 2' ' ' ILE . 47.9 mt -75.25 -56.71 4.45 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.511 -1.368 . . . . 0.0 108.692 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -46.76 -30.64 2.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.57 -45.43 45.44 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.2 t -77.81 -61.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.765 0.793 . . . . 0.0 109.886 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.39 -47.17 68.04 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.721 -0.612 . . . . 0.0 111.867 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.46 -118.83 13.54 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.628 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 44' ' ' GLY . 18.1 tp10 -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -1.08 . . . . 0.0 111.058 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -47.58 -17.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 110.406 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.21 -176.54 40.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.436 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.8 p90 . . . . . 0 C--N 1.302 -1.495 0 O-C-N 120.215 -1.756 . . . . 0.0 110.972 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.829 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.346 0.593 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.5 t -60.93 -51.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.799 -1.188 . . . . 0.0 110.705 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.61 -62.17 1.79 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.526 -1.359 . . . . 0.0 110.85 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.582 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.83 -41.33 91.08 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.0 111.913 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.7 m -86.41 -45.62 11.0 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.109 -0.994 . . . . 0.0 112.189 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.8 t -82.57 -53.02 6.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.711 -1.243 . . . . 0.0 110.962 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -71.57 -28.05 63.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.806 -1.184 . . . . 0.0 108.985 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.8 m -135.72 174.35 10.71 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mt -86.83 134.13 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.618 -1.301 . . . . 0.0 109.151 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -99.95 -172.96 2.33 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.141 0.972 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.463 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -138.23 156.12 47.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.67 -60.42 2.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.345 1.069 . . . . 0.0 109.285 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -46.31 -44.83 17.0 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.2 mt-30 -65.41 -32.44 74.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.61 -34.62 65.14 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.881 -1.127 . . . . 0.0 108.063 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.4 mt-10 -65.15 -37.89 88.86 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.157 0.98 . . . . 0.0 110.329 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -48.91 -37.29 19.39 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.977 0.894 . . . . 0.0 110.047 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.5 m-85 -87.79 3.21 49.06 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.17 73.55 2.3 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 119.853 -1.779 . . . . 0.0 109.819 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' OXT' ' A' ' 21' ' ' ASN . 51.2 t-20 . . . . . 0 C--N 1.292 -1.903 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.459 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.578 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.2 p -151.02 165.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.073 . . . . 0.0 109.992 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.578 ' N ' HG22 ' B' ' 23' ' ' VAL . 23.3 m-20 -122.91 72.32 1.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -120.57 169.09 10.68 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.738 0.78 . . . . 0.0 109.85 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -90.67 91.69 8.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.57 140.05 33.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.614 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 45.3 m -140.92 123.99 16.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.697 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -110.43 0.13 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 32.0 m -38.66 -55.57 1.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.408 -1.054 . . . . 0.0 111.527 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.15 -31.49 71.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.915 -1.115 . . . . 0.0 109.808 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 2' ' ' ILE . 20.3 tp -82.36 -61.51 1.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 109.644 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' B' ' 29' ' ' GLY . 32.4 t -40.67 -57.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.005 0.907 . . . . 0.0 108.554 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -53.51 -39.76 64.86 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.23 -35.82 74.32 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 2' ' ' ILE . 48.7 mt -75.01 -56.99 4.19 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.494 -1.379 . . . . 0.0 108.749 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.2 t80 -46.5 -30.7 2.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.433 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.2 tt -75.4 -47.15 28.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.29 -61.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.817 0.817 . . . . 0.0 109.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.8 m -68.05 -47.25 68.88 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.71 -0.619 . . . . 0.0 111.989 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.62 -117.92 11.53 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.681 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.3 tt0 -64.98 -43.04 93.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.325 -1.103 . . . . 0.0 111.317 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -48.2 -17.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.866 -1.146 . . . . 0.0 110.46 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.09 -175.51 42.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.423 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.3 p90 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 120.063 -1.845 . . . . 0.0 111.367 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.815 HD13 HD11 ' B' ' 36' ' ' LEU . 7.6 tt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.358 0.599 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 80.3 t -59.06 -50.23 80.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.898 -1.126 . . . . 0.0 110.866 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -51.35 -62.65 1.49 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.65 -1.281 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.0 mp0 -60.5 -39.94 89.53 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.925 -1.109 . . . . 0.0 111.914 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.45 -46.21 10.42 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.986 -1.071 . . . . 0.0 112.034 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.77 -52.98 6.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.198 . . . . 0.0 110.942 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -70.88 -28.17 64.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.752 -1.217 . . . . 0.0 108.945 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.3 m -136.14 174.03 11.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.28 127.35 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.639 -1.288 . . . . 0.0 108.944 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -89.44 -173.19 3.89 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.262 1.03 . . . . 0.0 109.942 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.09 151.4 48.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -42.09 -60.48 1.42 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.259 1.028 . . . . 0.0 109.516 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.82 -45.22 19.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.77 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.2 mt-30 -64.49 -32.41 74.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.66 -35.32 65.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.132 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.36 -37.73 88.52 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 122.096 0.95 . . . . 0.0 110.398 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.88 -36.89 18.13 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.858 0.837 . . . . 0.0 110.02 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.626 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.0 m-85 -88.54 3.76 49.16 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.8 m -75.55 73.22 2.57 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.8 -1.813 . . . . 0.0 110.007 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 13.9 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.186 -0.911 . . . . 0.0 109.452 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.579 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.88 166.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.046 -1.033 . . . . 0.0 109.823 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.579 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.6 m120 -123.42 71.49 1.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -120.87 169.9 10.0 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.798 0.809 . . . . 0.0 110.242 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -90.69 92.89 9.02 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 mt -84.73 140.96 30.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -142.24 124.28 15.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.74 -107.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' B' ' 31' ' ' ASP . 12.4 p -38.55 -60.28 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -1.012 . . . . 0.0 111.342 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.464 ' N ' ' OG ' ' B' ' 30' ' ' SER . 3.4 m-20 -64.4 -43.5 94.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 109.617 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 2' ' ' ILE . 24.9 tp -66.74 -63.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.841 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.3 t -40.47 -57.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 108.708 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.27 -39.15 66.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.57 -35.45 74.29 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.815 HD11 HD13 ' A' ' 2' ' ' ILE . 49.0 mt -75.63 -56.62 4.52 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.464 -1.398 . . . . 0.0 108.693 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.6 t80 -46.52 -30.38 2.2 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.09 -47.4 28.95 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 t -75.42 -61.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.796 0.807 . . . . 0.0 109.775 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.9 m -67.93 -47.19 69.39 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.745 -0.597 . . . . 0.0 111.808 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.15 -117.65 11.82 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.632 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.03 -43.08 96.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.435 -1.038 . . . . 0.0 111.438 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -49.06 -18.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.0 110.628 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.6 -177.41 43.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.426 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.071 -1.84 . . . . 0.0 111.478 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 36' ' ' LEU . 8.1 tt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.323 0.582 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.6 t -59.82 -50.65 79.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.892 -1.13 . . . . 0.0 110.836 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -51.34 -62.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.583 -1.323 . . . . 0.0 110.988 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.534 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 3.2 mp0 -59.95 -40.96 90.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.928 -1.108 . . . . 0.0 111.883 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.31 -46.06 10.66 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.087 -1.008 . . . . 0.0 112.142 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.8 t -82.26 -52.72 6.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.797 -1.189 . . . . 0.0 110.886 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.38 -30.09 65.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.798 -1.188 . . . . 0.0 108.961 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -133.43 174.19 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.08 129.17 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.662 -1.274 . . . . 0.0 108.795 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.72 -173.15 3.25 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.23 1.014 . . . . 0.0 109.845 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.451 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.81 155.02 49.45 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -44.24 -60.54 1.86 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.338 1.066 . . . . 0.0 109.352 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.32 -45.11 17.28 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.957 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.3 mt-30 -64.97 -32.44 74.16 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.66 -34.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.065 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.2 mt-10 -65.05 -37.86 88.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.149 0.976 . . . . 0.0 110.365 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.9 -37.42 19.7 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.907 0.86 . . . . 0.0 110.085 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.609 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.2 m-85 -87.66 2.72 50.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.5 m -74.43 73.09 1.88 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 119.806 -1.809 . . . . 0.0 109.961 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 55.1 t-20 . . . . . 0 C--N 1.292 -1.923 0 CA-C-O 118.182 -0.914 . . . . 0.0 109.528 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.601 HG22 ' N ' ' B' ' 24' ' ' ASN . 5.3 p -122.15 164.63 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.601 ' N ' HG22 ' B' ' 23' ' ' VAL . 69.7 m-20 -122.54 71.05 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -122.02 169.49 10.78 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.8 0.809 . . . . 0.0 110.166 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.55 91.57 8.74 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.7 mt -81.79 138.76 35.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 110.73 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 44.0 m -139.53 123.74 17.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.409 -0.807 . . . . 0.0 109.54 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -110.63 0.13 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.455 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 19.7 m -38.68 -54.22 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -1.015 . . . . 0.0 111.515 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -69.19 -30.84 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.644 -1.285 . . . . 0.0 109.644 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 2' ' ' ILE . 21.0 tp -82.95 -61.37 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.716 -0.615 . . . . 0.0 110.077 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 31.3 t -40.0 -60.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.04 0.924 . . . . 0.0 108.752 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 2.9 mp0 -50.51 -40.74 52.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -57.8 -36.2 71.88 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.816 HD11 HD13 ' A' ' 2' ' ' ILE . 46.5 mt -75.26 -56.73 4.43 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.575 -1.328 . . . . 0.0 108.724 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -46.11 -31.47 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 tt -74.48 -47.93 30.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.0 t -74.57 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.743 0.782 . . . . 0.0 109.97 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.6 m -67.94 -47.13 69.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.752 -0.592 . . . . 0.0 111.977 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.3 -117.72 11.92 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -64.5 -43.01 95.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -1.133 . . . . 0.0 111.386 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -48.81 -18.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.856 -1.153 . . . . 0.0 110.425 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.85 -177.32 41.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.3 p90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.174 -1.78 . . . . 0.0 111.211 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.804 HD11 HD11 ' B' ' 32' ' ' LEU . 8.7 tt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.293 0.568 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.9 t -60.02 -49.58 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.818 -1.176 . . . . 0.0 110.875 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.95 -62.49 1.6 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.698 -1.251 . . . . 0.0 111.198 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.1 mp0 -61.61 -39.31 90.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 111.882 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.59 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.46 -46.32 10.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.038 -1.039 . . . . 0.0 112.121 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.6 t -83.01 -53.1 6.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.701 -1.25 . . . . 0.0 110.921 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -70.27 -28.55 65.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.793 -1.192 . . . . 0.0 108.909 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.9 m -136.13 174.31 10.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.01 131.43 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.583 -1.323 . . . . 0.0 109.106 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -95.4 -173.02 2.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.22 1.009 . . . . 0.0 109.924 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.1 154.9 50.19 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.27 -60.46 1.9 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.321 1.058 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.31 -45.07 17.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.937 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.2 mt-30 -64.66 -32.67 74.44 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.64 -35.0 65.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.223 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.3 mt-10 -64.7 -37.79 88.79 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.167 0.984 . . . . 0.0 110.433 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.9 -37.26 19.25 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.085 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.1 m-85 -87.73 2.85 50.1 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -74.49 74.09 1.93 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 119.797 -1.815 . . . . 0.0 109.938 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.7 t30 . . . . . 0 C--N 1.293 -1.858 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.592 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.587 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.88 166.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.01 -1.056 . . . . 0.0 109.909 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.587 ' N ' HG22 ' B' ' 23' ' ' VAL . 6.9 m120 -123.27 71.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -120.27 170.25 9.51 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -90.83 91.96 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.61 140.67 32.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.465 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.1 m -142.58 124.15 14.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.903 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.98 -107.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 29.8 m -38.64 -61.08 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.33 -1.1 . . . . 0.0 111.526 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -42.13 98.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 109.783 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 2' ' ' ILE . 24.0 tp -68.77 -63.13 1.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.657 -0.652 . . . . 0.0 109.813 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' B' ' 29' ' ' GLY . 34.5 t -40.59 -57.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 122.027 0.917 . . . . 0.0 108.679 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -54.17 -39.15 66.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.75 -35.99 75.72 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.802 HD11 HD13 ' A' ' 2' ' ' ILE . 49.3 mt -74.77 -57.39 3.95 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.583 -1.323 . . . . 0.0 108.842 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.2 -30.53 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.471 ' C ' HD23 ' B' ' 38' ' ' LEU . 9.7 tt -75.73 -46.91 28.41 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.3 t -75.22 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.75 0.786 . . . . 0.0 109.777 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 29.5 m -68.01 -47.13 69.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.769 -0.582 . . . . 0.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.88 11.71 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.718 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.9 tt0 -64.88 -43.12 93.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -1.075 . . . . 0.0 111.333 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.3 mtm180 -48.3 -18.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.17 . . . . 0.0 110.358 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.81 43.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.425 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.2 p90 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.186 -1.773 . . . . 0.0 111.047 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.806 HD11 HD11 ' B' ' 32' ' ' LEU . 8.1 tt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.273 0.559 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 7' ' ' CYS . 94.5 t -59.5 -49.97 81.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.913 -1.117 . . . . 0.0 110.738 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -51.73 -62.54 1.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.609 -1.307 . . . . 0.0 111.022 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.9 mp0 -59.83 -40.63 89.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.936 -1.103 . . . . 0.0 111.878 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.44 -46.21 10.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.045 -1.035 . . . . 0.0 112.125 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.7 t -82.74 -53.05 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.774 -1.204 . . . . 0.0 111.079 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -70.82 -28.43 64.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.772 -1.205 . . . . 0.0 108.948 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.6 m -135.77 174.16 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.05 129.14 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 108.846 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.63 -173.1 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.238 1.018 . . . . 0.0 109.99 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.21 151.65 48.99 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.68 -60.53 1.53 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.298 1.047 . . . . 0.0 109.611 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -46.8 -45.05 19.75 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.828 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.6 mt-30 -64.7 -32.22 73.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.98 -35.51 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.207 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.9 mt-10 -64.07 -37.78 88.68 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.112 0.958 . . . . 0.0 110.369 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.03 -37.65 21.35 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.941 0.877 . . . . 0.0 110.049 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -87.37 2.61 49.86 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.72 73.35 2.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.831 -1.793 . . . . 0.0 109.899 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 45.3 t-20 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.269 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.601 HG22 ' N ' ' B' ' 24' ' ' ASN . 4.9 p -137.03 165.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.35 -0.844 . . . . 0.0 109.766 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.601 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.4 m120 -123.15 71.18 1.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -120.75 170.37 9.52 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.819 0.818 . . . . 0.0 109.992 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.93 92.3 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.19 139.82 32.92 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.32 -0.862 . . . . 0.0 110.667 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 m -141.83 124.25 15.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.254 -0.904 . . . . 0.0 109.927 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.87 -107.75 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 55.8 m -38.49 -59.74 0.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.393 -1.063 . . . . 0.0 111.464 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -43.5 93.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.928 -1.107 . . . . 0.0 109.674 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 2' ' ' ILE . 24.6 tp -67.2 -63.41 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.618 -0.676 . . . . 0.0 109.603 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.33 -56.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.934 0.873 . . . . 0.0 108.737 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -54.35 -40.62 68.23 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.15 -36.59 73.23 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.801 HD11 HD13 ' A' ' 2' ' ' ILE . 49.3 mt -74.87 -56.43 4.78 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 120.59 -1.319 . . . . 0.0 108.779 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -46.11 -31.42 2.35 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.17 0.985 . . . . 0.0 108.365 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.477 ' C ' HD23 ' B' ' 38' ' ' LEU . 9.3 tt -75.3 -48.59 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 t -73.01 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.746 0.784 . . . . 0.0 109.889 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.6 m -68.6 -47.49 66.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.707 -0.621 . . . . 0.0 111.971 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.52 -117.82 11.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.627 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -42.78 92.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -1.061 . . . . 0.0 111.432 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.31 -18.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.815 -1.178 . . . . 0.0 110.329 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.49 -176.59 44.91 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.084 -1.833 . . . . 0.0 111.372 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.797 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.313 0.577 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 7' ' ' CYS . 88.5 t -59.99 -50.38 80.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.826 -1.171 . . . . 0.0 110.974 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.16 -62.34 1.7 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.576 -1.328 . . . . 0.0 110.927 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 23.3 mp0 -59.34 -40.92 87.91 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.971 -1.081 . . . . 0.0 111.872 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -45.99 10.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.053 -1.029 . . . . 0.0 112.126 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.4 t -82.82 -52.86 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.792 -1.192 . . . . 0.0 110.99 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 m -71.18 -28.0 63.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.5 m -136.1 174.04 11.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.39 128.92 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.646 -1.284 . . . . 0.0 109.01 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.18 -173.06 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.167 0.984 . . . . 0.0 109.867 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -136.84 154.44 50.51 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.17 -60.66 1.79 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.322 1.058 . . . . 0.0 109.327 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.26 -45.22 17.05 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.878 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.4 mt-30 -64.76 -32.64 74.42 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.63 -34.7 65.13 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.807 -1.157 . . . . 0.0 108.156 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.0 mt-10 -65.19 -37.77 88.39 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.146 0.974 . . . . 0.0 110.385 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.78 -36.89 17.61 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.916 0.865 . . . . 0.0 110.054 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.628 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.5 m-85 -88.14 3.01 50.76 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 m -74.66 75.42 2.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 119.809 -1.807 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 32.9 t30 . . . . . 0 C--N 1.293 -1.88 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.588 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -150.12 165.82 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.994 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.588 ' N ' HG22 ' B' ' 23' ' ' VAL . 12.9 m120 -123.46 71.64 1.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -121.2 170.58 9.44 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.813 0.816 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -91.0 91.98 8.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.92 141.32 31.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 110.568 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 43.6 m -142.66 124.31 14.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.026 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.64 -107.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.406 ' C ' ' O ' ' B' ' 29' ' ' GLY . 39.2 m -38.61 -59.56 0.91 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -1.04 . . . . 0.0 111.328 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.73 -44.42 90.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 109.572 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 2' ' ' ILE . 24.8 tp -66.24 -63.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.628 -0.67 . . . . 0.0 109.72 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.9 t -40.58 -57.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 122.061 0.934 . . . . 0.0 108.724 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -54.16 -39.35 66.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.49 74.32 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.79 HD11 HD13 ' A' ' 2' ' ' ILE . 49.1 mt -75.37 -57.36 3.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.575 -1.328 . . . . 0.0 108.798 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -46.41 -30.19 2.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.9 -47.09 31.75 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.63 -61.15 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.834 0.826 . . . . 0.0 109.873 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.9 m -68.03 -47.19 69.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.766 -0.584 . . . . 0.0 111.992 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.05 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.545 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.6 tt0 -63.42 -43.08 98.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -1.064 . . . . 0.0 110.997 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.51 -18.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 110.372 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -176.42 42.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.581 -2.207 . . . . 0.0 107.581 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.458 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.202 -1.764 . . . . 0.0 111.082 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 32' ' ' LEU . 8.7 tt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.41 0.624 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 7' ' ' CYS . 74.7 t -61.65 -50.12 81.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.804 -1.185 . . . . 0.0 110.763 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.56 -62.45 1.62 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.642 -1.287 . . . . 0.0 111.073 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.7 mp0 -61.83 -39.92 93.49 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 111.866 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.8 m -86.07 -45.73 11.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.051 -1.031 . . . . 0.0 112.241 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 3' ' ' VAL . 41.5 t -83.23 -52.91 6.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.671 -1.268 . . . . 0.0 110.957 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 m -70.65 -28.01 64.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.795 -1.191 . . . . 0.0 108.935 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.4 m -136.04 174.03 11.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.52 135.78 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.566 -1.334 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -101.09 -172.9 2.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.1 0.953 . . . . 0.0 109.659 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -137.51 156.35 48.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.7 -60.48 1.99 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 109.327 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.3 -45.21 17.25 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.892 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.9 mt-30 -64.76 -32.57 74.31 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.77 -34.59 64.74 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.117 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 13.3 mt-10 -65.32 -37.71 87.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.131 0.967 . . . . 0.0 110.327 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.9 -36.96 18.39 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.889 0.852 . . . . 0.0 109.94 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.622 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -88.42 4.01 47.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -76.29 73.58 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.773 -1.829 . . . . 0.0 110.05 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.416 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 47.5 t30 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.46 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.58 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -151.27 165.85 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.957 -1.09 . . . . 0.0 110.084 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.58 ' N ' HG22 ' B' ' 23' ' ' VAL . 11.0 m120 -123.16 71.27 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -120.44 170.49 9.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.826 0.822 . . . . 0.0 110.139 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -90.87 92.05 8.61 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.68 140.74 31.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.421 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -142.67 124.2 14.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.12 -107.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.8 m -38.44 -59.75 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -1.059 . . . . 0.0 111.368 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.23 -44.4 88.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.988 -1.07 . . . . 0.0 109.609 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 2' ' ' ILE . 25.4 tp -66.22 -63.33 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.693 -0.63 . . . . 0.0 109.873 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' GLY . 42.5 t -40.47 -57.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.043 0.925 . . . . 0.0 108.75 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -54.24 -39.09 66.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.71 -35.45 74.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.814 HD11 HD13 ' A' ' 2' ' ' ILE . 49.8 mt -75.46 -57.29 3.98 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.452 -1.405 . . . . 0.0 108.741 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -46.12 -30.61 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.53 -45.93 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.0 t -77.38 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.716 0.77 . . . . 0.0 109.949 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.63 -47.3 66.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.788 -0.57 . . . . 0.0 111.897 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 -117.91 10.65 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.642 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' B' ' 44' ' ' GLY . 41.5 tt0 -66.14 -41.31 90.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.321 -1.105 . . . . 0.0 111.233 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.1 mtm180 -49.38 -16.27 0.18 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.48 -173.79 43.02 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.193 -2.363 . . . . 0.0 107.193 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.416 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.0 p90 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 119.996 -1.885 . . . . 0.0 111.434 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.798 HD11 HD11 ' B' ' 32' ' ' LEU . 8.5 tt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.301 0.572 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 7' ' ' CYS . 64.0 t -59.63 -51.52 71.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.861 -1.15 . . . . 0.0 110.736 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -50.92 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.593 -1.317 . . . . 0.0 110.907 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.57 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.7 mp0 -59.68 -41.36 90.51 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.045 -1.034 . . . . 0.0 111.975 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.2 -45.56 11.2 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 0.0 112.047 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.474 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.69 -53.18 6.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.837 -1.165 . . . . 0.0 111.053 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 m -71.43 -27.62 63.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.187 . . . . 0.0 108.945 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.5 m -136.14 173.96 11.14 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.21 130.04 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.61 -1.306 . . . . 0.0 108.851 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.31 -173.08 3.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.212 1.006 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.89 151.85 48.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.15 -60.52 1.42 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.286 1.041 . . . . 0.0 109.622 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.71 -45.22 19.38 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.84 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.3 mt-30 -64.4 -32.61 74.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.51 -35.25 65.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.167 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.6 mt-10 -64.68 -37.59 88.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.124 0.964 . . . . 0.0 110.367 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.86 -36.85 17.92 Favored 'General case' 0 C--N 1.286 -2.196 0 CA-C-O 121.982 0.896 . . . . 0.0 109.982 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.615 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.53 4.33 47.14 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.0 m -76.55 74.27 3.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.787 -1.821 . . . . 0.0 109.824 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 18.7 t30 . . . . . 0 C--N 1.294 -1.826 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.547 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.591 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -147.81 165.58 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.591 ' N ' HG22 ' B' ' 23' ' ' VAL . 67.2 m-20 -122.69 71.27 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -120.37 169.56 10.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.802 0.811 . . . . 0.0 110.166 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -90.53 92.69 8.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.06 138.82 32.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.677 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' GLY . 56.4 m -140.15 124.04 17.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.363 -0.836 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -108.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' ' 29' ' ' GLY . 10.0 t -39.08 -56.29 1.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.433 -1.039 . . . . 0.0 111.403 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -27.49 65.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.113 . . . . 0.0 110.022 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.798 HD11 HD11 ' A' ' 2' ' ' ILE . 19.8 tp -84.23 -61.57 1.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.78 . . . . 0.0 109.272 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' B' ' 29' ' ' GLY . 43.2 t -40.97 -57.68 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.828 0.823 . . . . 0.0 109.028 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.08 -36.71 63.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.24 -36.33 79.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 2' ' ' ILE . 52.1 mt -75.06 -56.52 4.66 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.568 -1.333 . . . . 0.0 108.654 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.67 -30.72 2.49 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.446 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.0 tt -75.76 -47.9 23.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.98 -60.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.707 0.765 . . . . 0.0 109.819 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' B' ' 36' ' ' LEU . 23.7 m -69.38 -47.29 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.699 -0.626 . . . . 0.0 112.096 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.26 -118.15 11.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.564 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 4.7 tp10 -63.83 -43.77 95.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -1.098 . . . . 0.0 111.123 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -49.22 -14.69 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.854 -1.153 . . . . 0.0 110.637 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.21 -173.15 39.91 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.7 p90 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.026 -1.867 . . . . 0.0 111.471 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 36' ' ' LEU . 8.0 tt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.336 0.589 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' CYS . 84.4 t -59.34 -50.43 79.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.893 -1.129 . . . . 0.0 110.909 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -51.1 -62.49 1.58 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.62 -1.3 . . . . 0.0 111.088 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.4 mp0 -60.5 -40.25 90.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 111.945 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.43 -46.03 10.61 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.014 -1.054 . . . . 0.0 112.081 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.9 t -82.7 -53.05 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.855 -1.153 . . . . 0.0 111.057 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.01 -28.51 64.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.793 -1.192 . . . . 0.0 108.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.8 m -135.8 174.18 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.63 131.05 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.611 -1.306 . . . . 0.0 108.763 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -93.69 -173.07 3.06 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.26 1.029 . . . . 0.0 109.927 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.459 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -138.11 152.19 48.52 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -42.55 -60.76 1.42 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.267 1.032 . . . . 0.0 109.49 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.52 -45.3 18.43 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.845 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.573 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.3 mt-30 -64.61 -32.47 74.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.72 -34.98 65.05 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.166 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.66 -37.74 88.62 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 122.147 0.975 . . . . 0.0 110.387 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.01 18.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.983 0.897 . . . . 0.0 110.086 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.609 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.3 m-85 -88.21 3.42 49.45 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.0 m -75.61 74.95 2.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 119.803 -1.811 . . . . 0.0 109.785 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.435 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 12.0 t-20 . . . . . 0 C--N 1.295 -1.785 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.534 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.604 HG22 ' N ' ' B' ' 24' ' ' ASN . 5.0 p -120.92 164.97 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.384 -0.822 . . . . 0.0 109.995 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.604 ' N ' HG22 ' B' ' 23' ' ' VAL . 69.2 m-20 -123.56 71.55 1.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -121.61 170.51 9.63 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.853 0.835 . . . . 0.0 110.058 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -89.33 91.72 8.86 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.96 138.23 33.88 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.638 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.8 m -139.62 124.09 18.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.604 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.83 -108.99 0.09 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 29' ' ' GLY . 58.5 m -38.85 -58.14 1.13 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.37 -1.076 . . . . 0.0 111.642 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 -27.02 66.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 110.11 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 2' ' ' ILE . 19.7 tp -84.15 -61.44 1.81 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.442 -0.786 . . . . 0.0 109.262 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.5 t -41.28 -57.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 121.773 0.797 . . . . 0.0 109.001 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -54.14 -35.95 62.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.98 -36.09 80.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.816 HD11 HD13 ' A' ' 2' ' ' ILE . 50.2 mt -74.75 -57.77 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.886 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.3 t80 -45.58 -31.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.477 ' C ' HD23 ' B' ' 38' ' ' LEU . 9.5 tt -74.91 -47.07 31.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.95 -60.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.725 0.774 . . . . 0.0 109.818 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.2 m -68.69 -47.18 67.11 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.773 -0.579 . . . . 0.0 112.055 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.23 -117.86 11.66 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.465 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' B' ' 44' ' ' GLY . 15.8 tp10 -63.46 -43.92 95.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -1.095 . . . . 0.0 111.221 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -49.72 -15.49 0.18 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.869 -1.144 . . . . 0.0 110.631 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.43 -174.88 37.62 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.9 p90 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.116 -1.814 . . . . 0.0 111.194 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.815 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.283 0.563 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.0 t -60.26 -51.68 70.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.742 -1.224 . . . . 0.0 110.673 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -50.83 -62.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.62 -1.3 . . . . 0.0 110.888 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -60.09 -41.15 91.86 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.956 -1.09 . . . . 0.0 112.028 -177.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.583 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.21 -45.51 11.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.032 -1.043 . . . . 0.0 111.975 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 38.3 t -82.67 -53.1 6.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.795 -1.191 . . . . 0.0 111.056 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 m -71.47 -27.87 63.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.742 -1.224 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.2 m -135.76 174.12 10.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.61 130.28 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.651 -1.28 . . . . 0.0 109.039 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.22 -172.97 2.95 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.152 0.977 . . . . 0.0 109.855 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -137.5 154.31 49.9 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -43.83 -60.57 1.76 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.4 1.095 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -46.43 -44.96 17.73 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.2 mt-30 -64.99 -32.41 74.12 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.59 -34.86 65.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.909 -1.117 . . . . 0.0 108.128 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.9 mt-10 -65.03 -37.75 88.64 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.122 0.963 . . . . 0.0 110.398 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.09 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.907 0.86 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.615 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.0 m-85 -87.77 3.12 49.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -75.42 75.79 2.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 119.702 -1.874 . . . . 0.0 109.993 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.45 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 26.6 t30 . . . . . 0 C--N 1.295 -1.804 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.646 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.584 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -148.23 165.59 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 109.937 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.584 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.0 m120 -121.85 71.11 0.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -119.49 169.65 9.86 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.824 0.821 . . . . 0.0 110.196 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.69 92.02 8.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -83.75 139.71 32.55 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.43 -0.794 . . . . 0.0 110.734 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 m -140.28 124.11 17.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.339 -0.851 . . . . 0.0 109.745 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -109.98 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 41.5 t -38.82 -54.84 1.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.378 -1.072 . . . . 0.0 111.464 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.5 OUTLIER -70.49 -27.8 64.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.98 -1.075 . . . . 0.0 109.889 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 2' ' ' ILE . 19.6 tp -84.23 -61.5 1.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.457 -0.777 . . . . 0.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.3 t -41.15 -57.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.836 0.827 . . . . 0.0 108.948 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.31 -36.48 63.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.37 -36.08 79.24 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.795 HD11 HD13 ' A' ' 2' ' ' ILE . 50.8 mt -75.02 -57.24 4.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.644 -1.285 . . . . 0.0 108.765 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -46.2 -31.29 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -74.65 -48.22 27.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -73.93 -60.68 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.789 0.804 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.7 m -68.69 -47.22 66.99 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 112.166 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.67 -120.76 17.96 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.572 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.4 tt0 -63.58 -43.18 97.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.337 -1.096 . . . . 0.0 111.121 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -46.77 -18.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.982 -1.074 . . . . 0.0 110.448 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.04 -176.07 41.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.45 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 120.164 -1.786 . . . . 0.0 111.201 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.821 HD11 HD11 ' B' ' 32' ' ' LEU . 8.0 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.278 0.561 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -59.36 -49.7 82.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.881 -1.137 . . . . 0.0 110.821 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -52.2 -62.5 1.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.668 -1.27 . . . . 0.0 111.055 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 3.1 mp0 -60.59 -39.88 89.72 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.936 -1.103 . . . . 0.0 111.836 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.49 -46.22 10.39 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.068 -1.02 . . . . 0.0 112.164 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.1 t -82.84 -52.88 6.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.77 -1.206 . . . . 0.0 110.897 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -70.34 -30.61 67.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.758 -1.214 . . . . 0.0 108.849 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.7 m -133.41 174.22 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.73 129.57 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.627 -1.295 . . . . 0.0 109.077 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.33 -173.07 3.12 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.191 0.996 . . . . 0.0 109.838 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.471 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -137.38 155.46 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.26 -60.56 1.86 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.355 1.074 . . . . 0.0 109.363 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.39 -45.05 17.61 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.889 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.5 mt-30 -64.86 -32.52 74.27 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.67 -35.17 65.18 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.156 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 31.3 mt-10 -64.6 -37.81 88.84 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.154 0.978 . . . . 0.0 110.39 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.0 -37.02 19.05 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.913 0.863 . . . . 0.0 110.136 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.627 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -88.2 2.8 51.41 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.01 73.56 2.19 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 119.848 -1.783 . . . . 0.0 110.111 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 38.7 t-20 . . . . . 0 C--N 1.293 -1.878 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.576 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.28 165.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.993 -1.067 . . . . 0.0 109.985 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.576 ' N ' HG22 ' B' ' 23' ' ' VAL . 61.0 m-20 -121.66 70.99 0.96 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -119.39 169.19 10.23 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.05 92.29 8.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -83.7 141.2 31.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.387 -0.82 . . . . 0.0 110.6 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.5 m -142.5 124.25 15.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 109.954 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.5 -107.45 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 13.1 t -38.65 -59.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.343 -1.092 . . . . 0.0 111.447 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -42.73 93.25 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 2' ' ' ILE . 24.4 tp -68.03 -63.23 1.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.724 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.569 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.8 t -40.52 -56.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 122.018 0.913 . . . . 0.0 108.655 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.39 -40.05 67.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.9 -36.03 74.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 2' ' ' ILE . 49.5 mt -74.95 -57.48 3.88 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.518 -1.364 . . . . 0.0 108.736 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -46.09 -30.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.445 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.0 tt -75.92 -47.33 25.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.71 -60.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.24 -47.3 68.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.727 -0.608 . . . . 0.0 112.091 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.1 -117.91 10.41 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.4 tt0 -65.89 -41.88 90.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 111.354 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -49.45 -15.78 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.868 -1.145 . . . . 0.0 110.327 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.16 -172.77 40.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.8 p90 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 120.112 -1.817 . . . . 0.0 110.936 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 HD11 ' B' ' 32' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -68.47 -50.71 54.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.561 -1.337 . . . . 0.0 110.641 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -50.89 -62.58 1.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.58 -1.325 . . . . 0.0 111.097 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.576 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 1.9 mp0 -62.69 -40.05 95.9 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.896 -1.127 . . . . 0.0 111.948 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 4.3 m -85.81 -44.96 12.03 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.06 -1.025 . . . . 0.0 112.222 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 3' ' ' VAL . 49.0 t -83.14 -53.07 6.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.536 -1.353 . . . . 0.0 110.906 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -69.9 -31.47 69.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.822 -1.174 . . . . 0.0 108.807 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.9 m -132.09 174.01 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.81 136.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.598 -1.314 . . . . 0.0 108.975 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -102.71 -172.92 2.21 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.127 0.965 . . . . 0.0 109.668 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.455 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -137.45 157.08 47.35 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -44.34 -60.26 2.01 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.296 1.046 . . . . 0.0 109.452 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.27 -45.13 17.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.948 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 64.1 mt-30 -64.7 -32.55 74.28 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.87 -35.35 64.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.28 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 21.8 mt-10 -64.34 -37.73 88.55 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.12 0.962 . . . . 0.0 110.464 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.83 -37.17 18.59 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.94 0.876 . . . . 0.0 110.173 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.613 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.9 m-85 -87.71 2.73 50.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.5 m -74.12 74.29 1.75 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 119.806 -1.809 . . . . 0.0 110.045 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 32.3 t30 . . . . . 0 C--N 1.293 -1.861 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.74 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.599 HG22 ' N ' ' B' ' 24' ' ' ASN . 4.0 p -149.16 166.06 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.083 . . . . 0.0 109.801 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.599 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.0 m120 -123.47 69.73 1.03 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -118.63 168.24 10.89 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.789 0.804 . . . . 0.0 109.957 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -88.8 91.85 8.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.43 138.91 33.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.432 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.4 m -140.29 124.04 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.18 -109.43 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.5 m -38.92 -58.18 1.14 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -1.094 . . . . 0.0 111.674 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.73 -27.27 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.917 -1.114 . . . . 0.0 110.057 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.82 HD11 HD11 ' A' ' 2' ' ' ILE . 18.9 tp -84.16 -61.47 1.8 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.324 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 33.1 t -41.28 -57.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.771 0.796 . . . . 0.0 108.992 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.07 -36.17 62.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.58 -36.32 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.812 HD11 HD13 ' A' ' 2' ' ' ILE . 48.9 mt -74.44 -57.84 3.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.617 -1.302 . . . . 0.0 108.876 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.7 t80 -45.94 -30.02 1.62 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.53 ' C ' HD23 ' B' ' 38' ' ' LEU . 8.9 tt -76.73 -46.03 27.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.0 t -75.88 -60.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.757 0.789 . . . . 0.0 109.677 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.3 m -68.17 -47.06 69.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.704 -0.623 . . . . 0.0 111.942 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -118.4 12.23 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.755 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.7 tt0 -64.75 -43.14 94.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -1.076 . . . . 0.0 111.351 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.2 mtm180 -48.24 -17.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.912 -1.118 . . . . 0.0 110.415 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -175.51 44.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.431 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.6 p90 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.203 -1.763 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.788 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.275 0.56 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.7 t -59.17 -50.1 81.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.813 -1.179 . . . . 0.0 110.814 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.65 -62.45 1.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.596 -1.315 . . . . 0.0 111.032 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.55 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -60.24 -40.25 89.58 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.954 -1.091 . . . . 0.0 111.949 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.49 -46.16 10.44 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.038 -1.039 . . . . 0.0 112.008 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.93 -52.95 6.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.797 -1.19 . . . . 0.0 111.023 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.87 -28.32 64.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.731 -1.231 . . . . 0.0 108.889 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.9 m -135.97 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.22 128.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.616 -1.302 . . . . 0.0 108.981 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.32 -173.05 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.259 1.028 . . . . 0.0 109.974 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.11 151.61 49.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.35 -60.56 1.45 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.237 1.017 . . . . 0.0 109.572 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.66 -45.13 19.07 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.823 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.0 mt-30 -64.35 -32.59 74.25 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.82 -35.37 64.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.268 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.2 mt-10 -64.43 -37.61 88.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.088 0.947 . . . . 0.0 110.43 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.79 -37.13 18.28 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.929 0.871 . . . . 0.0 110.088 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.646 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.9 m-85 -88.29 3.81 48.28 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.2 m -76.04 75.0 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 119.83 -1.794 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.434 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 14.1 t-20 . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.576 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.591 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -147.81 165.47 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.018 -1.051 . . . . 0.0 109.847 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.591 ' N ' HG22 ' B' ' 23' ' ' VAL . 15.0 m120 -122.93 71.7 1.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -120.94 170.75 9.19 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.804 0.812 . . . . 0.0 110.09 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -90.89 92.63 8.86 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.96 140.25 32.04 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.366 -0.833 . . . . 0.0 110.572 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' B' ' 29' ' ' GLY . 54.4 m -142.38 124.36 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 67.1 m -38.53 -60.56 0.79 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.391 -1.064 . . . . 0.0 111.391 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.91 -45.46 89.21 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.014 -1.054 . . . . 0.0 109.636 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 2' ' ' ILE . 25.3 tp -64.84 -63.71 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.663 . . . . 0.0 109.638 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.9 t -40.85 -57.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -53.97 -39.66 66.17 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.56 -36.65 76.61 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.786 HD11 HD13 ' A' ' 2' ' ' ILE . 52.1 mt -74.29 -57.1 4.17 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.505 -1.372 . . . . 0.0 108.844 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.8 t80 -46.66 -30.57 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.555 ' C ' HD23 ' B' ' 38' ' ' LEU . 8.4 tt -75.96 -47.49 24.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.78 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.747 0.784 . . . . 0.0 109.669 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.7 m -67.94 -47.24 69.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.777 -0.577 . . . . 0.0 112.037 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.76 -117.84 10.56 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.696 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -39.59 90.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -1.059 . . . . 0.0 111.403 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 2.6 mtm180 -52.56 -15.68 0.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.78 -173.87 40.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.434 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.8 p90 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 120.083 -1.834 . . . . 0.0 111.273 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.792 HD11 HD11 ' B' ' 32' ' ' LEU . 7.8 tt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.372 0.606 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.0 t -58.98 -49.46 83.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.831 -1.168 . . . . 0.0 110.838 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -52.57 -62.37 1.69 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.591 -1.318 . . . . 0.0 111.042 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.9 mp0 -59.82 -40.48 88.59 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.879 -1.138 . . . . 0.0 111.82 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.3 -46.13 10.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.084 -1.01 . . . . 0.0 112.111 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.2 t -82.98 -53.04 6.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.719 -1.238 . . . . 0.0 110.953 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.67 -28.07 64.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.763 -1.211 . . . . 0.0 108.883 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.1 m -136.31 174.22 10.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.63 127.65 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.625 -1.297 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -90.31 -173.08 3.68 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.209 1.005 . . . . 0.0 109.959 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.44 152.51 49.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.59 -60.59 1.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 122.369 1.08 . . . . 0.0 109.651 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -46.52 -45.19 18.39 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.874 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.7 mt-30 -64.26 -32.53 74.15 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -74.03 -35.1 64.33 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.256 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 18.5 mt-10 -64.37 -37.74 88.57 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.126 0.965 . . . . 0.0 110.393 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -49.04 -37.36 20.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.972 0.892 . . . . 0.0 110.217 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.632 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.5 m-85 -87.7 2.66 50.49 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.3 m -75.71 75.03 2.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 119.886 -1.759 . . . . 0.0 110.069 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 27.1 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.053 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.586 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.7 p -148.38 165.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.076 -1.015 . . . . 0.0 109.817 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.586 ' N ' HG22 ' B' ' 23' ' ' VAL . 8.5 m120 -123.18 71.22 1.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -119.87 170.06 9.59 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.752 0.787 . . . . 0.0 109.994 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -90.9 94.22 9.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -85.48 140.78 30.41 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.488 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.412 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.0 m -142.53 124.25 15.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.32 -107.17 0.06 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 29' ' ' GLY . 11.1 t -38.58 -59.98 0.86 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -1.109 . . . . 0.0 111.344 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.77 -43.63 92.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.977 -1.077 . . . . 0.0 109.689 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 2' ' ' ILE . 23.9 tp -66.9 -63.26 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 109.642 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.7 t -40.6 -57.16 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.021 0.915 . . . . 0.0 108.709 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -53.86 -39.65 65.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.43 -36.21 75.46 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.791 HD11 HD13 ' A' ' 2' ' ' ILE . 49.1 mt -74.68 -57.33 3.99 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.527 -1.358 . . . . 0.0 108.825 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.41 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.4 t80 -46.04 -31.23 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.435 ' C ' HD23 ' B' ' 38' ' ' LEU . 9.8 tt -74.76 -47.82 28.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.3 t -74.16 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.71 0.767 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 22.2 m -67.98 -47.19 69.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.748 -0.595 . . . . 0.0 112.058 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.7 11.6 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.539 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' B' ' 44' ' ' GLY . 52.2 tp10 -62.58 -44.07 97.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.318 -1.107 . . . . 0.0 111.446 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -50.72 -14.0 0.17 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.918 -1.114 . . . . 0.0 110.667 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 68.53 -173.44 33.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 24.7 p90 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 120.138 -1.801 . . . . 0.0 110.841 -179.284 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.821 HD11 HD11 ' B' ' 32' ' ' LEU . 8.0 tt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.344 0.593 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 7' ' ' CYS . 85.0 t -59.84 -50.3 80.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.889 -1.132 . . . . 0.0 110.809 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.32 -62.44 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.7 -1.25 . . . . 0.0 111.041 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.0 mp0 -60.76 -40.36 92.18 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 111.889 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.29 -46.03 10.7 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.047 -1.033 . . . . 0.0 112.164 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.8 t -82.83 -52.97 6.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.719 -1.238 . . . . 0.0 111.027 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -70.99 -28.25 64.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.793 -1.192 . . . . 0.0 108.919 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -135.99 174.17 10.9 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mt -87.09 130.86 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.587 -1.321 . . . . 0.0 109.051 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.67 -173.19 2.94 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.223 1.011 . . . . 0.0 109.845 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -136.96 155.43 49.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.7 tp -44.97 -60.69 1.94 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.303 1.049 . . . . 0.0 109.239 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.2 -45.07 16.66 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.847 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.586 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.9 mt-30 -64.86 -32.73 74.57 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.6 -35.19 65.34 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.159 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 29.2 mt-10 -64.59 -37.76 88.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.134 0.969 . . . . 0.0 110.37 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.92 -36.99 18.55 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 121.871 0.843 . . . . 0.0 110.066 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.29 2.93 51.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.32 74.41 1.85 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.8 -1.812 . . . . 0.0 109.892 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.446 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 21.4 t-20 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.668 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.574 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -149.72 165.53 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.054 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.574 ' N ' HG22 ' B' ' 23' ' ' VAL . 11.8 m120 -121.31 71.27 0.95 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -120.22 169.84 9.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.832 0.825 . . . . 0.0 110.179 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -91.13 92.75 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.36 140.65 31.44 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 110.514 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -142.05 124.26 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.66 -107.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.8 m -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.381 -1.07 . . . . 0.0 111.358 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -42.9 95.99 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.962 -1.086 . . . . 0.0 109.695 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 2' ' ' ILE . 25.2 tp -68.17 -63.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.81 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.66 -57.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -53.79 -39.29 65.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.68 -36.46 76.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.8 HD11 HD13 ' A' ' 2' ' ' ILE . 50.7 mt -74.49 -56.74 4.5 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.55 -1.344 . . . . 0.0 108.703 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -46.45 -30.71 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.616 ' C ' HD23 ' B' ' 38' ' ' LEU . 7.3 tt -75.98 -46.52 29.18 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.03 -61.17 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.82 0.819 . . . . 0.0 109.73 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.5 m -68.05 -47.23 68.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.772 -0.58 . . . . 0.0 111.993 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.22 -117.87 11.02 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.665 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.37 -42.46 92.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -1.06 . . . . 0.0 111.309 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.99 -17.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.853 -1.155 . . . . 0.0 110.506 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.7 -175.03 44.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.446 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.3 p90 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.088 -1.831 . . . . 0.0 111.174 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.804 HD11 HD11 ' B' ' 32' ' ' LEU . 8.8 tt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.33 0.586 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.2 t -61.75 -49.34 84.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.78 -1.2 . . . . 0.0 111.01 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -51.95 -62.54 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.24 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mp0 -62.38 -38.8 90.99 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.845 -1.159 . . . . 0.0 111.872 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 3.8 m -86.33 -46.13 10.58 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.976 -1.078 . . . . 0.0 112.101 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.0 t -83.31 -53.0 6.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.649 -1.282 . . . . 0.0 110.945 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -69.91 -29.73 66.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.725 -1.234 . . . . 0.0 108.857 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.3 m -134.83 174.19 10.86 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -86.41 134.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.587 -1.321 . . . . 0.0 108.951 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -98.82 -172.96 2.4 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.203 1.001 . . . . 0.0 109.838 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.28 152.46 49.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.16 -60.32 1.49 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.229 1.014 . . . . 0.0 109.617 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.91 -45.24 20.45 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.824 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.0 mt-30 -64.19 -32.56 74.18 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -35.72 65.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.267 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.453 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 25.8 mt-10 -64.2 -37.64 88.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.128 0.965 . . . . 0.0 110.462 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.78 -37.21 18.46 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.885 0.85 . . . . 0.0 110.063 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.63 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.4 m-85 -88.01 2.81 50.9 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.4 m -75.41 74.51 2.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 119.84 -1.788 . . . . 0.0 110.189 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' CYS . 37.2 t-20 . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.988 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.584 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -150.21 165.91 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 109.841 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.584 ' N ' HG22 ' B' ' 23' ' ' VAL . 7.5 m120 -123.49 71.69 1.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -120.42 169.74 10.03 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.752 0.786 . . . . 0.0 110.057 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -90.06 92.02 8.8 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.54 141.26 31.73 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.3 m -143.17 124.33 14.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.956 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 29' ' ' GLY . 26.4 t -38.73 -60.75 0.79 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -1.085 . . . . 0.0 111.46 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -43.57 95.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.934 -1.104 . . . . 0.0 109.72 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 2' ' ' ILE . 24.4 tp -67.24 -63.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 0.0 109.732 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.1 t -40.62 -57.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.033 0.92 . . . . 0.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -53.65 -39.53 65.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.46 -36.63 76.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.789 HD11 HD13 ' A' ' 2' ' ' ILE . 49.8 mt -74.44 -56.67 4.59 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.553 -1.342 . . . . 0.0 108.722 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -46.33 -30.67 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.595 ' C ' HD23 ' B' ' 38' ' ' LEU . 7.7 tt -76.39 -48.23 20.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.83 -60.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.828 0.823 . . . . 0.0 109.687 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.38 -47.17 68.07 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.802 -0.561 . . . . 0.0 112.152 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -121.72 22.44 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.353 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' B' ' 44' ' ' GLY . 8.3 tp10 -61.26 -44.14 97.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -1.096 . . . . 0.0 110.979 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -16.68 0.07 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.999 -1.063 . . . . 0.0 110.622 -177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.45 -174.62 38.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.404 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.1 p90 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 120.185 -1.773 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.451 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.947 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt -49.63 -30.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.7 t -59.85 -50.3 80.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.799 -1.188 . . . . 0.0 110.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -51.87 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.56 -1.338 . . . . 0.0 110.928 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.73 -41.04 89.99 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 111.884 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.33 -46.0 10.7 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.033 -1.042 . . . . 0.0 112.129 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.5 t -82.97 -53.0 6.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.723 -1.236 . . . . 0.0 111.039 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -70.85 -28.71 64.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.734 -1.229 . . . . 0.0 108.884 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.8 m -135.27 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.74 129.23 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.62 -1.3 . . . . 0.0 109.1 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.68 -173.06 3.23 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.219 1.009 . . . . 0.0 109.868 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.21 154.85 50.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.21 -60.54 1.85 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 122.325 1.059 . . . . 0.0 109.364 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.33 -45.1 17.32 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.87 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.584 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.8 mt-30 -64.86 -32.51 74.25 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.63 -34.87 65.2 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.179 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 20.1 mt-10 -64.96 -37.75 88.69 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.107 0.956 . . . . 0.0 110.324 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.88 -37.15 18.81 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.901 0.857 . . . . 0.0 110.103 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.2 m-85 -87.92 3.04 50.07 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.9 m -74.84 75.77 2.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.749 -1.844 . . . . 0.0 109.961 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 23.9 t30 . . . . . 0 C--N 1.293 -1.87 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.57 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -147.98 165.89 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.0 109.837 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.57 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.1 m120 -122.9 71.2 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -120.05 169.87 9.81 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.78 0.8 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.16 92.63 8.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.94 141.04 31.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.405 -0.81 . . . . 0.0 110.551 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.7 m -142.53 124.28 15.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.76 -107.59 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.415 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.5 m -38.59 -60.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.386 -1.067 . . . . 0.0 111.45 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.2 m-20 -64.23 -43.39 95.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.922 -1.111 . . . . 0.0 109.665 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.82 HD11 HD11 ' A' ' 2' ' ' ILE . 24.8 tp -67.51 -63.25 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.68 -57.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.97 0.891 . . . . 0.0 108.644 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -53.83 -38.86 65.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -60.18 -35.87 76.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.82 HD11 HD13 ' A' ' 2' ' ' ILE . 50.4 mt -75.06 -57.08 4.12 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.506 -1.371 . . . . 0.0 108.748 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.22 -31.11 2.28 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.3 tt -74.8 -48.13 26.99 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.7 t -74.19 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.766 0.794 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' B' ' 36' ' ' LEU . 30.1 m -68.25 -47.12 68.6 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.775 -0.578 . . . . 0.0 112.101 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.56 -121.14 19.36 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.496 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 9.7 tp10 -62.35 -44.0 97.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.265 -1.138 . . . . 0.0 111.036 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.447 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -47.02 -17.33 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.064 -1.022 . . . . 0.0 110.594 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.94 -175.4 41.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.7 p90 -168.34 169.62 10.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.174 -1.78 . . . . 0.0 110.952 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.483 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.97 -83.52 0.0 OUTLIER 'General case' 0 C--N 1.401 2.823 0 O-C-N 119.712 -1.867 . . . . 0.0 108.119 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.07 106.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.584 ' H ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -74.64 168.58 25.72 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -51.28 -72.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.431 1.421 . . . . 0.0 110.432 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.446 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.524 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.98 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 32' ' ' LEU . 7.6 tt -65.53 -30.0 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.554 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 7' ' ' CYS . 89.9 t -59.34 -50.43 79.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.874 -1.141 . . . . 0.0 110.849 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -50.96 -62.16 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.669 -1.27 . . . . 0.0 111.14 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.7 mp0 -61.32 -39.89 92.19 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.9 -1.125 . . . . 0.0 111.948 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -46.02 10.6 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.014 -1.053 . . . . 0.0 112.106 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.78 -52.94 6.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.85 -1.156 . . . . 0.0 111.043 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.17 -28.31 64.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.178 . . . . 0.0 108.927 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.5 m -135.86 174.09 11.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.06 129.32 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.601 -1.312 . . . . 0.0 109.01 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.17 -173.16 3.35 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.195 0.997 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.51 151.65 48.65 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -42.16 -60.41 1.46 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 122.255 1.026 . . . . 0.0 109.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.73 -45.41 19.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.779 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.6 mt-30 -64.15 -32.55 74.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.69 -35.64 65.19 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.246 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 24.6 mt-10 -64.03 -37.66 88.24 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.152 0.977 . . . . 0.0 110.467 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.76 -37.13 18.12 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.917 0.865 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.19 3.28 49.93 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.1 m -75.18 74.06 2.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 119.826 -1.796 . . . . 0.0 110.027 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.441 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 21.9 t-20 . . . . . 0 C--N 1.294 -1.839 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.752 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.575 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.96 165.94 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.026 -1.046 . . . . 0.0 109.84 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.575 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.2 m120 -122.68 71.07 1.01 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -120.27 169.91 9.83 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.861 0.839 . . . . 0.0 110.063 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -91.01 92.29 8.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.73 139.71 32.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 110.671 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 51.2 m -140.89 124.17 16.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 109.727 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.82 -111.4 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.407 ' C ' ' O ' ' B' ' 29' ' ' GLY . 38.8 t -38.62 -54.18 1.56 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.405 -1.056 . . . . 0.0 111.473 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.91 -31.7 70.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.886 -1.133 . . . . 0.0 109.666 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 2' ' ' ILE . 20.7 tp -82.1 -61.51 1.88 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.658 -0.651 . . . . 0.0 109.554 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' B' ' 29' ' ' GLY . 29.2 t -40.8 -56.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 108.585 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -53.51 -39.47 64.65 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.47 -36.34 75.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.799 HD11 HD13 ' A' ' 2' ' ' ILE . 48.9 mt -74.67 -56.06 5.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.622 -1.299 . . . . 0.0 108.603 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -46.69 -31.12 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.568 ' C ' HD23 ' B' ' 38' ' ' LEU . 8.1 tt -75.87 -47.75 24.2 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 t -73.79 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.745 0.783 . . . . 0.0 109.785 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.34 -47.45 67.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.74 -0.6 . . . . 0.0 112.025 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.48 -117.75 11.88 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.796 -1.193 . . . . 0.0 110.71 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.31 -43.18 95.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -1.103 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -48.41 -19.35 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.904 -1.123 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.69 44.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.441 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 27.2 p90 -166.16 170.8 12.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.125 -1.809 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.48 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.429 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -177.82 118.67 0.1 Allowed 'General case' 0 C--N 1.402 2.858 0 O-C-N 119.47 -2.019 . . . . 0.0 108.815 178.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.523 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.3 t -89.93 -132.12 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.286 -0.884 . . . . 0.0 108.804 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' N ' ' OG1' ' B' ' 48' ' ' THR . 8.2 ptpp? -86.91 151.65 52.45 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.02 -1.05 . . . . 0.0 108.891 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -49.04 -64.05 0.25 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 120.678 0.919 . . . . 0.0 110.496 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.478 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.994 0 N-CA-C 119.647 2.619 . . . . 0.0 119.647 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.797 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt -55.26 -30.91 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.656 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.7 t -59.32 -50.12 81.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.797 -1.189 . . . . 0.0 110.743 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -51.47 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.644 -1.285 . . . . 0.0 111.047 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -60.71 -40.18 91.33 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 111.929 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.39 -46.18 10.5 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.031 -1.043 . . . . 0.0 112.076 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.72 -52.86 6.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.804 -1.185 . . . . 0.0 111.023 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -71.15 -28.68 64.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.241 . . . . 0.0 108.971 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.3 m -135.45 174.36 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.29 130.22 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.584 -1.322 . . . . 0.0 109.086 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.48 -173.01 3.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.184 0.992 . . . . 0.0 109.92 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -138.1 152.32 48.65 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.8 tp -42.53 -60.63 1.46 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 122.338 1.066 . . . . 0.0 109.599 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.7 -44.87 19.06 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.794 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.581 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -65.0 -32.38 74.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -34.99 65.23 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.126 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.84 -37.77 88.73 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.117 0.961 . . . . 0.0 110.374 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -48.9 -36.84 18.11 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.899 0.857 . . . . 0.0 110.079 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.8 m-85 -88.1 3.25 49.76 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -74.82 74.64 2.11 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 119.735 -1.853 . . . . 0.0 110.043 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.438 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 12.4 t-20 . . . . . 0 C--N 1.294 -1.835 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.56 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.3 p -148.81 165.68 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.045 . . . . 0.0 109.922 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.563 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.1 m120 -122.55 71.58 1.03 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -120.51 169.94 9.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.814 0.816 . . . . 0.0 110.215 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -91.36 92.49 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.98 140.82 31.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 110.581 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 m -142.15 124.21 15.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 109.915 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -107.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 29' ' ' GLY . 8.7 t -38.58 -59.41 0.93 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -1.049 . . . . 0.0 111.398 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.06 -42.78 93.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 109.629 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 2' ' ' ILE . 24.7 tp -68.21 -63.29 1.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.64 . . . . 0.0 109.82 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.56 -57.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.073 0.94 . . . . 0.0 108.614 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -54.05 -39.65 66.43 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.29 -36.13 75.02 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.788 HD11 HD13 ' A' ' 2' ' ' ILE . 49.9 mt -74.8 -57.52 3.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.46 -1.4 . . . . 0.0 108.732 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.5 t80 -46.07 -30.77 2.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.4 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.4 tt -75.24 -47.51 27.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.88 -61.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.778 0.799 . . . . 0.0 109.832 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.1 m -68.3 -47.13 68.44 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.757 -0.589 . . . . 0.0 112.068 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -121.61 22.67 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.473 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' B' ' 44' ' ' GLY . 12.0 tp10 -61.33 -44.05 97.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -1.096 . . . . 0.0 111.111 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -47.02 -18.28 0.07 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.99 -1.069 . . . . 0.0 110.696 -178.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.25 43.87 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.438 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.8 p90 -168.02 170.03 10.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.19 -1.77 . . . . 0.0 111.265 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.478 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.419 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.65 103.93 0.06 Allowed 'General case' 0 C--N 1.4 2.804 0 O-C-N 119.779 -1.826 . . . . 0.0 107.959 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -144.25 112.24 6.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 5.8 mttt -78.22 -42.87 2.13 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.993 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 19.5 Cg_exo -54.34 -57.11 1.98 Allowed 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.964 1.109 . . . . 0.0 110.501 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.32 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 5.024 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.829 HD11 HD11 ' B' ' 32' ' ' LEU . 7.5 tt -55.17 -30.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -1.147 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' CYS . 75.8 t -59.27 -50.88 78.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.816 -1.177 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -51.02 -62.43 1.62 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.571 -1.33 . . . . 0.0 110.993 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.9 mp0 -60.33 -40.56 91.05 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.977 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.22 -45.69 11.07 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.067 -1.021 . . . . 0.0 111.974 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.65 -52.91 6.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.795 -1.191 . . . . 0.0 110.995 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.47 -28.11 63.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.73 -1.231 . . . . 0.0 109.014 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' CYS . 70.9 m -135.72 174.19 10.88 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.43 129.02 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.542 -1.349 . . . . 0.0 108.961 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.79 -173.12 3.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.157 0.979 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.451 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -137.24 155.49 49.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.354 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.64 -60.54 1.95 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 122.407 1.098 . . . . 0.0 109.242 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.35 -45.09 17.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.936 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 64.4 mt-30 -64.94 -32.61 74.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.85 -34.18 64.41 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.11 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.6 mt-10 -65.63 -37.68 87.24 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.196 0.998 . . . . 0.0 110.324 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.93 -37.04 18.78 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.966 0.889 . . . . 0.0 110.101 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.0 m-85 -87.85 2.87 50.36 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 m -74.91 76.23 2.16 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.801 -1.812 . . . . 0.0 109.915 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.436 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 24.5 t-20 . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.677 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.586 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.3 p -150.52 165.96 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.999 -1.063 . . . . 0.0 109.887 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.586 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.6 m120 -123.08 71.53 1.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -120.69 170.15 9.72 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.799 0.809 . . . . 0.0 110.167 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -91.28 92.57 8.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.81 140.57 31.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.11 124.0 16.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 109.798 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.0 -110.03 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -38.73 -55.7 1.44 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.058 . . . . 0.0 111.444 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -34.86 78.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 109.621 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 2' ' ' ILE . 20.9 tp -78.23 -61.78 1.89 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.582 . . . . 0.0 109.769 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 24.8 t -40.84 -56.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 122.056 0.932 . . . . 0.0 108.567 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.84 -39.74 65.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.36 74.06 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.794 HD11 HD13 ' A' ' 2' ' ' ILE . 47.9 mt -75.25 -56.71 4.45 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.511 -1.368 . . . . 0.0 108.692 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -46.76 -30.64 2.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.57 -45.43 45.44 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.2 t -77.81 -61.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.765 0.793 . . . . 0.0 109.886 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.39 -47.17 68.04 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.721 -0.612 . . . . 0.0 111.867 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.46 -118.83 13.54 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.628 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 44' ' ' GLY . 18.1 tp10 -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -1.08 . . . . 0.0 111.058 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -47.58 -17.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 110.406 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.21 -176.54 40.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.436 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.8 p90 -168.08 169.27 11.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.215 -1.756 . . . . 0.0 110.972 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.481 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -179.95 -87.92 0.0 OUTLIER 'General case' 0 C--N 1.399 2.737 0 O-C-N 120.038 -1.664 . . . . 0.0 107.301 178.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.464 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 6.7 p 40.54 -134.97 0.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.567 -0.708 . . . . 0.0 110.929 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.464 ' N ' ' OG1' ' B' ' 48' ' ' THR . 7.5 pttp -149.82 91.63 4.29 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.517 -0.739 . . . . 0.0 109.249 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -56.17 -75.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 120.736 0.957 . . . . 0.0 110.616 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.428 179.944 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.97 0 N-CA-C 119.686 2.634 . . . . 0.0 119.686 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.829 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt -49.04 -30.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.5 t -60.93 -51.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.799 -1.188 . . . . 0.0 110.705 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.61 -62.17 1.79 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.526 -1.359 . . . . 0.0 110.85 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.582 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 21.9 mp0 -59.83 -41.33 91.08 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.0 111.913 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.7 m -86.41 -45.62 11.0 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.109 -0.994 . . . . 0.0 112.189 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.8 t -82.57 -53.02 6.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.711 -1.243 . . . . 0.0 110.962 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -71.57 -28.05 63.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.806 -1.184 . . . . 0.0 108.985 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.8 m -135.72 174.35 10.71 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mt -86.83 134.13 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.618 -1.301 . . . . 0.0 109.151 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -99.95 -172.96 2.33 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.141 0.972 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.463 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -138.23 156.12 47.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.67 -60.42 2.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.345 1.069 . . . . 0.0 109.285 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -46.31 -44.83 17.0 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.2 mt-30 -65.41 -32.44 74.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.61 -34.62 65.14 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.881 -1.127 . . . . 0.0 108.063 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.4 mt-10 -65.15 -37.89 88.86 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.157 0.98 . . . . 0.0 110.329 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -48.91 -37.29 19.39 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.977 0.894 . . . . 0.0 110.047 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.5 m-85 -87.79 3.21 49.06 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.17 73.55 2.3 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 119.853 -1.779 . . . . 0.0 109.819 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' OXT' ' A' ' 21' ' ' ASN . 51.2 t-20 . . . . . 0 C--N 1.292 -1.903 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.459 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.578 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.2 p -151.02 165.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.073 . . . . 0.0 109.992 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.578 ' N ' HG22 ' B' ' 23' ' ' VAL . 23.3 m-20 -122.91 72.32 1.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -120.57 169.09 10.68 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.738 0.78 . . . . 0.0 109.85 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -90.67 91.69 8.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.57 140.05 33.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.614 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 45.3 m -140.92 123.99 16.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.697 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -110.43 0.13 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 32.0 m -38.66 -55.57 1.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.408 -1.054 . . . . 0.0 111.527 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.15 -31.49 71.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.915 -1.115 . . . . 0.0 109.808 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 2' ' ' ILE . 20.3 tp -82.36 -61.51 1.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 109.644 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' B' ' 29' ' ' GLY . 32.4 t -40.67 -57.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.005 0.907 . . . . 0.0 108.554 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -53.51 -39.76 64.86 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.23 -35.82 74.32 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 2' ' ' ILE . 48.7 mt -75.01 -56.99 4.19 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.494 -1.379 . . . . 0.0 108.749 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.2 t80 -46.5 -30.7 2.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.433 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.2 tt -75.4 -47.15 28.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.29 -61.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.817 0.817 . . . . 0.0 109.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.8 m -68.05 -47.25 68.88 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.71 -0.619 . . . . 0.0 111.989 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.62 -117.92 11.53 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.681 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.3 tt0 -64.98 -43.04 93.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.325 -1.103 . . . . 0.0 111.317 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -48.2 -17.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.866 -1.146 . . . . 0.0 110.46 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.09 -175.51 42.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.423 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.3 p90 -168.1 169.96 10.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.063 -1.845 . . . . 0.0 111.367 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.476 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.76 82.59 0.02 OUTLIER 'General case' 0 C--N 1.398 2.717 0 O-C-N 119.894 -1.754 . . . . 0.0 107.686 178.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 80.0 p -86.76 -166.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.698 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' B' ' 50' ' ' PRO . 4.9 mptp? -71.94 -58.39 3.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.951 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 25.4 Cg_exo -44.27 -63.87 0.3 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.834 1.023 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.495 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.944 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.815 HD13 HD11 ' B' ' 36' ' ' LEU . 7.6 tt -66.55 -30.09 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.137 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 80.3 t -59.06 -50.23 80.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.898 -1.126 . . . . 0.0 110.866 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -51.35 -62.65 1.49 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.65 -1.281 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.0 mp0 -60.5 -39.94 89.53 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.925 -1.109 . . . . 0.0 111.914 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.45 -46.21 10.42 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.986 -1.071 . . . . 0.0 112.034 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.77 -52.98 6.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.198 . . . . 0.0 110.942 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -70.88 -28.17 64.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.752 -1.217 . . . . 0.0 108.945 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.3 m -136.14 174.03 11.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.28 127.35 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.639 -1.288 . . . . 0.0 108.944 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -89.44 -173.19 3.89 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.262 1.03 . . . . 0.0 109.942 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.09 151.4 48.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -42.09 -60.48 1.42 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.259 1.028 . . . . 0.0 109.516 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.82 -45.22 19.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.77 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.2 mt-30 -64.49 -32.41 74.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.66 -35.32 65.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.132 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.36 -37.73 88.52 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 122.096 0.95 . . . . 0.0 110.398 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.88 -36.89 18.13 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.858 0.837 . . . . 0.0 110.02 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.626 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.0 m-85 -88.54 3.76 49.16 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.8 m -75.55 73.22 2.57 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.8 -1.813 . . . . 0.0 110.007 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 13.9 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.186 -0.911 . . . . 0.0 109.452 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.579 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.88 166.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.046 -1.033 . . . . 0.0 109.823 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.579 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.6 m120 -123.42 71.49 1.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -120.87 169.9 10.0 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.798 0.809 . . . . 0.0 110.242 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -90.69 92.89 9.02 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 mt -84.73 140.96 30.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -142.24 124.28 15.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.74 -107.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' B' ' 31' ' ' ASP . 12.4 p -38.55 -60.28 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -1.012 . . . . 0.0 111.342 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.464 ' N ' ' OG ' ' B' ' 30' ' ' SER . 3.4 m-20 -64.4 -43.5 94.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 109.617 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 2' ' ' ILE . 24.9 tp -66.74 -63.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.841 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.3 t -40.47 -57.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 108.708 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.27 -39.15 66.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.57 -35.45 74.29 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.815 HD11 HD13 ' A' ' 2' ' ' ILE . 49.0 mt -75.63 -56.62 4.52 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.464 -1.398 . . . . 0.0 108.693 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.6 t80 -46.52 -30.38 2.2 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.09 -47.4 28.95 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 t -75.42 -61.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.796 0.807 . . . . 0.0 109.775 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.9 m -67.93 -47.19 69.39 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.745 -0.597 . . . . 0.0 111.808 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.15 -117.65 11.82 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.632 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.03 -43.08 96.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.435 -1.038 . . . . 0.0 111.438 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -49.06 -18.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.0 110.628 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.6 -177.41 43.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.426 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 -166.56 171.1 12.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.071 -1.84 . . . . 0.0 111.478 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.472 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.49 94.82 0.05 OUTLIER 'General case' 0 C--N 1.402 2.85 0 O-C-N 119.615 -1.928 . . . . 0.0 108.37 178.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 39.2 p -153.27 112.29 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttp 47.09 71.14 1.69 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.887 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.64 -56.64 1.84 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.702 1.601 . . . . 0.0 110.481 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.488 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.929 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 36' ' ' LEU . 8.1 tt -54.92 -30.12 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.24 -1.153 . . . . 0.0 109.508 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.6 t -59.82 -50.65 79.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.892 -1.13 . . . . 0.0 110.836 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -51.34 -62.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.583 -1.323 . . . . 0.0 110.988 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.534 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 3.2 mp0 -59.95 -40.96 90.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.928 -1.108 . . . . 0.0 111.883 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.31 -46.06 10.66 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.087 -1.008 . . . . 0.0 112.142 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.8 t -82.26 -52.72 6.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.797 -1.189 . . . . 0.0 110.886 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.38 -30.09 65.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.798 -1.188 . . . . 0.0 108.961 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -133.43 174.19 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.08 129.17 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.662 -1.274 . . . . 0.0 108.795 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.72 -173.15 3.25 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.23 1.014 . . . . 0.0 109.845 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.451 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.81 155.02 49.45 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -44.24 -60.54 1.86 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.338 1.066 . . . . 0.0 109.352 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.32 -45.11 17.28 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.957 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.3 mt-30 -64.97 -32.44 74.16 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.66 -34.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.065 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.2 mt-10 -65.05 -37.86 88.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.149 0.976 . . . . 0.0 110.365 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.9 -37.42 19.7 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.907 0.86 . . . . 0.0 110.085 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.609 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.2 m-85 -87.66 2.72 50.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.5 m -74.43 73.09 1.88 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 119.806 -1.809 . . . . 0.0 109.961 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 55.1 t-20 . . . . . 0 C--N 1.292 -1.923 0 CA-C-O 118.182 -0.914 . . . . 0.0 109.528 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.601 HG22 ' N ' ' B' ' 24' ' ' ASN . 5.3 p -122.15 164.63 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.601 ' N ' HG22 ' B' ' 23' ' ' VAL . 69.7 m-20 -122.54 71.05 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -122.02 169.49 10.78 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.8 0.809 . . . . 0.0 110.166 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.55 91.57 8.74 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.7 mt -81.79 138.76 35.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 110.73 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 44.0 m -139.53 123.74 17.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.409 -0.807 . . . . 0.0 109.54 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -110.63 0.13 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.455 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 19.7 m -38.68 -54.22 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -1.015 . . . . 0.0 111.515 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -69.19 -30.84 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.644 -1.285 . . . . 0.0 109.644 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 2' ' ' ILE . 21.0 tp -82.95 -61.37 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.716 -0.615 . . . . 0.0 110.077 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 31.3 t -40.0 -60.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.04 0.924 . . . . 0.0 108.752 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 2.9 mp0 -50.51 -40.74 52.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -57.8 -36.2 71.88 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.816 HD11 HD13 ' A' ' 2' ' ' ILE . 46.5 mt -75.26 -56.73 4.43 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.575 -1.328 . . . . 0.0 108.724 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -46.11 -31.47 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 tt -74.48 -47.93 30.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.0 t -74.57 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.743 0.782 . . . . 0.0 109.97 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.6 m -67.94 -47.13 69.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.752 -0.592 . . . . 0.0 111.977 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.3 -117.72 11.92 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -64.5 -43.01 95.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -1.133 . . . . 0.0 111.386 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -48.81 -18.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.856 -1.153 . . . . 0.0 110.425 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.85 -177.32 41.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.3 p90 -166.79 171.24 11.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.174 -1.78 . . . . 0.0 111.211 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.484 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -179.33 91.2 0.02 OUTLIER 'General case' 0 C--N 1.4 2.787 0 O-C-N 119.777 -1.827 . . . . 0.0 108.082 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.46 -28.2 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 109.67 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -139.79 71.7 36.03 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -56.65 -68.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.636 1.557 . . . . 0.0 110.399 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.492 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.985 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.804 HD11 HD11 ' B' ' 32' ' ' LEU . 8.7 tt -57.96 -30.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.119 . . . . 0.0 109.673 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.9 t -60.02 -49.58 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.818 -1.176 . . . . 0.0 110.875 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.95 -62.49 1.6 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.698 -1.251 . . . . 0.0 111.198 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.1 mp0 -61.61 -39.31 90.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 111.882 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.59 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.46 -46.32 10.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.038 -1.039 . . . . 0.0 112.121 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.6 t -83.01 -53.1 6.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.701 -1.25 . . . . 0.0 110.921 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -70.27 -28.55 65.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.793 -1.192 . . . . 0.0 108.909 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.9 m -136.13 174.31 10.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.01 131.43 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.583 -1.323 . . . . 0.0 109.106 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -95.4 -173.02 2.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.22 1.009 . . . . 0.0 109.924 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.1 154.9 50.19 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.27 -60.46 1.9 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.321 1.058 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.31 -45.07 17.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.937 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.2 mt-30 -64.66 -32.67 74.44 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.64 -35.0 65.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.223 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.3 mt-10 -64.7 -37.79 88.79 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.167 0.984 . . . . 0.0 110.433 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.9 -37.26 19.25 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.085 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.1 m-85 -87.73 2.85 50.1 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -74.49 74.09 1.93 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 119.797 -1.815 . . . . 0.0 109.938 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.7 t30 . . . . . 0 C--N 1.293 -1.858 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.592 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.587 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.88 166.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.01 -1.056 . . . . 0.0 109.909 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.587 ' N ' HG22 ' B' ' 23' ' ' VAL . 6.9 m120 -123.27 71.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -120.27 170.25 9.51 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -90.83 91.96 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.61 140.67 32.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.465 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.1 m -142.58 124.15 14.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.903 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.98 -107.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 29.8 m -38.64 -61.08 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.33 -1.1 . . . . 0.0 111.526 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -42.13 98.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 109.783 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 2' ' ' ILE . 24.0 tp -68.77 -63.13 1.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.657 -0.652 . . . . 0.0 109.813 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' B' ' 29' ' ' GLY . 34.5 t -40.59 -57.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 122.027 0.917 . . . . 0.0 108.679 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -54.17 -39.15 66.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.75 -35.99 75.72 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.802 HD11 HD13 ' A' ' 2' ' ' ILE . 49.3 mt -74.77 -57.39 3.95 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.583 -1.323 . . . . 0.0 108.842 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.2 -30.53 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.471 ' C ' HD23 ' B' ' 38' ' ' LEU . 9.7 tt -75.73 -46.91 28.41 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.3 t -75.22 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.75 0.786 . . . . 0.0 109.777 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 29.5 m -68.01 -47.13 69.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.769 -0.582 . . . . 0.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.88 11.71 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.718 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.9 tt0 -64.88 -43.12 93.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -1.075 . . . . 0.0 111.333 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.3 mtm180 -48.3 -18.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.17 . . . . 0.0 110.358 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.81 43.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.425 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.2 p90 -166.91 170.53 12.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.186 -1.773 . . . . 0.0 111.047 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.485 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.409 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -179.54 101.63 0.03 OUTLIER 'General case' 0 C--N 1.401 2.825 0 O-C-N 119.732 -1.855 . . . . 0.0 108.22 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' B' ' 47' ' ' TYR . 3.3 m -166.37 -60.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 0.0 109.681 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -146.2 71.98 13.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.267 -0.896 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.413 ' O ' ' OG1' ' B' ' 51' ' ' THR . 16.4 Cg_exo -56.23 -66.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.703 1.602 . . . . 0.0 110.559 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 35.1 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.651 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.995 0 N-CA-C 119.595 2.598 . . . . 0.0 119.595 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.806 HD11 HD11 ' B' ' 32' ' ' LEU . 8.1 tt -68.97 -29.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -1.164 . . . . 0.0 109.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 7' ' ' CYS . 94.5 t -59.5 -49.97 81.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.913 -1.117 . . . . 0.0 110.738 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -51.73 -62.54 1.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.609 -1.307 . . . . 0.0 111.022 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -59.83 -40.63 89.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.936 -1.103 . . . . 0.0 111.878 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.44 -46.21 10.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.045 -1.035 . . . . 0.0 112.125 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.7 t -82.74 -53.05 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.774 -1.204 . . . . 0.0 111.079 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -70.82 -28.43 64.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.772 -1.205 . . . . 0.0 108.948 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.6 m -135.77 174.16 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.05 129.14 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 108.846 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.63 -173.1 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.238 1.018 . . . . 0.0 109.99 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.21 151.65 48.99 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.68 -60.53 1.53 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.298 1.047 . . . . 0.0 109.611 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -46.8 -45.05 19.75 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.828 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.6 mt-30 -64.7 -32.22 73.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.98 -35.51 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.207 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.9 mt-10 -64.07 -37.78 88.68 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.112 0.958 . . . . 0.0 110.369 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.03 -37.65 21.35 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.941 0.877 . . . . 0.0 110.049 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -87.37 2.61 49.86 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.72 73.35 2.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.831 -1.793 . . . . 0.0 109.899 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 45.3 t-20 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.269 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.601 HG22 ' N ' ' B' ' 24' ' ' ASN . 4.9 p -137.03 165.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.35 -0.844 . . . . 0.0 109.766 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.601 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.4 m120 -123.15 71.18 1.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -120.75 170.37 9.52 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.819 0.818 . . . . 0.0 109.992 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.93 92.3 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.19 139.82 32.92 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.32 -0.862 . . . . 0.0 110.667 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 m -141.83 124.25 15.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.254 -0.904 . . . . 0.0 109.927 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.87 -107.75 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 55.8 m -38.49 -59.74 0.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.393 -1.063 . . . . 0.0 111.464 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -43.5 93.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.928 -1.107 . . . . 0.0 109.674 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 2' ' ' ILE . 24.6 tp -67.2 -63.41 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.618 -0.676 . . . . 0.0 109.603 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.33 -56.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.934 0.873 . . . . 0.0 108.737 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -54.35 -40.62 68.23 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.15 -36.59 73.23 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.801 HD11 HD13 ' A' ' 2' ' ' ILE . 49.3 mt -74.87 -56.43 4.78 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 120.59 -1.319 . . . . 0.0 108.779 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -46.11 -31.42 2.35 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.17 0.985 . . . . 0.0 108.365 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.477 ' C ' HD23 ' B' ' 38' ' ' LEU . 9.3 tt -75.3 -48.59 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 t -73.01 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.746 0.784 . . . . 0.0 109.889 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.6 m -68.6 -47.49 66.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.707 -0.621 . . . . 0.0 111.971 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.52 -117.82 11.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.627 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -42.78 92.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -1.061 . . . . 0.0 111.432 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.31 -18.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.815 -1.178 . . . . 0.0 110.329 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.49 -176.59 44.91 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 -166.94 171.05 11.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.084 -1.833 . . . . 0.0 111.372 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.471 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.5 135.97 0.25 Allowed 'General case' 0 C--N 1.4 2.791 0 O-C-N 119.762 -1.836 . . . . 0.0 108.058 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 121.4 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.975 . . . . 0.0 109.642 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.644 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 44.6 mtpt -89.66 -32.92 0.38 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 111.78 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 17.4 Cg_exo -56.06 -72.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.718 0.946 . . . . 0.0 110.514 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.53 -179.921 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.971 0 N-CA-C 119.791 2.676 . . . . 0.0 119.791 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.797 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt -48.56 -29.96 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -1.16 . . . . 0.0 109.608 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 7' ' ' CYS . 88.5 t -59.99 -50.38 80.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.826 -1.171 . . . . 0.0 110.974 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.16 -62.34 1.7 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.576 -1.328 . . . . 0.0 110.927 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 23.3 mp0 -59.34 -40.92 87.91 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.971 -1.081 . . . . 0.0 111.872 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -45.99 10.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.053 -1.029 . . . . 0.0 112.126 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.4 t -82.82 -52.86 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.792 -1.192 . . . . 0.0 110.99 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 m -71.18 -28.0 63.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.5 m -136.1 174.04 11.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.39 128.92 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.646 -1.284 . . . . 0.0 109.01 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.18 -173.06 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.167 0.984 . . . . 0.0 109.867 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -136.84 154.44 50.51 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.17 -60.66 1.79 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.322 1.058 . . . . 0.0 109.327 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.26 -45.22 17.05 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.878 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.4 mt-30 -64.76 -32.64 74.42 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.63 -34.7 65.13 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.807 -1.157 . . . . 0.0 108.156 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.0 mt-10 -65.19 -37.77 88.39 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.146 0.974 . . . . 0.0 110.385 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.78 -36.89 17.61 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.916 0.865 . . . . 0.0 110.054 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.628 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.5 m-85 -88.14 3.01 50.76 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 m -74.66 75.42 2.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 119.809 -1.807 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 32.9 t30 . . . . . 0 C--N 1.293 -1.88 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.588 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -150.12 165.82 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.994 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.588 ' N ' HG22 ' B' ' 23' ' ' VAL . 12.9 m120 -123.46 71.64 1.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -121.2 170.58 9.44 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.813 0.816 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -91.0 91.98 8.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.92 141.32 31.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 110.568 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 43.6 m -142.66 124.31 14.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.026 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.64 -107.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.406 ' C ' ' O ' ' B' ' 29' ' ' GLY . 39.2 m -38.61 -59.56 0.91 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -1.04 . . . . 0.0 111.328 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.73 -44.42 90.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 109.572 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 2' ' ' ILE . 24.8 tp -66.24 -63.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.628 -0.67 . . . . 0.0 109.72 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.9 t -40.58 -57.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 122.061 0.934 . . . . 0.0 108.724 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -54.16 -39.35 66.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.49 74.32 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.79 HD11 HD13 ' A' ' 2' ' ' ILE . 49.1 mt -75.37 -57.36 3.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.575 -1.328 . . . . 0.0 108.798 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -46.41 -30.19 2.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.9 -47.09 31.75 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.63 -61.15 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.834 0.826 . . . . 0.0 109.873 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.9 m -68.03 -47.19 69.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.766 -0.584 . . . . 0.0 111.992 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.05 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.545 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.6 tt0 -63.42 -43.08 98.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -1.064 . . . . 0.0 110.997 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.51 -18.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 110.372 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -176.42 42.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.581 -2.207 . . . . 0.0 107.581 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.458 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 -167.59 170.72 10.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.202 -1.764 . . . . 0.0 111.082 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.482 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.86 104.19 0.06 Allowed 'General case' 0 C--N 1.403 2.908 0 O-C-N 119.568 -1.957 . . . . 0.0 108.656 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 47.3 p -96.57 11.14 36.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.884 . . . . 0.0 109.253 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 45.88 72.27 1.29 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 109.742 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.18 -70.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.589 1.526 . . . . 0.0 110.32 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.511 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.917 0 N-CA-C 119.754 2.661 . . . . 0.0 119.754 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 32' ' ' LEU . 8.7 tt -65.08 -29.11 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.294 -1.121 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 7' ' ' CYS . 74.7 t -61.65 -50.12 81.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.804 -1.185 . . . . 0.0 110.763 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.56 -62.45 1.62 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.642 -1.287 . . . . 0.0 111.073 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.7 mp0 -61.83 -39.92 93.49 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 111.866 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.8 m -86.07 -45.73 11.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.051 -1.031 . . . . 0.0 112.241 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 3' ' ' VAL . 41.5 t -83.23 -52.91 6.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.671 -1.268 . . . . 0.0 110.957 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 m -70.65 -28.01 64.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.795 -1.191 . . . . 0.0 108.935 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.4 m -136.04 174.03 11.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.52 135.78 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.566 -1.334 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -101.09 -172.9 2.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.1 0.953 . . . . 0.0 109.659 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -137.51 156.35 48.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.7 -60.48 1.99 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 109.327 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.3 -45.21 17.25 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.892 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.9 mt-30 -64.76 -32.57 74.31 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.77 -34.59 64.74 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.117 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 13.3 mt-10 -65.32 -37.71 87.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.131 0.967 . . . . 0.0 110.327 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.9 -36.96 18.39 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.889 0.852 . . . . 0.0 109.94 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.622 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -88.42 4.01 47.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -76.29 73.58 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.773 -1.829 . . . . 0.0 110.05 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.416 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 47.5 t30 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.46 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.58 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -151.27 165.85 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.957 -1.09 . . . . 0.0 110.084 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.58 ' N ' HG22 ' B' ' 23' ' ' VAL . 11.0 m120 -123.16 71.27 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -120.44 170.49 9.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.826 0.822 . . . . 0.0 110.139 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -90.87 92.05 8.61 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.68 140.74 31.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.421 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -142.67 124.2 14.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.12 -107.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.8 m -38.44 -59.75 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -1.059 . . . . 0.0 111.368 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.23 -44.4 88.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.988 -1.07 . . . . 0.0 109.609 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 2' ' ' ILE . 25.4 tp -66.22 -63.33 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.693 -0.63 . . . . 0.0 109.873 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' GLY . 42.5 t -40.47 -57.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.043 0.925 . . . . 0.0 108.75 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -54.24 -39.09 66.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.71 -35.45 74.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.814 HD11 HD13 ' A' ' 2' ' ' ILE . 49.8 mt -75.46 -57.29 3.98 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.452 -1.405 . . . . 0.0 108.741 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -46.12 -30.61 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.53 -45.93 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.0 t -77.38 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.716 0.77 . . . . 0.0 109.949 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.63 -47.3 66.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.788 -0.57 . . . . 0.0 111.897 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 -117.91 10.65 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.642 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' B' ' 44' ' ' GLY . 41.5 tt0 -66.14 -41.31 90.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.321 -1.105 . . . . 0.0 111.233 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.1 mtm180 -49.38 -16.27 0.18 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.48 -173.79 43.02 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.193 -2.363 . . . . 0.0 107.193 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.416 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.0 p90 -169.04 169.59 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 119.996 -1.885 . . . . 0.0 111.434 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.479 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.552 ' O ' ' CB ' ' B' ' 48' ' ' THR . 0.2 OUTLIER -169.92 -64.39 0.02 OUTLIER 'General case' 0 C--N 1.405 2.991 0 O-C-N 119.376 -2.077 . . . . 0.0 109.239 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.552 ' CB ' ' O ' ' B' ' 47' ' ' TYR . 2.7 m 97.0 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 2.5 mtmt -70.38 -43.16 16.87 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.475 -0.765 . . . . 0.0 110.898 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 21.7 Cg_exo -53.53 -63.03 0.25 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.942 1.094 . . . . 0.0 110.537 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.54 179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.954 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.798 HD11 HD11 ' B' ' 32' ' ' LEU . 8.5 tt -49.04 -31.03 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.518 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 7' ' ' CYS . 64.0 t -59.63 -51.52 71.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.861 -1.15 . . . . 0.0 110.736 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -50.92 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.593 -1.317 . . . . 0.0 110.907 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.57 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.7 mp0 -59.68 -41.36 90.51 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.045 -1.034 . . . . 0.0 111.975 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.2 -45.56 11.2 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 0.0 112.047 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.474 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.69 -53.18 6.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.837 -1.165 . . . . 0.0 111.053 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 m -71.43 -27.62 63.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.187 . . . . 0.0 108.945 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.5 m -136.14 173.96 11.14 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.21 130.04 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.61 -1.306 . . . . 0.0 108.851 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.31 -173.08 3.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.212 1.006 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.89 151.85 48.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.15 -60.52 1.42 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.286 1.041 . . . . 0.0 109.622 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.71 -45.22 19.38 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.84 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.3 mt-30 -64.4 -32.61 74.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.51 -35.25 65.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.167 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.6 mt-10 -64.68 -37.59 88.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.124 0.964 . . . . 0.0 110.367 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.86 -36.85 17.92 Favored 'General case' 0 C--N 1.286 -2.196 0 CA-C-O 121.982 0.896 . . . . 0.0 109.982 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.615 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.53 4.33 47.14 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.0 m -76.55 74.27 3.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.787 -1.821 . . . . 0.0 109.824 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 18.7 t30 . . . . . 0 C--N 1.294 -1.826 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.547 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.591 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -147.81 165.58 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.591 ' N ' HG22 ' B' ' 23' ' ' VAL . 67.2 m-20 -122.69 71.27 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -120.37 169.56 10.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.802 0.811 . . . . 0.0 110.166 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -90.53 92.69 8.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.06 138.82 32.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.677 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' GLY . 56.4 m -140.15 124.04 17.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.363 -0.836 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -108.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' ' 29' ' ' GLY . 10.0 t -39.08 -56.29 1.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.433 -1.039 . . . . 0.0 111.403 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -27.49 65.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.113 . . . . 0.0 110.022 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.798 HD11 HD11 ' A' ' 2' ' ' ILE . 19.8 tp -84.23 -61.57 1.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.78 . . . . 0.0 109.272 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' B' ' 29' ' ' GLY . 43.2 t -40.97 -57.68 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.828 0.823 . . . . 0.0 109.028 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.08 -36.71 63.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.24 -36.33 79.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 2' ' ' ILE . 52.1 mt -75.06 -56.52 4.66 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.568 -1.333 . . . . 0.0 108.654 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.67 -30.72 2.49 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.446 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.0 tt -75.76 -47.9 23.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.98 -60.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.707 0.765 . . . . 0.0 109.819 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' B' ' 36' ' ' LEU . 23.7 m -69.38 -47.29 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.699 -0.626 . . . . 0.0 112.096 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.26 -118.15 11.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.564 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 4.7 tp10 -63.83 -43.77 95.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -1.098 . . . . 0.0 111.123 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -49.22 -14.69 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.854 -1.153 . . . . 0.0 110.637 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.21 -173.15 39.91 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.7 p90 -169.31 169.79 8.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.026 -1.867 . . . . 0.0 111.471 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.477 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.58 97.78 0.24 Allowed 'General case' 0 C--N 1.403 2.928 0 O-C-N 119.637 -1.914 . . . . 0.0 108.404 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -64.25 107.93 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.475 -0.766 . . . . 0.0 109.643 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -65.23 116.64 32.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -53.19 -55.09 3.99 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 CA-C-N 119.102 0.715 . . . . 0.0 110.359 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.49 179.961 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.515 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.974 0 N-CA-C 119.767 2.667 . . . . 0.0 119.767 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 36' ' ' LEU . 8.0 tt -62.35 -29.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -1.128 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' CYS . 84.4 t -59.34 -50.43 79.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.893 -1.129 . . . . 0.0 110.909 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -51.1 -62.49 1.58 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.62 -1.3 . . . . 0.0 111.088 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.4 mp0 -60.5 -40.25 90.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 111.945 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.43 -46.03 10.61 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.014 -1.054 . . . . 0.0 112.081 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.9 t -82.7 -53.05 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.855 -1.153 . . . . 0.0 111.057 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.01 -28.51 64.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.793 -1.192 . . . . 0.0 108.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.8 m -135.8 174.18 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.63 131.05 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.611 -1.306 . . . . 0.0 108.763 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -93.69 -173.07 3.06 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.26 1.029 . . . . 0.0 109.927 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.459 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -138.11 152.19 48.52 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -42.55 -60.76 1.42 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.267 1.032 . . . . 0.0 109.49 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.52 -45.3 18.43 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.845 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.573 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.3 mt-30 -64.61 -32.47 74.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.72 -34.98 65.05 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.166 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.66 -37.74 88.62 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 122.147 0.975 . . . . 0.0 110.387 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.01 18.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.983 0.897 . . . . 0.0 110.086 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.609 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.3 m-85 -88.21 3.42 49.45 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.0 m -75.61 74.95 2.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 119.803 -1.811 . . . . 0.0 109.785 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.435 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 12.0 t-20 . . . . . 0 C--N 1.295 -1.785 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.534 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.604 HG22 ' N ' ' B' ' 24' ' ' ASN . 5.0 p -120.92 164.97 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.384 -0.822 . . . . 0.0 109.995 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.604 ' N ' HG22 ' B' ' 23' ' ' VAL . 69.2 m-20 -123.56 71.55 1.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -121.61 170.51 9.63 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.853 0.835 . . . . 0.0 110.058 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -89.33 91.72 8.86 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.96 138.23 33.88 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.638 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.8 m -139.62 124.09 18.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.604 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.83 -108.99 0.09 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 29' ' ' GLY . 58.5 m -38.85 -58.14 1.13 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.37 -1.076 . . . . 0.0 111.642 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 -27.02 66.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 110.11 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 2' ' ' ILE . 19.7 tp -84.15 -61.44 1.81 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.442 -0.786 . . . . 0.0 109.262 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.5 t -41.28 -57.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 121.773 0.797 . . . . 0.0 109.001 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -54.14 -35.95 62.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.98 -36.09 80.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.816 HD11 HD13 ' A' ' 2' ' ' ILE . 50.2 mt -74.75 -57.77 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.886 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.3 t80 -45.58 -31.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.477 ' C ' HD23 ' B' ' 38' ' ' LEU . 9.5 tt -74.91 -47.07 31.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.95 -60.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.725 0.774 . . . . 0.0 109.818 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.2 m -68.69 -47.18 67.11 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.773 -0.579 . . . . 0.0 112.055 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.23 -117.86 11.66 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.465 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' B' ' 44' ' ' GLY . 15.8 tp10 -63.46 -43.92 95.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -1.095 . . . . 0.0 111.221 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -49.72 -15.49 0.18 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.869 -1.144 . . . . 0.0 110.631 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.43 -174.88 37.62 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.9 p90 -167.95 170.69 10.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.116 -1.814 . . . . 0.0 111.194 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.484 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.413 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -175.86 84.11 0.03 OUTLIER 'General case' 0 C--N 1.402 2.86 0 O-C-N 119.68 -1.887 . . . . 0.0 108.11 178.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.454 ' O ' ' O ' ' B' ' 49' ' ' LYS . 26.3 p -147.55 -144.92 0.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.985 . . . . 0.0 109.229 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' B' ' 48' ' ' THR . 10.1 mtmt 58.27 158.0 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -51.75 -59.21 1.2 Allowed 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 120.624 0.883 . . . . 0.0 110.393 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.477 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.951 0 N-CA-C 119.757 2.663 . . . . 0.0 119.757 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.815 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt -48.76 -30.28 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.515 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.0 t -60.26 -51.68 70.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.742 -1.224 . . . . 0.0 110.673 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -50.83 -62.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.62 -1.3 . . . . 0.0 110.888 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 22.0 mp0 -60.09 -41.15 91.86 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.956 -1.09 . . . . 0.0 112.028 -177.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.583 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.21 -45.51 11.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.032 -1.043 . . . . 0.0 111.975 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 38.3 t -82.67 -53.1 6.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.795 -1.191 . . . . 0.0 111.056 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 m -71.47 -27.87 63.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.742 -1.224 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.2 m -135.76 174.12 10.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.61 130.28 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.651 -1.28 . . . . 0.0 109.039 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.22 -172.97 2.95 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.152 0.977 . . . . 0.0 109.855 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -137.5 154.31 49.9 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -43.83 -60.57 1.76 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.4 1.095 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -46.43 -44.96 17.73 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.2 mt-30 -64.99 -32.41 74.12 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.59 -34.86 65.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.909 -1.117 . . . . 0.0 108.128 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.9 mt-10 -65.03 -37.75 88.64 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.122 0.963 . . . . 0.0 110.398 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.09 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.907 0.86 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.615 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.0 m-85 -87.77 3.12 49.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -75.42 75.79 2.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 119.702 -1.874 . . . . 0.0 109.993 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.45 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 26.6 t30 . . . . . 0 C--N 1.295 -1.804 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.646 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.584 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -148.23 165.59 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 109.937 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.584 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.0 m120 -121.85 71.11 0.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -119.49 169.65 9.86 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.824 0.821 . . . . 0.0 110.196 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.69 92.02 8.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -83.75 139.71 32.55 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.43 -0.794 . . . . 0.0 110.734 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 m -140.28 124.11 17.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.339 -0.851 . . . . 0.0 109.745 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -109.98 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 41.5 t -38.82 -54.84 1.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.378 -1.072 . . . . 0.0 111.464 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.5 OUTLIER -70.49 -27.8 64.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.98 -1.075 . . . . 0.0 109.889 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 2' ' ' ILE . 19.6 tp -84.23 -61.5 1.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.457 -0.777 . . . . 0.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.3 t -41.15 -57.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.836 0.827 . . . . 0.0 108.948 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.31 -36.48 63.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.37 -36.08 79.24 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.795 HD11 HD13 ' A' ' 2' ' ' ILE . 50.8 mt -75.02 -57.24 4.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.644 -1.285 . . . . 0.0 108.765 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -46.2 -31.29 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -74.65 -48.22 27.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -73.93 -60.68 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.789 0.804 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.7 m -68.69 -47.22 66.99 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 112.166 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.67 -120.76 17.96 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.572 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.4 tt0 -63.58 -43.18 97.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.337 -1.096 . . . . 0.0 111.121 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -46.77 -18.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.982 -1.074 . . . . 0.0 110.448 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.04 -176.07 41.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.45 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 -167.6 170.11 11.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.164 -1.786 . . . . 0.0 111.201 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.48 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.409 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -175.91 92.12 0.05 Allowed 'General case' 0 C--N 1.401 2.843 0 O-C-N 119.581 -1.949 . . . . 0.0 108.639 178.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.7 OUTLIER -80.95 -117.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 108.843 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.525 ' N ' ' OG1' ' B' ' 48' ' ' THR . 0.3 OUTLIER -93.3 169.49 10.2 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -50.31 -67.22 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.289 1.326 . . . . 0.0 110.497 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.405 HG22 ' H ' ' B' ' 51' ' ' THR . 1.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.421 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.999 0 N-CA-C 119.719 2.647 . . . . 0.0 119.719 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.821 HD11 HD11 ' B' ' 32' ' ' LEU . 8.0 tt -59.52 -30.95 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -1.142 . . . . 0.0 109.564 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -59.36 -49.7 82.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.881 -1.137 . . . . 0.0 110.821 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -52.2 -62.5 1.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.668 -1.27 . . . . 0.0 111.055 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.1 mp0 -60.59 -39.88 89.72 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.936 -1.103 . . . . 0.0 111.836 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.49 -46.22 10.39 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.068 -1.02 . . . . 0.0 112.164 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.1 t -82.84 -52.88 6.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.77 -1.206 . . . . 0.0 110.897 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -70.34 -30.61 67.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.758 -1.214 . . . . 0.0 108.849 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.7 m -133.41 174.22 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.73 129.57 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.627 -1.295 . . . . 0.0 109.077 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.33 -173.07 3.12 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.191 0.996 . . . . 0.0 109.838 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.471 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -137.38 155.46 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.26 -60.56 1.86 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.355 1.074 . . . . 0.0 109.363 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.39 -45.05 17.61 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.889 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.5 mt-30 -64.86 -32.52 74.27 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.67 -35.17 65.18 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.156 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 31.3 mt-10 -64.6 -37.81 88.84 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.154 0.978 . . . . 0.0 110.39 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.0 -37.02 19.05 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.913 0.863 . . . . 0.0 110.136 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.627 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -88.2 2.8 51.41 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.01 73.56 2.19 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 119.848 -1.783 . . . . 0.0 110.111 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 38.7 t-20 . . . . . 0 C--N 1.293 -1.878 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.576 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.28 165.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.993 -1.067 . . . . 0.0 109.985 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.576 ' N ' HG22 ' B' ' 23' ' ' VAL . 61.0 m-20 -121.66 70.99 0.96 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -119.39 169.19 10.23 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.05 92.29 8.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -83.7 141.2 31.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.387 -0.82 . . . . 0.0 110.6 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.5 m -142.5 124.25 15.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 109.954 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.5 -107.45 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 13.1 t -38.65 -59.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.343 -1.092 . . . . 0.0 111.447 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -42.73 93.25 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 2' ' ' ILE . 24.4 tp -68.03 -63.23 1.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.724 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.569 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.8 t -40.52 -56.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 122.018 0.913 . . . . 0.0 108.655 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.39 -40.05 67.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.9 -36.03 74.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 2' ' ' ILE . 49.5 mt -74.95 -57.48 3.88 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.518 -1.364 . . . . 0.0 108.736 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -46.09 -30.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.445 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.0 tt -75.92 -47.33 25.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.71 -60.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.24 -47.3 68.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.727 -0.608 . . . . 0.0 112.091 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.1 -117.91 10.41 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.4 tt0 -65.89 -41.88 90.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 111.354 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -49.45 -15.78 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.868 -1.145 . . . . 0.0 110.327 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.16 -172.77 40.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.8 p90 -169.76 170.14 8.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.112 -1.817 . . . . 0.0 110.936 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.475 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.407 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -176.39 -84.88 0.0 OUTLIER 'General case' 0 C--N 1.401 2.821 0 O-C-N 119.815 -1.803 . . . . 0.0 107.797 178.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.502 HG22 ' H ' ' B' ' 49' ' ' LYS . 1.6 m 43.67 -140.37 0.22 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.246 -0.909 . . . . 0.0 110.048 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.502 ' H ' HG22 ' B' ' 48' ' ' THR . 50.1 mttm 46.82 72.42 1.26 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 109.874 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -57.2 -54.13 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.736 1.624 . . . . 0.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.327 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.938 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 HD11 ' B' ' 32' ' ' LEU . 9.4 tt -53.06 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -68.47 -50.71 54.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.561 -1.337 . . . . 0.0 110.641 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -50.89 -62.58 1.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.58 -1.325 . . . . 0.0 111.097 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.576 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 1.9 mp0 -62.69 -40.05 95.9 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.896 -1.127 . . . . 0.0 111.948 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 4.3 m -85.81 -44.96 12.03 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.06 -1.025 . . . . 0.0 112.222 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 3' ' ' VAL . 49.0 t -83.14 -53.07 6.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.536 -1.353 . . . . 0.0 110.906 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -69.9 -31.47 69.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.822 -1.174 . . . . 0.0 108.807 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.9 m -132.09 174.01 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.81 136.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.598 -1.314 . . . . 0.0 108.975 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -102.71 -172.92 2.21 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.127 0.965 . . . . 0.0 109.668 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.455 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -137.45 157.08 47.35 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -44.34 -60.26 2.01 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.296 1.046 . . . . 0.0 109.452 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.27 -45.13 17.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.948 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 64.1 mt-30 -64.7 -32.55 74.28 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.87 -35.35 64.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.28 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 21.8 mt-10 -64.34 -37.73 88.55 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.12 0.962 . . . . 0.0 110.464 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.83 -37.17 18.59 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.94 0.876 . . . . 0.0 110.173 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.613 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.9 m-85 -87.71 2.73 50.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.5 m -74.12 74.29 1.75 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 119.806 -1.809 . . . . 0.0 110.045 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 32.3 t30 . . . . . 0 C--N 1.293 -1.861 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.74 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.599 HG22 ' N ' ' B' ' 24' ' ' ASN . 4.0 p -149.16 166.06 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.083 . . . . 0.0 109.801 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.599 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.0 m120 -123.47 69.73 1.03 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -118.63 168.24 10.89 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.789 0.804 . . . . 0.0 109.957 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -88.8 91.85 8.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.43 138.91 33.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.432 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.4 m -140.29 124.04 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.18 -109.43 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.5 m -38.92 -58.18 1.14 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -1.094 . . . . 0.0 111.674 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.73 -27.27 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.917 -1.114 . . . . 0.0 110.057 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.82 HD11 HD11 ' A' ' 2' ' ' ILE . 18.9 tp -84.16 -61.47 1.8 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.324 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 33.1 t -41.28 -57.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.771 0.796 . . . . 0.0 108.992 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.07 -36.17 62.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.58 -36.32 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.812 HD11 HD13 ' A' ' 2' ' ' ILE . 48.9 mt -74.44 -57.84 3.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.617 -1.302 . . . . 0.0 108.876 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.7 t80 -45.94 -30.02 1.62 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.53 ' C ' HD23 ' B' ' 38' ' ' LEU . 8.9 tt -76.73 -46.03 27.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.0 t -75.88 -60.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.757 0.789 . . . . 0.0 109.677 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.3 m -68.17 -47.06 69.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.704 -0.623 . . . . 0.0 111.942 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -118.4 12.23 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.755 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.7 tt0 -64.75 -43.14 94.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -1.076 . . . . 0.0 111.351 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.2 mtm180 -48.24 -17.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.912 -1.118 . . . . 0.0 110.415 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -175.51 44.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.431 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.6 p90 -168.13 170.93 9.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.203 -1.763 . . . . 0.0 110.905 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.485 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.407 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER 179.48 134.06 0.1 Allowed 'General case' 0 C--N 1.401 2.808 0 O-C-N 119.811 -1.806 . . . . 0.0 108.236 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -82.17 171.28 14.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.22 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -50.65 151.97 3.75 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.139 -0.976 . . . . 0.0 108.709 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -50.38 -71.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 120.514 0.809 . . . . 0.0 110.478 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.124 -179.751 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.98 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.788 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt -54.21 -30.95 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -1.148 . . . . 0.0 109.618 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.7 t -59.17 -50.1 81.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.813 -1.179 . . . . 0.0 110.814 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.65 -62.45 1.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.596 -1.315 . . . . 0.0 111.032 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.55 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -60.24 -40.25 89.58 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.954 -1.091 . . . . 0.0 111.949 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.49 -46.16 10.44 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.038 -1.039 . . . . 0.0 112.008 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.93 -52.95 6.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.797 -1.19 . . . . 0.0 111.023 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.87 -28.32 64.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.731 -1.231 . . . . 0.0 108.889 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.9 m -135.97 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.22 128.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.616 -1.302 . . . . 0.0 108.981 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.32 -173.05 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.259 1.028 . . . . 0.0 109.974 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.11 151.61 49.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.35 -60.56 1.45 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.237 1.017 . . . . 0.0 109.572 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.66 -45.13 19.07 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.823 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.0 mt-30 -64.35 -32.59 74.25 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.82 -35.37 64.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.268 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.2 mt-10 -64.43 -37.61 88.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.088 0.947 . . . . 0.0 110.43 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.79 -37.13 18.28 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.929 0.871 . . . . 0.0 110.088 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.646 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.9 m-85 -88.29 3.81 48.28 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.2 m -76.04 75.0 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 119.83 -1.794 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.434 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 14.1 t-20 . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.576 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.591 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -147.81 165.47 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.018 -1.051 . . . . 0.0 109.847 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.591 ' N ' HG22 ' B' ' 23' ' ' VAL . 15.0 m120 -122.93 71.7 1.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -120.94 170.75 9.19 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.804 0.812 . . . . 0.0 110.09 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -90.89 92.63 8.86 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.96 140.25 32.04 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.366 -0.833 . . . . 0.0 110.572 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' B' ' 29' ' ' GLY . 54.4 m -142.38 124.36 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 67.1 m -38.53 -60.56 0.79 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.391 -1.064 . . . . 0.0 111.391 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.91 -45.46 89.21 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.014 -1.054 . . . . 0.0 109.636 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 2' ' ' ILE . 25.3 tp -64.84 -63.71 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.663 . . . . 0.0 109.638 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.9 t -40.85 -57.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -53.97 -39.66 66.17 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.56 -36.65 76.61 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.786 HD11 HD13 ' A' ' 2' ' ' ILE . 52.1 mt -74.29 -57.1 4.17 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.505 -1.372 . . . . 0.0 108.844 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.8 t80 -46.66 -30.57 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.555 ' C ' HD23 ' B' ' 38' ' ' LEU . 8.4 tt -75.96 -47.49 24.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.78 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.747 0.784 . . . . 0.0 109.669 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.7 m -67.94 -47.24 69.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.777 -0.577 . . . . 0.0 112.037 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.76 -117.84 10.56 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.696 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -39.59 90.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -1.059 . . . . 0.0 111.403 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 2.6 mtm180 -52.56 -15.68 0.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.78 -173.87 40.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.434 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.8 p90 -168.31 170.57 9.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.083 -1.834 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.489 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' B' ' 48' ' ' THR . 0.2 OUTLIER -172.69 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.403 2.924 0 O-C-N 119.461 -2.024 . . . . 0.0 108.984 178.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 47' ' ' TYR . 60.8 p -41.02 143.63 0.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 110.246 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 53.09 71.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.857 . . . . 0.0 109.35 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -57.7 -71.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.819 1.679 . . . . 0.0 110.52 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.495 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.515 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.948 0 N-CA-C 119.916 2.727 . . . . 0.0 119.916 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.792 HD11 HD11 ' B' ' 32' ' ' LEU . 7.8 tt -68.32 -30.8 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.0 t -58.98 -49.46 83.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.831 -1.168 . . . . 0.0 110.838 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -52.57 -62.37 1.69 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.591 -1.318 . . . . 0.0 111.042 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -59.82 -40.48 88.59 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.879 -1.138 . . . . 0.0 111.82 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.3 -46.13 10.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.084 -1.01 . . . . 0.0 112.111 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.2 t -82.98 -53.04 6.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.719 -1.238 . . . . 0.0 110.953 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.67 -28.07 64.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.763 -1.211 . . . . 0.0 108.883 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.1 m -136.31 174.22 10.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.63 127.65 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.625 -1.297 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -90.31 -173.08 3.68 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.209 1.005 . . . . 0.0 109.959 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.44 152.51 49.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.59 -60.59 1.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 122.369 1.08 . . . . 0.0 109.651 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -46.52 -45.19 18.39 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.874 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.7 mt-30 -64.26 -32.53 74.15 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -74.03 -35.1 64.33 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.256 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 18.5 mt-10 -64.37 -37.74 88.57 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.126 0.965 . . . . 0.0 110.393 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -49.04 -37.36 20.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.972 0.892 . . . . 0.0 110.217 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.632 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.5 m-85 -87.7 2.66 50.49 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.3 m -75.71 75.03 2.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 119.886 -1.759 . . . . 0.0 110.069 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 27.1 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.053 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.586 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.7 p -148.38 165.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.076 -1.015 . . . . 0.0 109.817 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.586 ' N ' HG22 ' B' ' 23' ' ' VAL . 8.5 m120 -123.18 71.22 1.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -119.87 170.06 9.59 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.752 0.787 . . . . 0.0 109.994 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -90.9 94.22 9.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -85.48 140.78 30.41 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.488 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.412 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.0 m -142.53 124.25 15.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.32 -107.17 0.06 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 29' ' ' GLY . 11.1 t -38.58 -59.98 0.86 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -1.109 . . . . 0.0 111.344 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.77 -43.63 92.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.977 -1.077 . . . . 0.0 109.689 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 2' ' ' ILE . 23.9 tp -66.9 -63.26 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 109.642 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.7 t -40.6 -57.16 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.021 0.915 . . . . 0.0 108.709 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -53.86 -39.65 65.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.43 -36.21 75.46 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.791 HD11 HD13 ' A' ' 2' ' ' ILE . 49.1 mt -74.68 -57.33 3.99 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.527 -1.358 . . . . 0.0 108.825 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.41 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.4 t80 -46.04 -31.23 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.435 ' C ' HD23 ' B' ' 38' ' ' LEU . 9.8 tt -74.76 -47.82 28.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.3 t -74.16 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.71 0.767 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 22.2 m -67.98 -47.19 69.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.748 -0.595 . . . . 0.0 112.058 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.7 11.6 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.539 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' B' ' 44' ' ' GLY . 52.2 tp10 -62.58 -44.07 97.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.318 -1.107 . . . . 0.0 111.446 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -50.72 -14.0 0.17 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.918 -1.114 . . . . 0.0 110.667 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 68.53 -173.44 33.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -169.38 169.48 8.99 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.138 -1.801 . . . . 0.0 110.841 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.492 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' B' ' 48' ' ' THR . 0.1 OUTLIER -178.6 140.74 0.2 Allowed 'General case' 0 C--N 1.401 2.807 0 O-C-N 119.689 -1.882 . . . . 0.0 108.534 178.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.43 ' O ' ' O ' ' B' ' 47' ' ' TYR . 16.9 m 52.98 101.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -0.818 . . . . 0.0 109.861 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.59 ' H ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -82.25 160.5 62.45 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -49.75 -72.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.407 1.405 . . . . 0.0 110.695 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.457 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.999 0 N-CA-C 119.817 2.687 . . . . 0.0 119.817 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.821 HD11 HD11 ' B' ' 32' ' ' LEU . 8.0 tt -65.54 -29.81 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.502 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 7' ' ' CYS . 85.0 t -59.84 -50.3 80.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.889 -1.132 . . . . 0.0 110.809 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.32 -62.44 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.7 -1.25 . . . . 0.0 111.041 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.0 mp0 -60.76 -40.36 92.18 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 111.889 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.29 -46.03 10.7 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.047 -1.033 . . . . 0.0 112.164 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.8 t -82.83 -52.97 6.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.719 -1.238 . . . . 0.0 111.027 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -70.99 -28.25 64.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.793 -1.192 . . . . 0.0 108.919 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -135.99 174.17 10.9 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mt -87.09 130.86 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.587 -1.321 . . . . 0.0 109.051 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.67 -173.19 2.94 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.223 1.011 . . . . 0.0 109.845 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -136.96 155.43 49.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.7 tp -44.97 -60.69 1.94 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.303 1.049 . . . . 0.0 109.239 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.2 -45.07 16.66 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.847 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.586 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 63.9 mt-30 -64.86 -32.73 74.57 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.6 -35.19 65.34 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.159 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 29.2 mt-10 -64.59 -37.76 88.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.134 0.969 . . . . 0.0 110.37 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.92 -36.99 18.55 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 121.871 0.843 . . . . 0.0 110.066 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.29 2.93 51.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.32 74.41 1.85 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.8 -1.812 . . . . 0.0 109.892 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.446 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 21.4 t-20 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.668 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.574 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -149.72 165.53 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.054 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.574 ' N ' HG22 ' B' ' 23' ' ' VAL . 11.8 m120 -121.31 71.27 0.95 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -120.22 169.84 9.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.832 0.825 . . . . 0.0 110.179 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -91.13 92.75 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.36 140.65 31.44 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 110.514 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -142.05 124.26 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.66 -107.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.8 m -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.381 -1.07 . . . . 0.0 111.358 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -42.9 95.99 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.962 -1.086 . . . . 0.0 109.695 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 2' ' ' ILE . 25.2 tp -68.17 -63.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.81 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.66 -57.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -53.79 -39.29 65.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.68 -36.46 76.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.8 HD11 HD13 ' A' ' 2' ' ' ILE . 50.7 mt -74.49 -56.74 4.5 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.55 -1.344 . . . . 0.0 108.703 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -46.45 -30.71 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.616 ' C ' HD23 ' B' ' 38' ' ' LEU . 7.3 tt -75.98 -46.52 29.18 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.03 -61.17 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.82 0.819 . . . . 0.0 109.73 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.5 m -68.05 -47.23 68.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.772 -0.58 . . . . 0.0 111.993 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.22 -117.87 11.02 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.665 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.37 -42.46 92.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -1.06 . . . . 0.0 111.309 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.99 -17.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.853 -1.155 . . . . 0.0 110.506 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.7 -175.03 44.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.446 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.3 p90 -167.98 170.66 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.088 -1.831 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.472 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.416 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -177.04 87.79 0.03 OUTLIER 'General case' 0 C--N 1.4 2.779 0 O-C-N 119.826 -1.796 . . . . 0.0 107.654 178.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -86.78 -19.31 29.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.17 -0.956 . . . . 0.0 110.204 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.45 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 7.6 mtmp? 53.42 75.8 0.59 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.08 -1.013 . . . . 0.0 109.436 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -55.6 -72.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.494 1.463 . . . . 0.0 110.555 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.565 179.988 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.95 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.804 HD11 HD11 ' B' ' 32' ' ' LEU . 8.8 tt -62.32 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -1.118 . . . . 0.0 109.716 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.2 t -61.75 -49.34 84.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.78 -1.2 . . . . 0.0 111.01 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -51.95 -62.54 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.24 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.6 mp0 -62.38 -38.8 90.99 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.845 -1.159 . . . . 0.0 111.872 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 3.8 m -86.33 -46.13 10.58 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.976 -1.078 . . . . 0.0 112.101 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.0 t -83.31 -53.0 6.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.649 -1.282 . . . . 0.0 110.945 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -69.91 -29.73 66.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.725 -1.234 . . . . 0.0 108.857 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.3 m -134.83 174.19 10.86 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -86.41 134.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.587 -1.321 . . . . 0.0 108.951 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -98.82 -172.96 2.4 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.203 1.001 . . . . 0.0 109.838 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.28 152.46 49.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.16 -60.32 1.49 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.229 1.014 . . . . 0.0 109.617 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.91 -45.24 20.45 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.824 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 62.0 mt-30 -64.19 -32.56 74.18 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -35.72 65.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.267 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.453 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 25.8 mt-10 -64.2 -37.64 88.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.128 0.965 . . . . 0.0 110.462 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -48.78 -37.21 18.46 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.885 0.85 . . . . 0.0 110.063 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.63 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.4 m-85 -88.01 2.81 50.9 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.4 m -75.41 74.51 2.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 119.84 -1.788 . . . . 0.0 110.189 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' CYS . 37.2 t-20 . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.988 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.584 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -150.21 165.91 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 109.841 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.584 ' N ' HG22 ' B' ' 23' ' ' VAL . 7.5 m120 -123.49 71.69 1.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -120.42 169.74 10.03 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.752 0.786 . . . . 0.0 110.057 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -90.06 92.02 8.8 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.54 141.26 31.73 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.3 m -143.17 124.33 14.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.956 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 29' ' ' GLY . 26.4 t -38.73 -60.75 0.79 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -1.085 . . . . 0.0 111.46 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -43.57 95.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.934 -1.104 . . . . 0.0 109.72 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 2' ' ' ILE . 24.4 tp -67.24 -63.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 0.0 109.732 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.1 t -40.62 -57.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.033 0.92 . . . . 0.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -53.65 -39.53 65.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.46 -36.63 76.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.789 HD11 HD13 ' A' ' 2' ' ' ILE . 49.8 mt -74.44 -56.67 4.59 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.553 -1.342 . . . . 0.0 108.722 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -46.33 -30.67 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.595 ' C ' HD23 ' B' ' 38' ' ' LEU . 7.7 tt -76.39 -48.23 20.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.83 -60.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.828 0.823 . . . . 0.0 109.687 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.38 -47.17 68.07 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.802 -0.561 . . . . 0.0 112.152 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -121.72 22.44 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.353 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' B' ' 44' ' ' GLY . 8.3 tp10 -61.26 -44.14 97.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -1.096 . . . . 0.0 110.979 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -16.68 0.07 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.999 -1.063 . . . . 0.0 110.622 -177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.45 -174.62 38.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.404 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.1 p90 -169.24 169.92 8.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.185 -1.773 . . . . 0.0 110.917 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' 23F . . . . . 0.482 ' HD1' ' N ' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -178.11 114.31 0.08 Allowed 'General case' 0 C--N 1.402 2.861 0 O-C-N 119.573 -1.954 . . . . 0.0 108.535 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.3 t -89.02 -173.07 3.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.269 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.544 ' H ' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -149.45 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.309 -0.87 . . . . 0.0 109.677 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.544 ' HD2' ' H ' ' B' ' 49' ' ' LYS . 24.7 Cg_exo -41.59 -54.42 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.995 1.13 . . . . 0.0 110.769 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.768 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.313 0.578 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.7 t -59.85 -50.3 80.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.799 -1.188 . . . . 0.0 110.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -51.87 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.56 -1.338 . . . . 0.0 110.928 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.73 -41.04 89.99 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 111.884 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.33 -46.0 10.7 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.033 -1.042 . . . . 0.0 112.129 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.5 t -82.97 -53.0 6.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.723 -1.236 . . . . 0.0 111.039 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -70.85 -28.71 64.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.734 -1.229 . . . . 0.0 108.884 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.8 m -135.27 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.74 129.23 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.62 -1.3 . . . . 0.0 109.1 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.68 -173.06 3.23 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.219 1.009 . . . . 0.0 109.868 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.21 154.85 50.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.21 -60.54 1.85 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 122.325 1.059 . . . . 0.0 109.364 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.33 -45.1 17.32 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.87 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.584 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.7 mt-30 -64.86 -32.51 74.25 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.63 -34.87 65.2 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.179 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 20.1 mt-10 -64.96 -37.75 88.69 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.107 0.956 . . . . 0.0 110.324 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.88 -37.15 18.81 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.901 0.857 . . . . 0.0 110.103 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.2 m-85 -87.92 3.04 50.07 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.9 m -74.84 75.77 2.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.749 -1.844 . . . . 0.0 109.961 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.434 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 3.6 t-20 . . . . . 0 C--N 1.293 -1.87 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.57 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -147.98 165.89 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.0 109.837 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.57 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.1 m120 -122.9 71.2 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.05 169.87 9.81 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.78 0.8 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.16 92.63 8.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.94 141.04 31.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.405 -0.81 . . . . 0.0 110.551 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.7 m -142.53 124.28 15.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.76 -107.59 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.415 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.5 m -38.59 -60.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.386 -1.067 . . . . 0.0 111.45 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.2 m-20 -64.23 -43.39 95.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.922 -1.111 . . . . 0.0 109.665 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.82 HD11 HD11 ' A' ' 2' ' ' ILE . 24.8 tp -67.51 -63.25 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.68 -57.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.97 0.891 . . . . 0.0 108.644 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -53.83 -38.86 65.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -60.18 -35.87 76.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.82 HD11 HD13 ' A' ' 2' ' ' ILE . 50.4 mt -75.06 -57.08 4.12 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.506 -1.371 . . . . 0.0 108.748 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.22 -31.11 2.28 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.3 tt -74.8 -48.13 26.99 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.7 t -74.19 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.766 0.794 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' B' ' 36' ' ' LEU . 30.1 m -68.25 -47.12 68.6 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.775 -0.578 . . . . 0.0 112.101 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.56 -121.14 19.36 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.496 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 9.7 tp10 -62.35 -44.0 97.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.265 -1.138 . . . . 0.0 111.036 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.447 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -47.02 -17.33 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.064 -1.022 . . . . 0.0 110.594 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.94 -175.4 41.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.7 p90 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.174 -1.78 . . . . 0.0 110.952 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 32' ' ' LEU . 7.6 tt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.337 0.589 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 7' ' ' CYS . 89.9 t -59.34 -50.43 79.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.874 -1.141 . . . . 0.0 110.849 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -50.96 -62.16 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.669 -1.27 . . . . 0.0 111.14 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.7 mp0 -61.32 -39.89 92.19 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.9 -1.125 . . . . 0.0 111.948 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -46.02 10.6 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.014 -1.053 . . . . 0.0 112.106 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.78 -52.94 6.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.85 -1.156 . . . . 0.0 111.043 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.17 -28.31 64.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.178 . . . . 0.0 108.927 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.5 m -135.86 174.09 11.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.06 129.32 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.601 -1.312 . . . . 0.0 109.01 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.17 -173.16 3.35 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.195 0.997 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.51 151.65 48.65 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -42.16 -60.41 1.46 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 122.255 1.026 . . . . 0.0 109.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.73 -45.41 19.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.779 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.7 mt-30 -64.15 -32.55 74.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.69 -35.64 65.19 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.246 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 24.6 mt-10 -64.03 -37.66 88.24 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.152 0.977 . . . . 0.0 110.467 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.76 -37.13 18.12 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.917 0.865 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.19 3.28 49.93 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.1 m -75.18 74.06 2.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 119.826 -1.796 . . . . 0.0 110.027 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.441 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 21.9 t-20 . . . . . 0 C--N 1.294 -1.839 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.752 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.575 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.96 165.94 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.026 -1.046 . . . . 0.0 109.84 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.575 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.2 m120 -122.68 71.07 1.01 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -120.27 169.91 9.83 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.861 0.839 . . . . 0.0 110.063 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -91.01 92.29 8.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.73 139.71 32.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 110.671 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 51.2 m -140.89 124.17 16.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 109.727 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.82 -111.4 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.407 ' C ' ' O ' ' B' ' 29' ' ' GLY . 38.8 t -38.62 -54.18 1.56 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.405 -1.056 . . . . 0.0 111.473 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.91 -31.7 70.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.886 -1.133 . . . . 0.0 109.666 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 2' ' ' ILE . 20.7 tp -82.1 -61.51 1.88 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.658 -0.651 . . . . 0.0 109.554 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' B' ' 29' ' ' GLY . 29.2 t -40.8 -56.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 108.585 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -53.51 -39.47 64.65 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.47 -36.34 75.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.799 HD11 HD13 ' A' ' 2' ' ' ILE . 48.9 mt -74.67 -56.06 5.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.622 -1.299 . . . . 0.0 108.603 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -46.69 -31.12 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.568 HD23 ' C ' ' B' ' 38' ' ' LEU . 8.1 tt -75.87 -47.75 24.2 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 t -73.79 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.745 0.783 . . . . 0.0 109.785 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.34 -47.45 67.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.74 -0.6 . . . . 0.0 112.025 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.48 -117.75 11.88 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.796 -1.193 . . . . 0.0 110.71 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.31 -43.18 95.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -1.103 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -48.41 -19.35 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.904 -1.123 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.69 44.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.441 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 27.2 p90 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.125 -1.809 . . . . 0.0 111.288 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.797 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.332 0.587 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.7 t -59.32 -50.12 81.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.797 -1.189 . . . . 0.0 110.743 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -51.47 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.644 -1.285 . . . . 0.0 111.047 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.516 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.9 mp0 -60.71 -40.18 91.33 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 111.929 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.39 -46.18 10.5 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.031 -1.043 . . . . 0.0 112.076 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.72 -52.86 6.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.804 -1.185 . . . . 0.0 111.023 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -71.15 -28.68 64.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.241 . . . . 0.0 108.971 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.3 m -135.45 174.36 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.29 130.22 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.584 -1.322 . . . . 0.0 109.086 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.48 -173.01 3.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.184 0.992 . . . . 0.0 109.92 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -138.1 152.32 48.65 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.8 tp -42.53 -60.63 1.46 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 122.338 1.066 . . . . 0.0 109.599 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.7 -44.87 19.06 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.794 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.581 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -65.0 -32.38 74.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -34.99 65.23 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.126 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.84 -37.77 88.73 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.117 0.961 . . . . 0.0 110.374 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -36.84 18.11 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.899 0.857 . . . . 0.0 110.079 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.8 m-85 -88.1 3.25 49.76 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -74.82 74.64 2.11 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 119.735 -1.853 . . . . 0.0 110.043 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.438 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 12.4 t-20 . . . . . 0 C--N 1.294 -1.835 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.56 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.3 p -148.81 165.68 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.045 . . . . 0.0 109.922 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.563 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.1 m120 -122.55 71.58 1.03 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -120.51 169.94 9.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.814 0.816 . . . . 0.0 110.215 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -91.36 92.49 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.98 140.82 31.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 110.581 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 m -142.15 124.21 15.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 109.915 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -107.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 29' ' ' GLY . 8.7 t -38.58 -59.41 0.93 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -1.049 . . . . 0.0 111.398 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.06 -42.78 93.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 109.629 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 2' ' ' ILE . 24.7 tp -68.21 -63.29 1.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.64 . . . . 0.0 109.82 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.56 -57.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.073 0.94 . . . . 0.0 108.614 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -54.05 -39.65 66.43 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.29 -36.13 75.02 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.788 HD11 HD13 ' A' ' 2' ' ' ILE . 49.9 mt -74.8 -57.52 3.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.46 -1.4 . . . . 0.0 108.732 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.5 t80 -46.07 -30.77 2.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.4 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.4 tt -75.24 -47.51 27.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.88 -61.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.778 0.799 . . . . 0.0 109.832 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.1 m -68.3 -47.13 68.44 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.757 -0.589 . . . . 0.0 112.068 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -121.61 22.67 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.473 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' B' ' 44' ' ' GLY . 12.0 tp10 -61.33 -44.05 97.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -1.096 . . . . 0.0 111.111 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -47.02 -18.28 0.07 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.99 -1.069 . . . . 0.0 110.696 -178.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.25 43.87 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.438 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.8 p90 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.19 -1.77 . . . . 0.0 111.265 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.829 HD11 HD11 ' B' ' 32' ' ' LEU . 7.5 tt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' CYS . 75.8 t -59.27 -50.88 78.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.816 -1.177 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -51.02 -62.43 1.62 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.571 -1.33 . . . . 0.0 110.993 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.529 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.9 mp0 -60.33 -40.56 91.05 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.977 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.22 -45.69 11.07 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.067 -1.021 . . . . 0.0 111.974 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.65 -52.91 6.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.795 -1.191 . . . . 0.0 110.995 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.47 -28.11 63.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.73 -1.231 . . . . 0.0 109.014 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' CYS . 70.9 m -135.72 174.19 10.88 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.43 129.02 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.542 -1.349 . . . . 0.0 108.961 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.79 -173.12 3.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.157 0.979 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.451 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -137.24 155.49 49.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.64 -60.54 1.95 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 122.407 1.098 . . . . 0.0 109.242 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.35 -45.09 17.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.936 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.8 mt-30 -64.94 -32.61 74.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.85 -34.18 64.41 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.11 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.6 mt-10 -65.63 -37.68 87.24 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.196 0.998 . . . . 0.0 110.324 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.93 -37.04 18.78 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.966 0.889 . . . . 0.0 110.101 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.0 m-85 -87.85 2.87 50.36 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 m -74.91 76.23 2.16 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.801 -1.812 . . . . 0.0 109.915 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.436 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 24.5 t-20 . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.677 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.586 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.3 p -150.52 165.96 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.999 -1.063 . . . . 0.0 109.887 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.586 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.6 m120 -123.08 71.53 1.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.69 170.15 9.72 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.799 0.809 . . . . 0.0 110.167 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -91.28 92.57 8.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.81 140.57 31.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.11 124.0 16.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 109.798 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.0 -110.03 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -38.73 -55.7 1.44 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.058 . . . . 0.0 111.444 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -34.86 78.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 109.621 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 2' ' ' ILE . 20.9 tp -78.23 -61.78 1.89 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.582 . . . . 0.0 109.769 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 24.8 t -40.84 -56.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 122.056 0.932 . . . . 0.0 108.567 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.84 -39.74 65.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.36 74.06 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.794 HD11 HD13 ' A' ' 2' ' ' ILE . 47.9 mt -75.25 -56.71 4.45 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.511 -1.368 . . . . 0.0 108.692 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -46.76 -30.64 2.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.57 -45.43 45.44 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.2 t -77.81 -61.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.765 0.793 . . . . 0.0 109.886 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.39 -47.17 68.04 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.721 -0.612 . . . . 0.0 111.867 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.46 -118.83 13.54 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.628 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 44' ' ' GLY . 18.1 tp10 -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -1.08 . . . . 0.0 111.058 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -47.58 -17.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 110.406 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.21 -176.54 40.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.436 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.8 p90 . . . . . 0 C--N 1.302 -1.495 0 O-C-N 120.215 -1.756 . . . . 0.0 110.972 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.829 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.346 0.593 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.5 t -60.93 -51.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.799 -1.188 . . . . 0.0 110.705 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.61 -62.17 1.79 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.526 -1.359 . . . . 0.0 110.85 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.582 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.83 -41.33 91.08 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.0 111.913 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.7 m -86.41 -45.62 11.0 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.109 -0.994 . . . . 0.0 112.189 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.8 t -82.57 -53.02 6.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.711 -1.243 . . . . 0.0 110.962 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -71.57 -28.05 63.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.806 -1.184 . . . . 0.0 108.985 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.8 m -135.72 174.35 10.71 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mt -86.83 134.13 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.618 -1.301 . . . . 0.0 109.151 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -99.95 -172.96 2.33 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.141 0.972 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.463 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -138.23 156.12 47.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.67 -60.42 2.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.345 1.069 . . . . 0.0 109.285 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -46.31 -44.83 17.0 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.2 mt-30 -65.41 -32.44 74.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.61 -34.62 65.14 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.881 -1.127 . . . . 0.0 108.063 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.4 mt-10 -65.15 -37.89 88.86 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.157 0.98 . . . . 0.0 110.329 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.29 19.39 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.977 0.894 . . . . 0.0 110.047 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.5 m-85 -87.79 3.21 49.06 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.17 73.55 2.3 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 119.853 -1.779 . . . . 0.0 109.819 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OXT' ' OD1' ' A' ' 21' ' ' ASN . 51.2 t-20 . . . . . 0 C--N 1.292 -1.903 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.459 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.578 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.2 p -151.02 165.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.073 . . . . 0.0 109.992 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.578 ' N ' HG22 ' B' ' 23' ' ' VAL . 1.7 m120 -122.91 72.32 1.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -120.57 169.09 10.68 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.738 0.78 . . . . 0.0 109.85 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -90.67 91.69 8.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.57 140.05 33.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.614 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 45.3 m -140.92 123.99 16.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.697 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -110.43 0.13 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 32.0 m -38.66 -55.57 1.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.408 -1.054 . . . . 0.0 111.527 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.15 -31.49 71.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.915 -1.115 . . . . 0.0 109.808 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 2' ' ' ILE . 20.3 tp -82.36 -61.51 1.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 109.644 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' B' ' 29' ' ' GLY . 32.4 t -40.67 -57.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.005 0.907 . . . . 0.0 108.554 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -53.51 -39.76 64.86 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.23 -35.82 74.32 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 2' ' ' ILE . 48.7 mt -75.01 -56.99 4.19 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.494 -1.379 . . . . 0.0 108.749 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.2 t80 -46.5 -30.7 2.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.433 HD23 ' C ' ' B' ' 38' ' ' LEU . 10.2 tt -75.4 -47.15 28.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.29 -61.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.817 0.817 . . . . 0.0 109.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.8 m -68.05 -47.25 68.88 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.71 -0.619 . . . . 0.0 111.989 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.62 -117.92 11.53 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.681 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.3 tt0 -64.98 -43.04 93.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.325 -1.103 . . . . 0.0 111.317 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -48.2 -17.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.866 -1.146 . . . . 0.0 110.46 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.09 -175.51 42.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.423 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.3 p90 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 120.063 -1.845 . . . . 0.0 111.367 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.815 HD13 HD11 ' B' ' 36' ' ' LEU . 7.6 tt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.358 0.599 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 80.3 t -59.06 -50.23 80.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.898 -1.126 . . . . 0.0 110.866 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -51.35 -62.65 1.49 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.65 -1.281 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.0 mp0 -60.5 -39.94 89.53 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.925 -1.109 . . . . 0.0 111.914 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.45 -46.21 10.42 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.986 -1.071 . . . . 0.0 112.034 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.77 -52.98 6.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.198 . . . . 0.0 110.942 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -70.88 -28.17 64.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.752 -1.217 . . . . 0.0 108.945 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.3 m -136.14 174.03 11.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.28 127.35 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.639 -1.288 . . . . 0.0 108.944 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -89.44 -173.19 3.89 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.262 1.03 . . . . 0.0 109.942 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.09 151.4 48.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -42.09 -60.48 1.42 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.259 1.028 . . . . 0.0 109.516 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.82 -45.22 19.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.77 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.8 mt-30 -64.49 -32.41 74.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.66 -35.32 65.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.132 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.36 -37.73 88.52 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 122.096 0.95 . . . . 0.0 110.398 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.88 -36.89 18.13 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.858 0.837 . . . . 0.0 110.02 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.626 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.0 m-85 -88.54 3.76 49.16 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.8 m -75.55 73.22 2.57 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.8 -1.813 . . . . 0.0 110.007 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 13.9 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.186 -0.911 . . . . 0.0 109.452 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.579 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.88 166.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.046 -1.033 . . . . 0.0 109.823 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.579 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.6 m120 -123.42 71.49 1.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -120.87 169.9 10.0 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.798 0.809 . . . . 0.0 110.242 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -90.69 92.89 9.02 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 mt -84.73 140.96 30.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -142.24 124.28 15.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.74 -107.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' B' ' 31' ' ' ASP . 12.4 p -38.55 -60.28 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -1.012 . . . . 0.0 111.342 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.464 ' N ' ' OG ' ' B' ' 30' ' ' SER . 3.4 m-20 -64.4 -43.5 94.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 109.617 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 2' ' ' ILE . 24.9 tp -66.74 -63.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.841 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.3 t -40.47 -57.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 108.708 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.27 -39.15 66.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.57 -35.45 74.29 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.815 HD11 HD13 ' A' ' 2' ' ' ILE . 49.0 mt -75.63 -56.62 4.52 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.464 -1.398 . . . . 0.0 108.693 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.6 t80 -46.52 -30.38 2.2 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.09 -47.4 28.95 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 t -75.42 -61.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.796 0.807 . . . . 0.0 109.775 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.9 m -67.93 -47.19 69.39 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.745 -0.597 . . . . 0.0 111.808 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.15 -117.65 11.82 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.632 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.03 -43.08 96.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.435 -1.038 . . . . 0.0 111.438 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -49.06 -18.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.0 110.628 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.6 -177.41 43.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.426 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.071 -1.84 . . . . 0.0 111.478 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 36' ' ' LEU . 8.1 tt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.323 0.582 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.6 t -59.82 -50.65 79.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.892 -1.13 . . . . 0.0 110.836 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -51.34 -62.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.583 -1.323 . . . . 0.0 110.988 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.534 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 3.2 mp0 -59.95 -40.96 90.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.928 -1.108 . . . . 0.0 111.883 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.31 -46.06 10.66 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.087 -1.008 . . . . 0.0 112.142 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.8 t -82.26 -52.72 6.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.797 -1.189 . . . . 0.0 110.886 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.38 -30.09 65.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.798 -1.188 . . . . 0.0 108.961 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -133.43 174.19 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.08 129.17 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.662 -1.274 . . . . 0.0 108.795 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.72 -173.15 3.25 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.23 1.014 . . . . 0.0 109.845 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.451 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.81 155.02 49.45 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -44.24 -60.54 1.86 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.338 1.066 . . . . 0.0 109.352 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.32 -45.11 17.28 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.957 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.1 mt-30 -64.97 -32.44 74.16 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.66 -34.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.065 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.2 mt-10 -65.05 -37.86 88.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.149 0.976 . . . . 0.0 110.365 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.9 -37.42 19.7 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.907 0.86 . . . . 0.0 110.085 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.609 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.2 m-85 -87.66 2.72 50.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.5 m -74.43 73.09 1.88 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 119.806 -1.809 . . . . 0.0 109.961 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 21' ' ' ASN . 55.1 t-20 . . . . . 0 C--N 1.292 -1.923 0 CA-C-O 118.182 -0.914 . . . . 0.0 109.528 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.601 HG22 ' N ' ' B' ' 24' ' ' ASN . 5.3 p -122.15 164.63 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.601 ' N ' HG22 ' B' ' 23' ' ' VAL . 10.0 m120 -122.54 71.05 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -122.02 169.49 10.78 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.8 0.809 . . . . 0.0 110.166 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.55 91.57 8.74 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.7 mt -81.79 138.76 35.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 110.73 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 44.0 m -139.53 123.74 17.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.409 -0.807 . . . . 0.0 109.54 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -110.63 0.13 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.455 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 19.7 m -38.68 -54.22 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -1.015 . . . . 0.0 111.515 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -69.19 -30.84 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.644 -1.285 . . . . 0.0 109.644 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 2' ' ' ILE . 21.0 tp -82.95 -61.37 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.716 -0.615 . . . . 0.0 110.077 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 31.3 t -40.0 -60.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.04 0.924 . . . . 0.0 108.752 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 2.9 mp0 -50.51 -40.74 52.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -57.8 -36.2 71.88 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.816 HD11 HD13 ' A' ' 2' ' ' ILE . 46.5 mt -75.26 -56.73 4.43 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.575 -1.328 . . . . 0.0 108.724 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -46.11 -31.47 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 tt -74.48 -47.93 30.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.0 t -74.57 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.743 0.782 . . . . 0.0 109.97 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.6 m -67.94 -47.13 69.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.752 -0.592 . . . . 0.0 111.977 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.3 -117.72 11.92 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -64.5 -43.01 95.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -1.133 . . . . 0.0 111.386 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -48.81 -18.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.856 -1.153 . . . . 0.0 110.425 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.85 -177.32 41.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.3 p90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.174 -1.78 . . . . 0.0 111.211 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.804 HD11 HD11 ' B' ' 32' ' ' LEU . 8.7 tt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.293 0.568 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.9 t -60.02 -49.58 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.818 -1.176 . . . . 0.0 110.875 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.95 -62.49 1.6 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.698 -1.251 . . . . 0.0 111.198 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.1 mp0 -61.61 -39.31 90.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 111.882 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.59 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.46 -46.32 10.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.038 -1.039 . . . . 0.0 112.121 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.6 t -83.01 -53.1 6.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.701 -1.25 . . . . 0.0 110.921 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -70.27 -28.55 65.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.793 -1.192 . . . . 0.0 108.909 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.9 m -136.13 174.31 10.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.01 131.43 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.583 -1.323 . . . . 0.0 109.106 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -95.4 -173.02 2.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.22 1.009 . . . . 0.0 109.924 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.1 154.9 50.19 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.27 -60.46 1.9 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.321 1.058 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.31 -45.07 17.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.937 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.3 mt-30 -64.66 -32.67 74.44 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.64 -35.0 65.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.223 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.3 mt-10 -64.7 -37.79 88.79 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.167 0.984 . . . . 0.0 110.433 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.26 19.25 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.085 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.1 m-85 -87.73 2.85 50.1 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -74.49 74.09 1.93 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 119.797 -1.815 . . . . 0.0 109.938 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 36.7 t30 . . . . . 0 C--N 1.293 -1.858 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.592 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.587 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.88 166.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.01 -1.056 . . . . 0.0 109.909 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.587 ' N ' HG22 ' B' ' 23' ' ' VAL . 6.9 m120 -123.27 71.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.27 170.25 9.51 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -90.83 91.96 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.61 140.67 32.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.465 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.1 m -142.58 124.15 14.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.903 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.98 -107.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 29.8 m -38.64 -61.08 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.33 -1.1 . . . . 0.0 111.526 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -42.13 98.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 109.783 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 2' ' ' ILE . 24.0 tp -68.77 -63.13 1.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.657 -0.652 . . . . 0.0 109.813 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' B' ' 29' ' ' GLY . 34.5 t -40.59 -57.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 122.027 0.917 . . . . 0.0 108.679 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -54.17 -39.15 66.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.75 -35.99 75.72 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.802 HD11 HD13 ' A' ' 2' ' ' ILE . 49.3 mt -74.77 -57.39 3.95 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.583 -1.323 . . . . 0.0 108.842 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.2 -30.53 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.471 HD23 ' C ' ' B' ' 38' ' ' LEU . 9.7 tt -75.73 -46.91 28.41 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.3 t -75.22 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.75 0.786 . . . . 0.0 109.777 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 29.5 m -68.01 -47.13 69.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.769 -0.582 . . . . 0.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.88 11.71 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.718 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.9 tt0 -64.88 -43.12 93.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -1.075 . . . . 0.0 111.333 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.3 mtm180 -48.3 -18.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.17 . . . . 0.0 110.358 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.81 43.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.425 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.2 p90 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.186 -1.773 . . . . 0.0 111.047 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.806 HD11 HD11 ' B' ' 32' ' ' LEU . 8.1 tt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.273 0.559 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 7' ' ' CYS . 94.5 t -59.5 -49.97 81.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.913 -1.117 . . . . 0.0 110.738 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -51.73 -62.54 1.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.609 -1.307 . . . . 0.0 111.022 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.9 mp0 -59.83 -40.63 89.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.936 -1.103 . . . . 0.0 111.878 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.44 -46.21 10.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.045 -1.035 . . . . 0.0 112.125 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.7 t -82.74 -53.05 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.774 -1.204 . . . . 0.0 111.079 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -70.82 -28.43 64.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.772 -1.205 . . . . 0.0 108.948 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.6 m -135.77 174.16 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.05 129.14 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 108.846 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.63 -173.1 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.238 1.018 . . . . 0.0 109.99 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.21 151.65 48.99 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.68 -60.53 1.53 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.298 1.047 . . . . 0.0 109.611 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -46.8 -45.05 19.75 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.828 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.6 mt-30 -64.7 -32.22 73.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.98 -35.51 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.207 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.9 mt-10 -64.07 -37.78 88.68 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.112 0.958 . . . . 0.0 110.369 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.03 -37.65 21.35 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.941 0.877 . . . . 0.0 110.049 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -87.37 2.61 49.86 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.72 73.35 2.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.831 -1.793 . . . . 0.0 109.899 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 45.3 t-20 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.269 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.601 HG22 ' N ' ' B' ' 24' ' ' ASN . 4.9 p -137.03 165.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.35 -0.844 . . . . 0.0 109.766 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.601 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.4 m120 -123.15 71.18 1.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -120.75 170.37 9.52 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.819 0.818 . . . . 0.0 109.992 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.93 92.3 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.19 139.82 32.92 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.32 -0.862 . . . . 0.0 110.667 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 m -141.83 124.25 15.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.254 -0.904 . . . . 0.0 109.927 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.87 -107.75 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 55.8 m -38.49 -59.74 0.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.393 -1.063 . . . . 0.0 111.464 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -43.5 93.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.928 -1.107 . . . . 0.0 109.674 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 2' ' ' ILE . 24.6 tp -67.2 -63.41 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.618 -0.676 . . . . 0.0 109.603 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.33 -56.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.934 0.873 . . . . 0.0 108.737 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -54.35 -40.62 68.23 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.15 -36.59 73.23 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.801 HD11 HD13 ' A' ' 2' ' ' ILE . 49.3 mt -74.87 -56.43 4.78 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 120.59 -1.319 . . . . 0.0 108.779 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -46.11 -31.42 2.35 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.17 0.985 . . . . 0.0 108.365 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.477 HD23 ' C ' ' B' ' 38' ' ' LEU . 9.3 tt -75.3 -48.59 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 t -73.01 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.746 0.784 . . . . 0.0 109.889 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.6 m -68.6 -47.49 66.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.707 -0.621 . . . . 0.0 111.971 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.52 -117.82 11.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.627 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -42.78 92.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -1.061 . . . . 0.0 111.432 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.31 -18.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.815 -1.178 . . . . 0.0 110.329 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.49 -176.59 44.91 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.084 -1.833 . . . . 0.0 111.372 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.797 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.313 0.577 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 7' ' ' CYS . 88.5 t -59.99 -50.38 80.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.826 -1.171 . . . . 0.0 110.974 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.16 -62.34 1.7 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.576 -1.328 . . . . 0.0 110.927 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -59.34 -40.92 87.91 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.971 -1.081 . . . . 0.0 111.872 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -45.99 10.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.053 -1.029 . . . . 0.0 112.126 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.4 t -82.82 -52.86 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.792 -1.192 . . . . 0.0 110.99 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 m -71.18 -28.0 63.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.5 m -136.1 174.04 11.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.39 128.92 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.646 -1.284 . . . . 0.0 109.01 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.18 -173.06 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.167 0.984 . . . . 0.0 109.867 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -136.84 154.44 50.51 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.17 -60.66 1.79 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.322 1.058 . . . . 0.0 109.327 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.26 -45.22 17.05 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.878 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.4 mt-30 -64.76 -32.64 74.42 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 178.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.63 -34.7 65.13 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.807 -1.157 . . . . 0.0 108.156 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.0 mt-10 -65.19 -37.77 88.39 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.146 0.974 . . . . 0.0 110.385 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.78 -36.89 17.61 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.916 0.865 . . . . 0.0 110.054 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.628 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.5 m-85 -88.14 3.01 50.76 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 m -74.66 75.42 2.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 119.809 -1.807 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.492 ' OXT' ' ND2' ' A' ' 21' ' ' ASN . 2.5 t-20 . . . . . 0 C--N 1.293 -1.88 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.588 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -150.12 165.82 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.994 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.588 ' N ' HG22 ' B' ' 23' ' ' VAL . 12.9 m120 -123.46 71.64 1.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -121.2 170.58 9.44 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.813 0.816 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -91.0 91.98 8.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.92 141.32 31.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 110.568 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 43.6 m -142.66 124.31 14.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.026 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.64 -107.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.406 ' C ' ' O ' ' B' ' 29' ' ' GLY . 39.2 m -38.61 -59.56 0.91 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -1.04 . . . . 0.0 111.328 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.73 -44.42 90.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 109.572 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 2' ' ' ILE . 24.8 tp -66.24 -63.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.628 -0.67 . . . . 0.0 109.72 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.9 t -40.58 -57.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 122.061 0.934 . . . . 0.0 108.724 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -54.16 -39.35 66.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.49 74.32 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.79 HD11 HD13 ' A' ' 2' ' ' ILE . 49.1 mt -75.37 -57.36 3.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.575 -1.328 . . . . 0.0 108.798 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -46.41 -30.19 2.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.9 -47.09 31.75 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.63 -61.15 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.834 0.826 . . . . 0.0 109.873 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.9 m -68.03 -47.19 69.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.766 -0.584 . . . . 0.0 111.992 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.05 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.545 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.6 tt0 -63.42 -43.08 98.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -1.064 . . . . 0.0 110.997 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.51 -18.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 110.372 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -176.42 42.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.581 -2.207 . . . . 0.0 107.581 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.458 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.202 -1.764 . . . . 0.0 111.082 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 32' ' ' LEU . 8.7 tt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.41 0.624 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 7' ' ' CYS . 74.7 t -61.65 -50.12 81.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.804 -1.185 . . . . 0.0 110.763 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.56 -62.45 1.62 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.642 -1.287 . . . . 0.0 111.073 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.7 mp0 -61.83 -39.92 93.49 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 111.866 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.8 m -86.07 -45.73 11.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.051 -1.031 . . . . 0.0 112.241 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 3' ' ' VAL . 41.5 t -83.23 -52.91 6.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.671 -1.268 . . . . 0.0 110.957 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 m -70.65 -28.01 64.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.795 -1.191 . . . . 0.0 108.935 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.4 m -136.04 174.03 11.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.52 135.78 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.566 -1.334 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -101.09 -172.9 2.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.1 0.953 . . . . 0.0 109.659 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -137.51 156.35 48.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.7 -60.48 1.99 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 109.327 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.3 -45.21 17.25 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.892 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.9 mt-30 -64.76 -32.57 74.31 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.77 -34.59 64.74 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.117 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 13.3 mt-10 -65.32 -37.71 87.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.131 0.967 . . . . 0.0 110.327 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.9 -36.96 18.39 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.889 0.852 . . . . 0.0 109.94 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.622 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -88.42 4.01 47.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -76.29 73.58 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.773 -1.829 . . . . 0.0 110.05 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.416 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 47.5 t30 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.46 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.58 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -151.27 165.85 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.957 -1.09 . . . . 0.0 110.084 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.58 ' N ' HG22 ' B' ' 23' ' ' VAL . 11.0 m120 -123.16 71.27 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -120.44 170.49 9.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.826 0.822 . . . . 0.0 110.139 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -90.87 92.05 8.61 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.68 140.74 31.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.421 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -142.67 124.2 14.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.12 -107.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.8 m -38.44 -59.75 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -1.059 . . . . 0.0 111.368 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.23 -44.4 88.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.988 -1.07 . . . . 0.0 109.609 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 2' ' ' ILE . 25.4 tp -66.22 -63.33 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.693 -0.63 . . . . 0.0 109.873 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' GLY . 42.5 t -40.47 -57.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.043 0.925 . . . . 0.0 108.75 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -54.24 -39.09 66.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.71 -35.45 74.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.814 HD11 HD13 ' A' ' 2' ' ' ILE . 49.8 mt -75.46 -57.29 3.98 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.452 -1.405 . . . . 0.0 108.741 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -46.12 -30.61 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.53 -45.93 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.0 t -77.38 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.716 0.77 . . . . 0.0 109.949 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.63 -47.3 66.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.788 -0.57 . . . . 0.0 111.897 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 -117.91 10.65 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.642 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' B' ' 44' ' ' GLY . 41.5 tt0 -66.14 -41.31 90.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.321 -1.105 . . . . 0.0 111.233 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.1 mtm180 -49.38 -16.27 0.18 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.48 -173.79 43.02 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.193 -2.363 . . . . 0.0 107.193 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.416 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.0 p90 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 119.996 -1.885 . . . . 0.0 111.434 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.798 HD11 HD11 ' B' ' 32' ' ' LEU . 8.5 tt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.301 0.572 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 7' ' ' CYS . 64.0 t -59.63 -51.52 71.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.861 -1.15 . . . . 0.0 110.736 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -50.92 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.593 -1.317 . . . . 0.0 110.907 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.57 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.7 mp0 -59.68 -41.36 90.51 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.045 -1.034 . . . . 0.0 111.975 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.2 -45.56 11.2 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 0.0 112.047 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.474 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.69 -53.18 6.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.837 -1.165 . . . . 0.0 111.053 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 m -71.43 -27.62 63.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.187 . . . . 0.0 108.945 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.5 m -136.14 173.96 11.14 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.21 130.04 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.61 -1.306 . . . . 0.0 108.851 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.31 -173.08 3.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.212 1.006 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.89 151.85 48.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.15 -60.52 1.42 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.286 1.041 . . . . 0.0 109.622 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.71 -45.22 19.38 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.84 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.5 mt-30 -64.4 -32.61 74.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.51 -35.25 65.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.167 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.6 mt-10 -64.68 -37.59 88.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.124 0.964 . . . . 0.0 110.367 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -48.86 -36.85 17.92 Favored 'General case' 0 C--N 1.286 -2.196 0 CA-C-O 121.982 0.896 . . . . 0.0 109.982 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.615 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.53 4.33 47.14 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.0 m -76.55 74.27 3.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.787 -1.821 . . . . 0.0 109.824 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 18.7 t30 . . . . . 0 C--N 1.294 -1.826 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.547 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.591 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -147.81 165.58 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.591 ' N ' HG22 ' B' ' 23' ' ' VAL . 8.2 m120 -122.69 71.27 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -120.37 169.56 10.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.802 0.811 . . . . 0.0 110.166 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -90.53 92.69 8.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.06 138.82 32.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.677 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' GLY . 56.4 m -140.15 124.04 17.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.363 -0.836 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -108.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' ' 29' ' ' GLY . 10.0 t -39.08 -56.29 1.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.433 -1.039 . . . . 0.0 111.403 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -27.49 65.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.113 . . . . 0.0 110.022 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.798 HD11 HD11 ' A' ' 2' ' ' ILE . 19.8 tp -84.23 -61.57 1.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.78 . . . . 0.0 109.272 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' B' ' 29' ' ' GLY . 43.2 t -40.97 -57.68 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.828 0.823 . . . . 0.0 109.028 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.08 -36.71 63.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.24 -36.33 79.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 2' ' ' ILE . 52.1 mt -75.06 -56.52 4.66 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.568 -1.333 . . . . 0.0 108.654 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.67 -30.72 2.49 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.446 HD23 ' C ' ' B' ' 38' ' ' LEU . 10.0 tt -75.76 -47.9 23.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.98 -60.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.707 0.765 . . . . 0.0 109.819 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' B' ' 36' ' ' LEU . 23.7 m -69.38 -47.29 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.699 -0.626 . . . . 0.0 112.096 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.26 -118.15 11.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.564 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 4.7 tp10 -63.83 -43.77 95.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -1.098 . . . . 0.0 111.123 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -49.22 -14.69 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.854 -1.153 . . . . 0.0 110.637 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.21 -173.15 39.91 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.7 p90 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.026 -1.867 . . . . 0.0 111.471 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 36' ' ' LEU . 8.0 tt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.336 0.589 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' CYS . 84.4 t -59.34 -50.43 79.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.893 -1.129 . . . . 0.0 110.909 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -51.1 -62.49 1.58 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.62 -1.3 . . . . 0.0 111.088 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.4 mp0 -60.5 -40.25 90.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 111.945 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.43 -46.03 10.61 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.014 -1.054 . . . . 0.0 112.081 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.9 t -82.7 -53.05 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.855 -1.153 . . . . 0.0 111.057 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.01 -28.51 64.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.793 -1.192 . . . . 0.0 108.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.8 m -135.8 174.18 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.63 131.05 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.611 -1.306 . . . . 0.0 108.763 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -93.69 -173.07 3.06 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.26 1.029 . . . . 0.0 109.927 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.459 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -138.11 152.19 48.52 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -42.55 -60.76 1.42 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.267 1.032 . . . . 0.0 109.49 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.52 -45.3 18.43 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.845 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.573 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.7 mt-30 -64.61 -32.47 74.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.72 -34.98 65.05 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.166 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.66 -37.74 88.62 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 122.147 0.975 . . . . 0.0 110.387 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.01 18.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.983 0.897 . . . . 0.0 110.086 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.609 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.3 m-85 -88.21 3.42 49.45 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.0 m -75.61 74.95 2.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 119.803 -1.811 . . . . 0.0 109.785 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.435 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 12.0 t-20 . . . . . 0 C--N 1.295 -1.785 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.534 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.604 HG22 ' N ' ' B' ' 24' ' ' ASN . 5.0 p -120.92 164.97 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.384 -0.822 . . . . 0.0 109.995 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.604 ' N ' HG22 ' B' ' 23' ' ' VAL . 8.5 m120 -123.56 71.55 1.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -121.61 170.51 9.63 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.853 0.835 . . . . 0.0 110.058 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -89.33 91.72 8.86 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.96 138.23 33.88 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.638 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.8 m -139.62 124.09 18.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.604 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.83 -108.99 0.09 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 29' ' ' GLY . 58.5 m -38.85 -58.14 1.13 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.37 -1.076 . . . . 0.0 111.642 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 -27.02 66.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 110.11 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 2' ' ' ILE . 19.7 tp -84.15 -61.44 1.81 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.442 -0.786 . . . . 0.0 109.262 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.5 t -41.28 -57.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 121.773 0.797 . . . . 0.0 109.001 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -54.14 -35.95 62.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.98 -36.09 80.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.816 HD11 HD13 ' A' ' 2' ' ' ILE . 50.2 mt -74.75 -57.77 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.886 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.3 t80 -45.58 -31.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.477 HD23 ' C ' ' B' ' 38' ' ' LEU . 9.5 tt -74.91 -47.07 31.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.95 -60.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.725 0.774 . . . . 0.0 109.818 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.2 m -68.69 -47.18 67.11 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.773 -0.579 . . . . 0.0 112.055 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.23 -117.86 11.66 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.465 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' B' ' 44' ' ' GLY . 15.8 tp10 -63.46 -43.92 95.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -1.095 . . . . 0.0 111.221 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -49.72 -15.49 0.18 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.869 -1.144 . . . . 0.0 110.631 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.43 -174.88 37.62 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.9 p90 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 120.116 -1.814 . . . . 0.0 111.194 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.815 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.283 0.563 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.0 t -60.26 -51.68 70.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.742 -1.224 . . . . 0.0 110.673 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -50.83 -62.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.62 -1.3 . . . . 0.0 110.888 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -60.09 -41.15 91.86 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.956 -1.09 . . . . 0.0 112.028 -177.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.583 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.21 -45.51 11.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.032 -1.043 . . . . 0.0 111.975 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 38.3 t -82.67 -53.1 6.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.795 -1.191 . . . . 0.0 111.056 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 m -71.47 -27.87 63.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.742 -1.224 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.2 m -135.76 174.12 10.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.61 130.28 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.651 -1.28 . . . . 0.0 109.039 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.22 -172.97 2.95 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.152 0.977 . . . . 0.0 109.855 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -137.5 154.31 49.9 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -43.83 -60.57 1.76 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.4 1.095 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -46.43 -44.96 17.73 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.4 mt-30 -64.99 -32.41 74.12 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.59 -34.86 65.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.909 -1.117 . . . . 0.0 108.128 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.9 mt-10 -65.03 -37.75 88.64 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.122 0.963 . . . . 0.0 110.398 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.09 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.907 0.86 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.615 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.0 m-85 -87.77 3.12 49.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -75.42 75.79 2.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 119.702 -1.874 . . . . 0.0 109.993 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.45 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 26.6 t30 . . . . . 0 C--N 1.295 -1.804 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.646 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.584 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -148.23 165.59 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 109.937 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.584 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.0 m120 -121.85 71.11 0.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -119.49 169.65 9.86 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.824 0.821 . . . . 0.0 110.196 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.69 92.02 8.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -83.75 139.71 32.55 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.43 -0.794 . . . . 0.0 110.734 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 m -140.28 124.11 17.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.339 -0.851 . . . . 0.0 109.745 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -109.98 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 41.5 t -38.82 -54.84 1.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.378 -1.072 . . . . 0.0 111.464 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.5 OUTLIER -70.49 -27.8 64.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.98 -1.075 . . . . 0.0 109.889 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 2' ' ' ILE . 19.6 tp -84.23 -61.5 1.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.457 -0.777 . . . . 0.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.3 t -41.15 -57.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.836 0.827 . . . . 0.0 108.948 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.31 -36.48 63.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.37 -36.08 79.24 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.795 HD11 HD13 ' A' ' 2' ' ' ILE . 50.8 mt -75.02 -57.24 4.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.644 -1.285 . . . . 0.0 108.765 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -46.2 -31.29 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -74.65 -48.22 27.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -73.93 -60.68 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.789 0.804 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.7 m -68.69 -47.22 66.99 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 112.166 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.67 -120.76 17.96 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.572 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.4 tt0 -63.58 -43.18 97.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.337 -1.096 . . . . 0.0 111.121 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -46.77 -18.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.982 -1.074 . . . . 0.0 110.448 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.04 -176.07 41.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.45 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 120.164 -1.786 . . . . 0.0 111.201 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.821 HD11 HD11 ' B' ' 32' ' ' LEU . 8.0 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.278 0.561 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -59.36 -49.7 82.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.881 -1.137 . . . . 0.0 110.821 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -52.2 -62.5 1.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.668 -1.27 . . . . 0.0 111.055 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 3.1 mp0 -60.59 -39.88 89.72 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.936 -1.103 . . . . 0.0 111.836 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.49 -46.22 10.39 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.068 -1.02 . . . . 0.0 112.164 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.1 t -82.84 -52.88 6.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.77 -1.206 . . . . 0.0 110.897 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -70.34 -30.61 67.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.758 -1.214 . . . . 0.0 108.849 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.7 m -133.41 174.22 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.73 129.57 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.627 -1.295 . . . . 0.0 109.077 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.33 -173.07 3.12 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.191 0.996 . . . . 0.0 109.838 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.471 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -137.38 155.46 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.26 -60.56 1.86 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.355 1.074 . . . . 0.0 109.363 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.39 -45.05 17.61 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.889 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.0 mt-30 -64.86 -32.52 74.27 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.67 -35.17 65.18 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.156 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 31.3 mt-10 -64.6 -37.81 88.84 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.154 0.978 . . . . 0.0 110.39 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.0 -37.02 19.05 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.913 0.863 . . . . 0.0 110.136 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.627 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -88.2 2.8 51.41 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.01 73.56 2.19 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 119.848 -1.783 . . . . 0.0 110.111 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 38.7 t-20 . . . . . 0 C--N 1.293 -1.878 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.576 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.28 165.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.993 -1.067 . . . . 0.0 109.985 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.576 ' N ' HG22 ' B' ' 23' ' ' VAL . 9.9 m120 -121.66 70.99 0.96 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -119.39 169.19 10.23 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.05 92.29 8.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -83.7 141.2 31.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.387 -0.82 . . . . 0.0 110.6 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.5 m -142.5 124.25 15.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 109.954 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.5 -107.45 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 13.1 t -38.65 -59.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.343 -1.092 . . . . 0.0 111.447 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -42.73 93.25 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 2' ' ' ILE . 24.4 tp -68.03 -63.23 1.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.724 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.569 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.8 t -40.52 -56.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 122.018 0.913 . . . . 0.0 108.655 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.39 -40.05 67.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.9 -36.03 74.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 2' ' ' ILE . 49.5 mt -74.95 -57.48 3.88 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.518 -1.364 . . . . 0.0 108.736 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -46.09 -30.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.445 HD23 ' C ' ' B' ' 38' ' ' LEU . 10.0 tt -75.92 -47.33 25.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.71 -60.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.24 -47.3 68.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.727 -0.608 . . . . 0.0 112.091 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.1 -117.91 10.41 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.4 tt0 -65.89 -41.88 90.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 111.354 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -49.45 -15.78 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.868 -1.145 . . . . 0.0 110.327 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.16 -172.77 40.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.8 p90 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 120.112 -1.817 . . . . 0.0 110.936 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 HD11 ' B' ' 32' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -68.47 -50.71 54.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.561 -1.337 . . . . 0.0 110.641 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -50.89 -62.58 1.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.58 -1.325 . . . . 0.0 111.097 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.576 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 1.9 mp0 -62.69 -40.05 95.9 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.896 -1.127 . . . . 0.0 111.948 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 4.3 m -85.81 -44.96 12.03 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.06 -1.025 . . . . 0.0 112.222 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 3' ' ' VAL . 49.0 t -83.14 -53.07 6.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.536 -1.353 . . . . 0.0 110.906 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -69.9 -31.47 69.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.822 -1.174 . . . . 0.0 108.807 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.9 m -132.09 174.01 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.81 136.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.598 -1.314 . . . . 0.0 108.975 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -102.71 -172.92 2.21 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.127 0.965 . . . . 0.0 109.668 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.455 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -137.45 157.08 47.35 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -44.34 -60.26 2.01 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.296 1.046 . . . . 0.0 109.452 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.27 -45.13 17.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.948 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -64.7 -32.55 74.28 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.87 -35.35 64.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.28 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 21.8 mt-10 -64.34 -37.73 88.55 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.12 0.962 . . . . 0.0 110.464 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.83 -37.17 18.59 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.94 0.876 . . . . 0.0 110.173 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.613 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.9 m-85 -87.71 2.73 50.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.5 m -74.12 74.29 1.75 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 119.806 -1.809 . . . . 0.0 110.045 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 32.3 t30 . . . . . 0 C--N 1.293 -1.861 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.74 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.599 HG22 ' N ' ' B' ' 24' ' ' ASN . 4.0 p -149.16 166.06 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.083 . . . . 0.0 109.801 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.599 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.0 m120 -123.47 69.73 1.03 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -118.63 168.24 10.89 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.789 0.804 . . . . 0.0 109.957 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -88.8 91.85 8.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.43 138.91 33.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.432 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.4 m -140.29 124.04 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.18 -109.43 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.5 m -38.92 -58.18 1.14 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -1.094 . . . . 0.0 111.674 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.73 -27.27 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.917 -1.114 . . . . 0.0 110.057 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.82 HD11 HD11 ' A' ' 2' ' ' ILE . 18.9 tp -84.16 -61.47 1.8 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.324 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 33.1 t -41.28 -57.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.771 0.796 . . . . 0.0 108.992 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.07 -36.17 62.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.58 -36.32 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.812 HD11 HD13 ' A' ' 2' ' ' ILE . 48.9 mt -74.44 -57.84 3.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.617 -1.302 . . . . 0.0 108.876 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.7 t80 -45.94 -30.02 1.62 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.53 HD23 ' C ' ' B' ' 38' ' ' LEU . 8.9 tt -76.73 -46.03 27.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.0 t -75.88 -60.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.757 0.789 . . . . 0.0 109.677 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.3 m -68.17 -47.06 69.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.704 -0.623 . . . . 0.0 111.942 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -118.4 12.23 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.755 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.7 tt0 -64.75 -43.14 94.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -1.076 . . . . 0.0 111.351 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.2 mtm180 -48.24 -17.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.912 -1.118 . . . . 0.0 110.415 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -175.51 44.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.431 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.6 p90 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.203 -1.763 . . . . 0.0 110.905 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.788 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.275 0.56 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.7 t -59.17 -50.1 81.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.813 -1.179 . . . . 0.0 110.814 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.65 -62.45 1.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.596 -1.315 . . . . 0.0 111.032 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.55 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -60.24 -40.25 89.58 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.954 -1.091 . . . . 0.0 111.949 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.49 -46.16 10.44 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.038 -1.039 . . . . 0.0 112.008 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.93 -52.95 6.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.797 -1.19 . . . . 0.0 111.023 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.87 -28.32 64.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.731 -1.231 . . . . 0.0 108.889 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.9 m -135.97 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.22 128.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.616 -1.302 . . . . 0.0 108.981 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.32 -173.05 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.259 1.028 . . . . 0.0 109.974 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.11 151.61 49.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.35 -60.56 1.45 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.237 1.017 . . . . 0.0 109.572 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.66 -45.13 19.07 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.823 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.5 mt-30 -64.35 -32.59 74.25 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.82 -35.37 64.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.268 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.2 mt-10 -64.43 -37.61 88.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.088 0.947 . . . . 0.0 110.43 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.79 -37.13 18.28 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.929 0.871 . . . . 0.0 110.088 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.646 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.9 m-85 -88.29 3.81 48.28 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.2 m -76.04 75.0 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 119.83 -1.794 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.434 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 14.1 t-20 . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.576 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.591 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -147.81 165.47 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.018 -1.051 . . . . 0.0 109.847 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.591 ' N ' HG22 ' B' ' 23' ' ' VAL . 15.0 m120 -122.93 71.7 1.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -120.94 170.75 9.19 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.804 0.812 . . . . 0.0 110.09 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -90.89 92.63 8.86 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.96 140.25 32.04 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.366 -0.833 . . . . 0.0 110.572 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' B' ' 29' ' ' GLY . 54.4 m -142.38 124.36 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 67.1 m -38.53 -60.56 0.79 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.391 -1.064 . . . . 0.0 111.391 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.91 -45.46 89.21 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.014 -1.054 . . . . 0.0 109.636 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 2' ' ' ILE . 25.3 tp -64.84 -63.71 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.663 . . . . 0.0 109.638 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.9 t -40.85 -57.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -53.97 -39.66 66.17 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.56 -36.65 76.61 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.786 HD11 HD13 ' A' ' 2' ' ' ILE . 52.1 mt -74.29 -57.1 4.17 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.505 -1.372 . . . . 0.0 108.844 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.8 t80 -46.66 -30.57 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.555 HD23 ' C ' ' B' ' 38' ' ' LEU . 8.4 tt -75.96 -47.49 24.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.78 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.747 0.784 . . . . 0.0 109.669 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.7 m -67.94 -47.24 69.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.777 -0.577 . . . . 0.0 112.037 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.76 -117.84 10.56 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.696 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -39.59 90.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -1.059 . . . . 0.0 111.403 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 2.6 mtm180 -52.56 -15.68 0.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.78 -173.87 40.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.434 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.8 p90 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 120.083 -1.834 . . . . 0.0 111.273 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.792 HD11 HD11 ' B' ' 32' ' ' LEU . 7.8 tt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.372 0.606 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.0 t -58.98 -49.46 83.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.831 -1.168 . . . . 0.0 110.838 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -52.57 -62.37 1.69 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.591 -1.318 . . . . 0.0 111.042 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.9 mp0 -59.82 -40.48 88.59 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.879 -1.138 . . . . 0.0 111.82 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.3 -46.13 10.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.084 -1.01 . . . . 0.0 112.111 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.2 t -82.98 -53.04 6.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.719 -1.238 . . . . 0.0 110.953 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.67 -28.07 64.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.763 -1.211 . . . . 0.0 108.883 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.1 m -136.31 174.22 10.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.63 127.65 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.625 -1.297 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -90.31 -173.08 3.68 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.209 1.005 . . . . 0.0 109.959 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.44 152.51 49.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.59 -60.59 1.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 122.369 1.08 . . . . 0.0 109.651 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -46.52 -45.19 18.39 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.874 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.3 mt-30 -64.26 -32.53 74.15 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -74.03 -35.1 64.33 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.256 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 18.5 mt-10 -64.37 -37.74 88.57 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.126 0.965 . . . . 0.0 110.393 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -49.04 -37.36 20.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.972 0.892 . . . . 0.0 110.217 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.632 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.5 m-85 -87.7 2.66 50.49 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.3 m -75.71 75.03 2.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 119.886 -1.759 . . . . 0.0 110.069 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 27.1 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.053 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.586 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.7 p -148.38 165.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.076 -1.015 . . . . 0.0 109.817 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.586 ' N ' HG22 ' B' ' 23' ' ' VAL . 8.5 m120 -123.18 71.22 1.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -119.87 170.06 9.59 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.752 0.787 . . . . 0.0 109.994 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -90.9 94.22 9.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -85.48 140.78 30.41 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.488 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.412 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.0 m -142.53 124.25 15.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.32 -107.17 0.06 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 29' ' ' GLY . 11.1 t -38.58 -59.98 0.86 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -1.109 . . . . 0.0 111.344 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.77 -43.63 92.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.977 -1.077 . . . . 0.0 109.689 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 2' ' ' ILE . 23.9 tp -66.9 -63.26 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 109.642 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.7 t -40.6 -57.16 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.021 0.915 . . . . 0.0 108.709 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -53.86 -39.65 65.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.43 -36.21 75.46 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.791 HD11 HD13 ' A' ' 2' ' ' ILE . 49.1 mt -74.68 -57.33 3.99 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.527 -1.358 . . . . 0.0 108.825 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.41 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.4 t80 -46.04 -31.23 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.435 HD23 ' C ' ' B' ' 38' ' ' LEU . 9.8 tt -74.76 -47.82 28.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.3 t -74.16 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.71 0.767 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 22.2 m -67.98 -47.19 69.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.748 -0.595 . . . . 0.0 112.058 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.7 11.6 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.539 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' B' ' 44' ' ' GLY . 52.2 tp10 -62.58 -44.07 97.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.318 -1.107 . . . . 0.0 111.446 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -50.72 -14.0 0.17 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.918 -1.114 . . . . 0.0 110.667 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 68.53 -173.44 33.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 24.7 p90 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 120.138 -1.801 . . . . 0.0 110.841 -179.284 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.821 HD11 HD11 ' B' ' 32' ' ' LEU . 8.0 tt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.344 0.593 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 7' ' ' CYS . 85.0 t -59.84 -50.3 80.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.889 -1.132 . . . . 0.0 110.809 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.32 -62.44 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.7 -1.25 . . . . 0.0 111.041 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' SER . 3.0 mp0 -60.76 -40.36 92.18 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 111.889 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.29 -46.03 10.7 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.047 -1.033 . . . . 0.0 112.164 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.8 t -82.83 -52.97 6.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.719 -1.238 . . . . 0.0 111.027 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -70.99 -28.25 64.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.793 -1.192 . . . . 0.0 108.919 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -135.99 174.17 10.9 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mt -87.09 130.86 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.587 -1.321 . . . . 0.0 109.051 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.67 -173.19 2.94 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.223 1.011 . . . . 0.0 109.845 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -136.96 155.43 49.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.7 tp -44.97 -60.69 1.94 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.303 1.049 . . . . 0.0 109.239 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.2 -45.07 16.66 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.847 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.586 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.6 mt-30 -64.86 -32.73 74.57 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.6 -35.19 65.34 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.159 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 29.2 mt-10 -64.59 -37.76 88.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.134 0.969 . . . . 0.0 110.37 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.92 -36.99 18.55 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 121.871 0.843 . . . . 0.0 110.066 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.29 2.93 51.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.32 74.41 1.85 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.8 -1.812 . . . . 0.0 109.892 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.446 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 21.4 t-20 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.668 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.574 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -149.72 165.53 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.054 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.574 ' N ' HG22 ' B' ' 23' ' ' VAL . 11.8 m120 -121.31 71.27 0.95 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -120.22 169.84 9.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.832 0.825 . . . . 0.0 110.179 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -91.13 92.75 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.36 140.65 31.44 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 110.514 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -142.05 124.26 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.66 -107.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.8 m -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.381 -1.07 . . . . 0.0 111.358 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -42.9 95.99 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.962 -1.086 . . . . 0.0 109.695 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 2' ' ' ILE . 25.2 tp -68.17 -63.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.81 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.66 -57.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -53.79 -39.29 65.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.68 -36.46 76.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.8 HD11 HD13 ' A' ' 2' ' ' ILE . 50.7 mt -74.49 -56.74 4.5 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.55 -1.344 . . . . 0.0 108.703 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -46.45 -30.71 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.616 HD23 ' C ' ' B' ' 38' ' ' LEU . 7.3 tt -75.98 -46.52 29.18 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.03 -61.17 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.82 0.819 . . . . 0.0 109.73 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.5 m -68.05 -47.23 68.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.772 -0.58 . . . . 0.0 111.993 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.22 -117.87 11.02 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.665 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.37 -42.46 92.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -1.06 . . . . 0.0 111.309 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.99 -17.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.853 -1.155 . . . . 0.0 110.506 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.7 -175.03 44.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.446 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.3 p90 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.088 -1.831 . . . . 0.0 111.174 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.804 HD11 HD11 ' B' ' 32' ' ' LEU . 8.8 tt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.33 0.586 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.2 t -61.75 -49.34 84.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.78 -1.2 . . . . 0.0 111.01 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -51.95 -62.54 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.24 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mp0 -62.38 -38.8 90.99 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.845 -1.159 . . . . 0.0 111.872 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 3.8 m -86.33 -46.13 10.58 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.976 -1.078 . . . . 0.0 112.101 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.0 t -83.31 -53.0 6.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.649 -1.282 . . . . 0.0 110.945 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -69.91 -29.73 66.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.725 -1.234 . . . . 0.0 108.857 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.3 m -134.83 174.19 10.86 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -86.41 134.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.587 -1.321 . . . . 0.0 108.951 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -98.82 -172.96 2.4 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.203 1.001 . . . . 0.0 109.838 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.28 152.46 49.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.16 -60.32 1.49 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.229 1.014 . . . . 0.0 109.617 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.91 -45.24 20.45 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.824 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 25.8 mt-30 -64.19 -32.56 74.18 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -35.72 65.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.267 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.453 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 25.8 mt-10 -64.2 -37.64 88.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.128 0.965 . . . . 0.0 110.462 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.78 -37.21 18.46 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.885 0.85 . . . . 0.0 110.063 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.63 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.4 m-85 -88.01 2.81 50.9 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.4 m -75.41 74.51 2.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 119.84 -1.788 . . . . 0.0 110.189 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' CYS . 37.2 t-20 . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.988 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.584 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -150.21 165.91 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 109.841 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.584 ' N ' HG22 ' B' ' 23' ' ' VAL . 7.5 m120 -123.49 71.69 1.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -120.42 169.74 10.03 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.752 0.786 . . . . 0.0 110.057 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -90.06 92.02 8.8 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.54 141.26 31.73 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.3 m -143.17 124.33 14.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.956 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 29' ' ' GLY . 26.4 t -38.73 -60.75 0.79 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -1.085 . . . . 0.0 111.46 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -43.57 95.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.934 -1.104 . . . . 0.0 109.72 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 2' ' ' ILE . 24.4 tp -67.24 -63.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 0.0 109.732 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.1 t -40.62 -57.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.033 0.92 . . . . 0.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -53.65 -39.53 65.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.46 -36.63 76.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.789 HD11 HD13 ' A' ' 2' ' ' ILE . 49.8 mt -74.44 -56.67 4.59 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.553 -1.342 . . . . 0.0 108.722 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -46.33 -30.67 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.595 HD23 ' C ' ' B' ' 38' ' ' LEU . 7.7 tt -76.39 -48.23 20.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.83 -60.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.828 0.823 . . . . 0.0 109.687 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.38 -47.17 68.07 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.802 -0.561 . . . . 0.0 112.152 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -121.72 22.44 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.353 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' B' ' 44' ' ' GLY . 8.3 tp10 -61.26 -44.14 97.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -1.096 . . . . 0.0 110.979 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -16.68 0.07 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.999 -1.063 . . . . 0.0 110.622 -177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.45 -174.62 38.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.404 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.1 p90 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 120.185 -1.773 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.451 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.947 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt -49.63 -30.36 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 109.578 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.7 t -59.85 -50.3 80.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.799 -1.188 . . . . 0.0 110.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -51.87 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.56 -1.338 . . . . 0.0 110.928 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.73 -41.04 89.99 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 111.884 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.33 -46.0 10.7 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.033 -1.042 . . . . 0.0 112.129 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.5 t -82.97 -53.0 6.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.723 -1.236 . . . . 0.0 111.039 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 m -70.85 -28.71 64.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.734 -1.229 . . . . 0.0 108.884 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.8 m -135.27 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.74 129.23 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.62 -1.3 . . . . 0.0 109.1 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.68 -173.06 3.23 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.219 1.009 . . . . 0.0 109.868 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.21 154.85 50.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.21 -60.54 1.85 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 122.325 1.059 . . . . 0.0 109.364 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.33 -45.1 17.32 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.87 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.584 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.7 mt-30 -64.86 -32.51 74.25 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.63 -34.87 65.2 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.179 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 20.1 mt-10 -64.96 -37.75 88.69 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.107 0.956 . . . . 0.0 110.324 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.88 -37.15 18.81 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.901 0.857 . . . . 0.0 110.103 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.2 m-85 -87.92 3.04 50.07 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.9 m -74.84 75.77 2.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.749 -1.844 . . . . 0.0 109.961 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.434 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 3.6 t-20 . . . . . 0 C--N 1.293 -1.87 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.57 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -147.98 165.89 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.0 109.837 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.57 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.1 m120 -122.9 71.2 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.05 169.87 9.81 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.78 0.8 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.16 92.63 8.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.94 141.04 31.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.405 -0.81 . . . . 0.0 110.551 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.7 m -142.53 124.28 15.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.76 -107.59 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.415 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.5 m -38.59 -60.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.386 -1.067 . . . . 0.0 111.45 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.2 m-20 -64.23 -43.39 95.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.922 -1.111 . . . . 0.0 109.665 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.82 HD11 HD11 ' A' ' 2' ' ' ILE . 24.8 tp -67.51 -63.25 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.68 -57.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.97 0.891 . . . . 0.0 108.644 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -53.83 -38.86 65.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -60.18 -35.87 76.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.82 HD11 HD13 ' A' ' 2' ' ' ILE . 50.4 mt -75.06 -57.08 4.12 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.506 -1.371 . . . . 0.0 108.748 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.22 -31.11 2.28 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.3 tt -74.8 -48.13 26.99 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.7 t -74.19 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 121.766 0.794 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' B' ' 36' ' ' LEU . 30.1 m -68.25 -47.12 68.6 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.775 -0.578 . . . . 0.0 112.101 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.56 -121.14 19.36 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.496 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 9.7 tp10 -62.35 -44.0 97.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.265 -1.138 . . . . 0.0 111.036 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.447 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -47.02 -17.33 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.064 -1.022 . . . . 0.0 110.594 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.94 -175.4 41.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.7 p90 -168.34 169.62 10.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.174 -1.78 . . . . 0.0 110.952 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.483 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.97 -83.52 0.0 OUTLIER 'General case' 0 C--N 1.401 2.823 0 O-C-N 119.712 -1.867 . . . . 0.0 108.119 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.07 106.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -74.64 168.58 25.72 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -51.28 -72.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.992 0 C-N-CA 121.431 1.421 . . . . 0.0 110.432 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.446 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.524 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.98 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 32' ' ' LEU . 7.6 tt -65.53 -30.0 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -1.163 . . . . 0.0 109.554 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 7' ' ' CYS . 89.9 t -59.34 -50.43 79.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.874 -1.141 . . . . 0.0 110.849 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -50.96 -62.16 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.669 -1.27 . . . . 0.0 111.14 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.7 mp0 -61.32 -39.89 92.19 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.9 -1.125 . . . . 0.0 111.948 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -46.02 10.6 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.014 -1.053 . . . . 0.0 112.106 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.78 -52.94 6.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.85 -1.156 . . . . 0.0 111.043 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.17 -28.31 64.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.178 . . . . 0.0 108.927 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.5 m -135.86 174.09 11.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.06 129.32 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.601 -1.312 . . . . 0.0 109.01 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.17 -173.16 3.35 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.195 0.997 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.51 151.65 48.65 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -42.16 -60.41 1.46 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 122.255 1.026 . . . . 0.0 109.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.73 -45.41 19.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.779 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.7 mt-30 -64.15 -32.55 74.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.69 -35.64 65.19 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.246 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 24.6 mt-10 -64.03 -37.66 88.24 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.152 0.977 . . . . 0.0 110.467 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.76 -37.13 18.12 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.917 0.865 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.19 3.28 49.93 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.1 m -75.18 74.06 2.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 119.826 -1.796 . . . . 0.0 110.027 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.441 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 21.9 t-20 . . . . . 0 C--N 1.294 -1.839 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.752 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.575 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.96 165.94 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.026 -1.046 . . . . 0.0 109.84 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.575 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.2 m120 -122.68 71.07 1.01 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -120.27 169.91 9.83 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.861 0.839 . . . . 0.0 110.063 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -91.01 92.29 8.68 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.73 139.71 32.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 110.671 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 51.2 m -140.89 124.17 16.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 109.727 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.82 -111.4 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.407 ' C ' ' O ' ' B' ' 29' ' ' GLY . 38.8 t -38.62 -54.18 1.56 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.405 -1.056 . . . . 0.0 111.473 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.91 -31.7 70.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.886 -1.133 . . . . 0.0 109.666 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 2' ' ' ILE . 20.7 tp -82.1 -61.51 1.88 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.658 -0.651 . . . . 0.0 109.554 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' B' ' 29' ' ' GLY . 29.2 t -40.8 -56.96 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 108.585 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -53.51 -39.47 64.65 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.47 -36.34 75.8 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.799 HD11 HD13 ' A' ' 2' ' ' ILE . 48.9 mt -74.67 -56.06 5.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.622 -1.299 . . . . 0.0 108.603 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -46.69 -31.12 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.568 HD23 ' C ' ' B' ' 38' ' ' LEU . 8.1 tt -75.87 -47.75 24.2 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 t -73.79 -61.06 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.745 0.783 . . . . 0.0 109.785 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.34 -47.45 67.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.74 -0.6 . . . . 0.0 112.025 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.48 -117.75 11.88 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.796 -1.193 . . . . 0.0 110.71 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.31 -43.18 95.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.324 -1.103 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -48.41 -19.35 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.904 -1.123 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.69 44.16 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.441 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 27.2 p90 -166.16 170.8 12.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.125 -1.809 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.48 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.429 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -177.82 118.67 0.1 Allowed 'General case' 0 C--N 1.402 2.858 0 O-C-N 119.47 -2.019 . . . . 0.0 108.815 178.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.523 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.3 t -89.93 -132.12 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.286 -0.884 . . . . 0.0 108.804 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' N ' ' OG1' ' B' ' 48' ' ' THR . 8.2 ptpp? -86.91 151.65 52.45 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.02 -1.05 . . . . 0.0 108.891 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -49.04 -64.05 0.25 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 120.678 0.919 . . . . 0.0 110.496 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.478 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.994 0 N-CA-C 119.647 2.619 . . . . 0.0 119.647 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.797 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt -55.26 -30.91 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.656 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.7 t -59.32 -50.12 81.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.797 -1.189 . . . . 0.0 110.743 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -51.47 -62.32 1.7 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.644 -1.285 . . . . 0.0 111.047 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -60.71 -40.18 91.33 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 111.929 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.39 -46.18 10.5 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.031 -1.043 . . . . 0.0 112.076 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.72 -52.86 6.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.804 -1.185 . . . . 0.0 111.023 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -71.15 -28.68 64.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.241 . . . . 0.0 108.971 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.3 m -135.45 174.36 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.29 130.22 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.584 -1.322 . . . . 0.0 109.086 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.48 -173.01 3.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.184 0.992 . . . . 0.0 109.92 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -138.1 152.32 48.65 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.8 tp -42.53 -60.63 1.46 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 122.338 1.066 . . . . 0.0 109.599 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.7 -44.87 19.06 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.794 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.581 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -65.0 -32.38 74.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -34.99 65.23 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.126 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.84 -37.77 88.73 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.117 0.961 . . . . 0.0 110.374 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -36.84 18.11 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.899 0.857 . . . . 0.0 110.079 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.8 m-85 -88.1 3.25 49.76 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -74.82 74.64 2.11 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 119.735 -1.853 . . . . 0.0 110.043 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.438 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 12.4 t-20 . . . . . 0 C--N 1.294 -1.835 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.56 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.3 p -148.81 165.68 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.045 . . . . 0.0 109.922 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.563 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.1 m120 -122.55 71.58 1.03 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -120.51 169.94 9.87 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.814 0.816 . . . . 0.0 110.215 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -91.36 92.49 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.98 140.82 31.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 110.581 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 m -142.15 124.21 15.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 109.915 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -107.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 29' ' ' GLY . 8.7 t -38.58 -59.41 0.93 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -1.049 . . . . 0.0 111.398 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.06 -42.78 93.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 109.629 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 2' ' ' ILE . 24.7 tp -68.21 -63.29 1.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.64 . . . . 0.0 109.82 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.2 t -40.56 -57.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 122.073 0.94 . . . . 0.0 108.614 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -54.05 -39.65 66.43 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.29 -36.13 75.02 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.788 HD11 HD13 ' A' ' 2' ' ' ILE . 49.9 mt -74.8 -57.52 3.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.46 -1.4 . . . . 0.0 108.732 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.5 t80 -46.07 -30.77 2.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.4 ' C ' HD23 ' B' ' 38' ' ' LEU . 10.4 tt -75.24 -47.51 27.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.88 -61.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.778 0.799 . . . . 0.0 109.832 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.1 m -68.3 -47.13 68.44 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.757 -0.589 . . . . 0.0 112.068 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 -121.61 22.67 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.473 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' B' ' 44' ' ' GLY . 12.0 tp10 -61.33 -44.05 97.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -1.096 . . . . 0.0 111.111 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -47.02 -18.28 0.07 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.99 -1.069 . . . . 0.0 110.696 -178.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.25 43.87 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.438 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.8 p90 -168.02 170.03 10.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.19 -1.77 . . . . 0.0 111.265 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.478 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.419 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.65 103.93 0.06 Allowed 'General case' 0 C--N 1.4 2.804 0 O-C-N 119.779 -1.826 . . . . 0.0 107.959 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -144.25 112.24 6.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 5.8 mttt -78.22 -42.87 2.13 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.993 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 19.5 Cg_exo -54.34 -57.11 1.98 Allowed 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.964 1.109 . . . . 0.0 110.501 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.32 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 5.024 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.829 HD11 HD11 ' B' ' 32' ' ' LEU . 7.5 tt -55.17 -30.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -1.147 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' CYS . 75.8 t -59.27 -50.88 78.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.816 -1.177 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -51.02 -62.43 1.62 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.571 -1.33 . . . . 0.0 110.993 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.9 mp0 -60.33 -40.56 91.05 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.977 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.22 -45.69 11.07 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.067 -1.021 . . . . 0.0 111.974 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.65 -52.91 6.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.795 -1.191 . . . . 0.0 110.995 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 m -71.47 -28.11 63.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.73 -1.231 . . . . 0.0 109.014 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' CYS . 70.9 m -135.72 174.19 10.88 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.43 129.02 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.542 -1.349 . . . . 0.0 108.961 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.79 -173.12 3.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.157 0.979 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.451 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -137.24 155.49 49.43 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.64 -60.54 1.95 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 122.407 1.098 . . . . 0.0 109.242 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.35 -45.09 17.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.936 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.8 mt-30 -64.94 -32.61 74.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.85 -34.18 64.41 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.11 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.6 mt-10 -65.63 -37.68 87.24 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.196 0.998 . . . . 0.0 110.324 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.93 -37.04 18.78 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.966 0.889 . . . . 0.0 110.101 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.0 m-85 -87.85 2.87 50.36 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 m -74.91 76.23 2.16 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.801 -1.812 . . . . 0.0 109.915 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.436 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 24.5 t-20 . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.677 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.586 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.3 p -150.52 165.96 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.999 -1.063 . . . . 0.0 109.887 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.586 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.6 m120 -123.08 71.53 1.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.69 170.15 9.72 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.799 0.809 . . . . 0.0 110.167 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -91.28 92.57 8.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.81 140.57 31.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.11 124.0 16.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 109.798 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.0 -110.03 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 50.2 m -38.73 -55.7 1.44 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.402 -1.058 . . . . 0.0 111.444 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -34.86 78.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 0.0 109.621 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 2' ' ' ILE . 20.9 tp -78.23 -61.78 1.89 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.768 -0.582 . . . . 0.0 109.769 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 24.8 t -40.84 -56.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 122.056 0.932 . . . . 0.0 108.567 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.84 -39.74 65.88 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.36 74.06 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.794 HD11 HD13 ' A' ' 2' ' ' ILE . 47.9 mt -75.25 -56.71 4.45 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.511 -1.368 . . . . 0.0 108.692 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -46.76 -30.64 2.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.57 -45.43 45.44 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.2 t -77.81 -61.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.765 0.793 . . . . 0.0 109.886 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.39 -47.17 68.04 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.721 -0.612 . . . . 0.0 111.867 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.46 -118.83 13.54 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.628 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 44' ' ' GLY . 18.1 tp10 -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -1.08 . . . . 0.0 111.058 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -47.58 -17.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 110.406 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.21 -176.54 40.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.436 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.8 p90 -168.08 169.27 11.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.215 -1.756 . . . . 0.0 110.972 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.481 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -179.95 -87.92 0.0 OUTLIER 'General case' 0 C--N 1.399 2.737 0 O-C-N 120.038 -1.664 . . . . 0.0 107.301 178.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.464 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 6.7 p 40.54 -134.97 0.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.567 -0.708 . . . . 0.0 110.929 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.464 ' N ' ' OG1' ' B' ' 48' ' ' THR . 7.5 pttp -149.82 91.63 4.29 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.517 -0.739 . . . . 0.0 109.249 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -56.17 -75.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 120.736 0.957 . . . . 0.0 110.616 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.428 179.944 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.514 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.97 0 N-CA-C 119.686 2.634 . . . . 0.0 119.686 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.829 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt -49.04 -30.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 7' ' ' CYS . 98.5 t -60.93 -51.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.799 -1.188 . . . . 0.0 110.705 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.61 -62.17 1.79 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.526 -1.359 . . . . 0.0 110.85 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.582 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -59.83 -41.33 91.08 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.0 111.913 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.7 m -86.41 -45.62 11.0 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.109 -0.994 . . . . 0.0 112.189 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.8 t -82.57 -53.02 6.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.711 -1.243 . . . . 0.0 110.962 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -71.57 -28.05 63.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.806 -1.184 . . . . 0.0 108.985 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.8 m -135.72 174.35 10.71 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mt -86.83 134.13 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.618 -1.301 . . . . 0.0 109.151 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -99.95 -172.96 2.33 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.141 0.972 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.463 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -138.23 156.12 47.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.67 -60.42 2.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.345 1.069 . . . . 0.0 109.285 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -46.31 -44.83 17.0 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.2 mt-30 -65.41 -32.44 74.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.61 -34.62 65.14 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.881 -1.127 . . . . 0.0 108.063 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 14.4 mt-10 -65.15 -37.89 88.86 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.157 0.98 . . . . 0.0 110.329 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.29 19.39 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.977 0.894 . . . . 0.0 110.047 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.5 m-85 -87.79 3.21 49.06 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.17 73.55 2.3 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 119.853 -1.779 . . . . 0.0 109.819 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OXT' ' OD1' ' A' ' 21' ' ' ASN . 51.2 t-20 . . . . . 0 C--N 1.292 -1.903 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.459 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.578 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.2 p -151.02 165.74 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.073 . . . . 0.0 109.992 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.578 ' N ' HG22 ' B' ' 23' ' ' VAL . 1.7 m120 -122.91 72.32 1.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -120.57 169.09 10.68 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.738 0.78 . . . . 0.0 109.85 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -90.67 91.69 8.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.57 140.05 33.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.614 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 45.3 m -140.92 123.99 16.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.697 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.41 -110.43 0.13 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 32.0 m -38.66 -55.57 1.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.408 -1.054 . . . . 0.0 111.527 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.15 -31.49 71.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.915 -1.115 . . . . 0.0 109.808 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 2' ' ' ILE . 20.3 tp -82.36 -61.51 1.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 109.644 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' B' ' 29' ' ' GLY . 32.4 t -40.67 -57.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.005 0.907 . . . . 0.0 108.554 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -53.51 -39.76 64.86 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.23 -35.82 74.32 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 2' ' ' ILE . 48.7 mt -75.01 -56.99 4.19 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.494 -1.379 . . . . 0.0 108.749 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.2 t80 -46.5 -30.7 2.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.433 HD23 ' C ' ' B' ' 38' ' ' LEU . 10.2 tt -75.4 -47.15 28.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.29 -61.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.817 0.817 . . . . 0.0 109.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.8 m -68.05 -47.25 68.88 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.71 -0.619 . . . . 0.0 111.989 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.62 -117.92 11.53 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.681 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.3 tt0 -64.98 -43.04 93.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.325 -1.103 . . . . 0.0 111.317 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -48.2 -17.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.866 -1.146 . . . . 0.0 110.46 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.09 -175.51 42.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.423 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 24.3 p90 -168.1 169.96 10.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.063 -1.845 . . . . 0.0 111.367 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.476 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.76 82.59 0.02 OUTLIER 'General case' 0 C--N 1.398 2.717 0 O-C-N 119.894 -1.754 . . . . 0.0 107.686 178.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 80.0 p -86.76 -166.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.698 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' B' ' 50' ' ' PRO . 4.9 mptp? -71.94 -58.39 3.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.951 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 25.4 Cg_exo -44.27 -63.87 0.3 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.834 1.023 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.495 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.944 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.815 HD13 HD11 ' B' ' 36' ' ' LEU . 7.6 tt -66.55 -30.09 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.137 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 80.3 t -59.06 -50.23 80.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.898 -1.126 . . . . 0.0 110.866 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -51.35 -62.65 1.49 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.65 -1.281 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.0 mp0 -60.5 -39.94 89.53 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.925 -1.109 . . . . 0.0 111.914 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.45 -46.21 10.42 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.986 -1.071 . . . . 0.0 112.034 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.2 t -82.77 -52.98 6.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.198 . . . . 0.0 110.942 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -70.88 -28.17 64.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.752 -1.217 . . . . 0.0 108.945 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.3 m -136.14 174.03 11.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.28 127.35 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.639 -1.288 . . . . 0.0 108.944 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -89.44 -173.19 3.89 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.262 1.03 . . . . 0.0 109.942 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.09 151.4 48.84 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -42.09 -60.48 1.42 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 122.259 1.028 . . . . 0.0 109.516 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.82 -45.22 19.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.77 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.8 mt-30 -64.49 -32.41 74.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.66 -35.32 65.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.132 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.36 -37.73 88.52 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 122.096 0.95 . . . . 0.0 110.398 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.88 -36.89 18.13 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.858 0.837 . . . . 0.0 110.02 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.626 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.0 m-85 -88.54 3.76 49.16 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.8 m -75.55 73.22 2.57 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.8 -1.813 . . . . 0.0 110.007 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 13.9 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.186 -0.911 . . . . 0.0 109.452 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.579 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.88 166.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.046 -1.033 . . . . 0.0 109.823 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.579 ' N ' HG22 ' B' ' 23' ' ' VAL . 14.6 m120 -123.42 71.49 1.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -120.87 169.9 10.0 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.798 0.809 . . . . 0.0 110.242 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -90.69 92.89 9.02 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 mt -84.73 140.96 30.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -142.24 124.28 15.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.171 -0.956 . . . . 0.0 110.028 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.74 -107.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' B' ' 31' ' ' ASP . 12.4 p -38.55 -60.28 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -1.012 . . . . 0.0 111.342 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.464 ' N ' ' OG ' ' B' ' 30' ' ' SER . 3.4 m-20 -64.4 -43.5 94.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 109.617 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 2' ' ' ILE . 24.9 tp -66.74 -63.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.841 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.3 t -40.47 -57.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 108.708 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.27 -39.15 66.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.57 -35.45 74.29 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.815 HD11 HD13 ' A' ' 2' ' ' ILE . 49.0 mt -75.63 -56.62 4.52 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.464 -1.398 . . . . 0.0 108.693 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.6 t80 -46.52 -30.38 2.2 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.09 -47.4 28.95 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 t -75.42 -61.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.796 0.807 . . . . 0.0 109.775 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.9 m -67.93 -47.19 69.39 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.745 -0.597 . . . . 0.0 111.808 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.15 -117.65 11.82 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.632 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.03 -43.08 96.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.435 -1.038 . . . . 0.0 111.438 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -49.06 -18.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.865 -1.147 . . . . 0.0 110.628 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.6 -177.41 43.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.426 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 -166.56 171.1 12.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.071 -1.84 . . . . 0.0 111.478 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.472 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.49 94.82 0.05 OUTLIER 'General case' 0 C--N 1.402 2.85 0 O-C-N 119.615 -1.928 . . . . 0.0 108.37 178.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 39.2 p -153.27 112.29 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.307 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttp 47.09 71.14 1.69 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.887 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.64 -56.64 1.84 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.702 1.601 . . . . 0.0 110.481 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.488 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.929 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 36' ' ' LEU . 8.1 tt -54.92 -30.12 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.24 -1.153 . . . . 0.0 109.508 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.6 t -59.82 -50.65 79.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.892 -1.13 . . . . 0.0 110.836 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -51.34 -62.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.583 -1.323 . . . . 0.0 110.988 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.534 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 3.2 mp0 -59.95 -40.96 90.78 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.928 -1.108 . . . . 0.0 111.883 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.31 -46.06 10.66 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.087 -1.008 . . . . 0.0 112.142 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.8 t -82.26 -52.72 6.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.797 -1.189 . . . . 0.0 110.886 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.38 -30.09 65.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.798 -1.188 . . . . 0.0 108.961 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -133.43 174.19 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.08 129.17 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.662 -1.274 . . . . 0.0 108.795 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.72 -173.15 3.25 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.23 1.014 . . . . 0.0 109.845 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.451 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.81 155.02 49.45 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.9 tp -44.24 -60.54 1.86 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.338 1.066 . . . . 0.0 109.352 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.32 -45.11 17.28 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.957 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.1 mt-30 -64.97 -32.44 74.16 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.66 -34.63 65.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.065 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.2 mt-10 -65.05 -37.86 88.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.149 0.976 . . . . 0.0 110.365 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.9 -37.42 19.7 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.907 0.86 . . . . 0.0 110.085 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.609 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.2 m-85 -87.66 2.72 50.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.5 m -74.43 73.09 1.88 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 119.806 -1.809 . . . . 0.0 109.961 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 21' ' ' ASN . 55.1 t-20 . . . . . 0 C--N 1.292 -1.923 0 CA-C-O 118.182 -0.914 . . . . 0.0 109.528 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.601 HG22 ' N ' ' B' ' 24' ' ' ASN . 5.3 p -122.15 164.63 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.357 -0.839 . . . . 0.0 110.134 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.601 ' N ' HG22 ' B' ' 23' ' ' VAL . 10.0 m120 -122.54 71.05 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -122.02 169.49 10.78 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.8 0.809 . . . . 0.0 110.166 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.55 91.57 8.74 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.7 mt -81.79 138.76 35.09 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 110.73 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 44.0 m -139.53 123.74 17.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.409 -0.807 . . . . 0.0 109.54 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -110.63 0.13 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.455 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 19.7 m -38.68 -54.22 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -1.015 . . . . 0.0 111.515 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -69.19 -30.84 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.644 -1.285 . . . . 0.0 109.644 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 2' ' ' ILE . 21.0 tp -82.95 -61.37 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.716 -0.615 . . . . 0.0 110.077 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 31.3 t -40.0 -60.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 122.04 0.924 . . . . 0.0 108.752 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 2.9 mp0 -50.51 -40.74 52.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -57.8 -36.2 71.88 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.816 HD11 HD13 ' A' ' 2' ' ' ILE . 46.5 mt -75.26 -56.73 4.43 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.575 -1.328 . . . . 0.0 108.724 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -46.11 -31.47 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 tt -74.48 -47.93 30.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.0 t -74.57 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.743 0.782 . . . . 0.0 109.97 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.6 m -67.94 -47.13 69.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.752 -0.592 . . . . 0.0 111.977 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.3 -117.72 11.92 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -64.5 -43.01 95.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -1.133 . . . . 0.0 111.386 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -48.81 -18.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.856 -1.153 . . . . 0.0 110.425 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.85 -177.32 41.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.3 p90 -166.79 171.24 11.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.174 -1.78 . . . . 0.0 111.211 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.484 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -179.33 91.2 0.02 OUTLIER 'General case' 0 C--N 1.4 2.787 0 O-C-N 119.777 -1.827 . . . . 0.0 108.082 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.46 -28.2 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 109.67 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -139.79 71.7 36.03 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -56.65 -68.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.636 1.557 . . . . 0.0 110.399 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.492 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.985 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.804 HD11 HD11 ' B' ' 32' ' ' LEU . 8.7 tt -57.96 -30.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.119 . . . . 0.0 109.673 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.9 t -60.02 -49.58 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.818 -1.176 . . . . 0.0 110.875 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.95 -62.49 1.6 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.698 -1.251 . . . . 0.0 111.198 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.1 mp0 -61.61 -39.31 90.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 111.882 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.59 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.46 -46.32 10.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.038 -1.039 . . . . 0.0 112.121 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.6 t -83.01 -53.1 6.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.701 -1.25 . . . . 0.0 110.921 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -70.27 -28.55 65.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.793 -1.192 . . . . 0.0 108.909 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.9 m -136.13 174.31 10.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.01 131.43 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.583 -1.323 . . . . 0.0 109.106 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -95.4 -173.02 2.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.22 1.009 . . . . 0.0 109.924 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -137.1 154.9 50.19 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.27 -60.46 1.9 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.321 1.058 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.31 -45.07 17.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.937 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.3 mt-30 -64.66 -32.67 74.44 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.64 -35.0 65.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.223 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.3 mt-10 -64.7 -37.79 88.79 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.167 0.984 . . . . 0.0 110.433 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.26 19.25 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.085 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.1 m-85 -87.73 2.85 50.1 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -74.49 74.09 1.93 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 119.797 -1.815 . . . . 0.0 109.938 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 36.7 t30 . . . . . 0 C--N 1.293 -1.858 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.592 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.587 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -148.88 166.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.01 -1.056 . . . . 0.0 109.909 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.587 ' N ' HG22 ' B' ' 23' ' ' VAL . 6.9 m120 -123.27 71.54 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.27 170.25 9.51 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -90.83 91.96 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.61 140.67 32.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.465 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.1 m -142.58 124.15 14.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.903 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.98 -107.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 29.8 m -38.64 -61.08 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.33 -1.1 . . . . 0.0 111.526 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -42.13 98.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 109.783 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 2' ' ' ILE . 24.0 tp -68.77 -63.13 1.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.657 -0.652 . . . . 0.0 109.813 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' B' ' 29' ' ' GLY . 34.5 t -40.59 -57.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 122.027 0.917 . . . . 0.0 108.679 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -54.17 -39.15 66.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.75 -35.99 75.72 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.802 HD11 HD13 ' A' ' 2' ' ' ILE . 49.3 mt -74.77 -57.39 3.95 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.583 -1.323 . . . . 0.0 108.842 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' B' ' 36' ' ' LEU . 39.0 t80 -46.2 -30.53 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.471 HD23 ' C ' ' B' ' 38' ' ' LEU . 9.7 tt -75.73 -46.91 28.41 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.3 t -75.22 -61.13 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.75 0.786 . . . . 0.0 109.777 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 29.5 m -68.01 -47.13 69.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.769 -0.582 . . . . 0.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.88 11.71 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.718 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' B' ' 44' ' ' GLY . 22.9 tt0 -64.88 -43.12 93.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -1.075 . . . . 0.0 111.333 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.3 mtm180 -48.3 -18.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.17 . . . . 0.0 110.358 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.97 -176.81 43.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.425 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 26.2 p90 -166.91 170.53 12.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.186 -1.773 . . . . 0.0 111.047 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.485 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.409 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -179.54 101.63 0.03 OUTLIER 'General case' 0 C--N 1.401 2.825 0 O-C-N 119.732 -1.855 . . . . 0.0 108.22 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' B' ' 47' ' ' TYR . 3.3 m -166.37 -60.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.048 . . . . 0.0 109.681 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -146.2 71.98 13.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.267 -0.896 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.413 ' O ' ' OG1' ' B' ' 51' ' ' THR . 16.4 Cg_exo -56.23 -66.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.703 1.602 . . . . 0.0 110.559 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 35.1 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.651 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.995 0 N-CA-C 119.595 2.598 . . . . 0.0 119.595 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.806 HD11 HD11 ' B' ' 32' ' ' LEU . 8.1 tt -68.97 -29.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -1.164 . . . . 0.0 109.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 7' ' ' CYS . 94.5 t -59.5 -49.97 81.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.913 -1.117 . . . . 0.0 110.738 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -51.73 -62.54 1.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.609 -1.307 . . . . 0.0 111.022 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -59.83 -40.63 89.12 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.936 -1.103 . . . . 0.0 111.878 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.44 -46.21 10.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.045 -1.035 . . . . 0.0 112.125 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.7 t -82.74 -53.05 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.774 -1.204 . . . . 0.0 111.079 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 m -70.82 -28.43 64.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.772 -1.205 . . . . 0.0 108.948 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.6 m -135.77 174.16 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.05 129.14 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.622 -1.299 . . . . 0.0 108.846 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.63 -173.1 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.238 1.018 . . . . 0.0 109.99 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.21 151.65 48.99 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.68 -60.53 1.53 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.298 1.047 . . . . 0.0 109.611 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -46.8 -45.05 19.75 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.828 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.6 mt-30 -64.7 -32.22 73.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.98 -35.51 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.207 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.9 mt-10 -64.07 -37.78 88.68 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.112 0.958 . . . . 0.0 110.369 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.03 -37.65 21.35 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.941 0.877 . . . . 0.0 110.049 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -87.37 2.61 49.86 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.72 73.35 2.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 119.831 -1.793 . . . . 0.0 109.899 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 45.3 t-20 . . . . . 0 C--N 1.293 -1.886 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.269 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.601 HG22 ' N ' ' B' ' 24' ' ' ASN . 4.9 p -137.03 165.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.35 -0.844 . . . . 0.0 109.766 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.601 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.4 m120 -123.15 71.18 1.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -120.75 170.37 9.52 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.819 0.818 . . . . 0.0 109.992 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -89.93 92.3 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.19 139.82 32.92 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.32 -0.862 . . . . 0.0 110.667 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 50.4 m -141.83 124.25 15.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.254 -0.904 . . . . 0.0 109.927 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.87 -107.75 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.421 ' C ' ' O ' ' B' ' 29' ' ' GLY . 55.8 m -38.49 -59.74 0.88 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.393 -1.063 . . . . 0.0 111.464 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -43.5 93.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.928 -1.107 . . . . 0.0 109.674 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 2' ' ' ILE . 24.6 tp -67.2 -63.41 1.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.618 -0.676 . . . . 0.0 109.603 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.33 -56.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.934 0.873 . . . . 0.0 108.737 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -54.35 -40.62 68.23 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.15 -36.59 73.23 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.801 HD11 HD13 ' A' ' 2' ' ' ILE . 49.3 mt -74.87 -56.43 4.78 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 120.59 -1.319 . . . . 0.0 108.779 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -46.11 -31.42 2.35 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.17 0.985 . . . . 0.0 108.365 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.477 HD23 ' C ' ' B' ' 38' ' ' LEU . 9.3 tt -75.3 -48.59 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 t -73.01 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.746 0.784 . . . . 0.0 109.889 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.6 m -68.6 -47.49 66.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.707 -0.621 . . . . 0.0 111.971 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.52 -117.82 11.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.627 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -42.78 92.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -1.061 . . . . 0.0 111.432 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.31 -18.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.815 -1.178 . . . . 0.0 110.329 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.49 -176.59 44.91 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 -166.94 171.05 11.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.084 -1.833 . . . . 0.0 111.372 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.471 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.5 135.97 0.25 Allowed 'General case' 0 C--N 1.4 2.791 0 O-C-N 119.762 -1.836 . . . . 0.0 108.058 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 121.4 4.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.975 . . . . 0.0 109.642 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.644 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 44.6 mtpt -89.66 -32.92 0.38 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 111.78 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 17.4 Cg_exo -56.06 -72.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.718 0.946 . . . . 0.0 110.514 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.53 -179.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.438 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.971 0 N-CA-C 119.791 2.676 . . . . 0.0 119.791 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.797 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt -48.56 -29.96 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -1.16 . . . . 0.0 109.608 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 7' ' ' CYS . 88.5 t -59.99 -50.38 80.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.826 -1.171 . . . . 0.0 110.974 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.16 -62.34 1.7 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.576 -1.328 . . . . 0.0 110.927 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -59.34 -40.92 87.91 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.971 -1.081 . . . . 0.0 111.872 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.44 -45.99 10.63 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.053 -1.029 . . . . 0.0 112.126 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.4 t -82.82 -52.86 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.792 -1.192 . . . . 0.0 110.99 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 m -71.18 -28.0 63.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.791 -1.193 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.5 m -136.1 174.04 11.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -87.39 128.92 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.646 -1.284 . . . . 0.0 109.01 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -92.18 -173.06 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.167 0.984 . . . . 0.0 109.867 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -136.84 154.44 50.51 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -44.17 -60.66 1.79 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.322 1.058 . . . . 0.0 109.327 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -46.26 -45.22 17.05 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.878 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.4 mt-30 -64.76 -32.64 74.42 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 178.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.63 -34.7 65.13 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.807 -1.157 . . . . 0.0 108.156 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 16.0 mt-10 -65.19 -37.77 88.39 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.146 0.974 . . . . 0.0 110.385 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.78 -36.89 17.61 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.916 0.865 . . . . 0.0 110.054 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.628 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.5 m-85 -88.14 3.01 50.76 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 59.7 m -74.66 75.42 2.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 119.809 -1.807 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.492 ' OXT' ' ND2' ' A' ' 21' ' ' ASN . 2.5 t-20 . . . . . 0 C--N 1.293 -1.88 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.588 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -150.12 165.82 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.994 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.588 ' N ' HG22 ' B' ' 23' ' ' VAL . 12.9 m120 -123.46 71.64 1.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -121.2 170.58 9.44 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.813 0.816 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -91.0 91.98 8.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.92 141.32 31.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 110.568 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 43.6 m -142.66 124.31 14.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.026 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.64 -107.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.406 ' C ' ' O ' ' B' ' 29' ' ' GLY . 39.2 m -38.61 -59.56 0.91 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -1.04 . . . . 0.0 111.328 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.73 -44.42 90.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 109.572 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 2' ' ' ILE . 24.8 tp -66.24 -63.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.628 -0.67 . . . . 0.0 109.72 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.9 t -40.58 -57.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 122.061 0.934 . . . . 0.0 108.724 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -54.16 -39.35 66.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.54 -35.49 74.32 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.79 HD11 HD13 ' A' ' 2' ' ' ILE . 49.1 mt -75.37 -57.36 3.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.575 -1.328 . . . . 0.0 108.798 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -46.41 -30.19 2.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.9 -47.09 31.75 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -75.63 -61.15 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.834 0.826 . . . . 0.0 109.873 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.9 m -68.03 -47.19 69.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.766 -0.584 . . . . 0.0 111.992 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.05 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.545 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.6 tt0 -63.42 -43.08 98.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -1.064 . . . . 0.0 110.997 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.51 -18.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 110.372 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -176.42 42.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 107.581 -2.207 . . . . 0.0 107.581 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.458 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.0 p90 -167.59 170.72 10.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.202 -1.764 . . . . 0.0 111.082 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.482 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -176.86 104.19 0.06 Allowed 'General case' 0 C--N 1.403 2.908 0 O-C-N 119.568 -1.957 . . . . 0.0 108.656 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 47.3 p -96.57 11.14 36.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.884 . . . . 0.0 109.253 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 45.88 72.27 1.29 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 109.742 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.18 -70.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.589 1.526 . . . . 0.0 110.32 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.511 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.917 0 N-CA-C 119.754 2.661 . . . . 0.0 119.754 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 32' ' ' LEU . 8.7 tt -65.08 -29.11 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.294 -1.121 . . . . 0.0 109.62 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 7' ' ' CYS . 74.7 t -61.65 -50.12 81.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.804 -1.185 . . . . 0.0 110.763 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.56 -62.45 1.62 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.642 -1.287 . . . . 0.0 111.073 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.7 mp0 -61.83 -39.92 93.49 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.873 -1.142 . . . . 0.0 111.866 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.8 m -86.07 -45.73 11.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.051 -1.031 . . . . 0.0 112.241 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 3' ' ' VAL . 41.5 t -83.23 -52.91 6.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.671 -1.268 . . . . 0.0 110.957 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 m -70.65 -28.01 64.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.795 -1.191 . . . . 0.0 108.935 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 6' ' ' CYS . 68.4 m -136.04 174.03 11.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.52 135.78 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.566 -1.334 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -101.09 -172.9 2.25 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.1 0.953 . . . . 0.0 109.659 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -137.51 156.35 48.23 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.1 tp -44.7 -60.48 1.99 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.345 1.069 . . . . 0.0 109.327 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.3 -45.21 17.25 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.892 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.9 mt-30 -64.76 -32.57 74.31 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.77 -34.59 64.74 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.117 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 13.3 mt-10 -65.32 -37.71 87.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.131 0.967 . . . . 0.0 110.327 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -48.9 -36.96 18.39 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.889 0.852 . . . . 0.0 109.94 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.622 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -88.42 4.01 47.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.4 m -76.29 73.58 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.773 -1.829 . . . . 0.0 110.05 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.416 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 47.5 t30 . . . . . 0 C--N 1.294 -1.823 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.46 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.58 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -151.27 165.85 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.957 -1.09 . . . . 0.0 110.084 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.58 ' N ' HG22 ' B' ' 23' ' ' VAL . 11.0 m120 -123.16 71.27 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -120.44 170.49 9.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.826 0.822 . . . . 0.0 110.139 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -90.87 92.05 8.61 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.68 140.74 31.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.421 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -142.67 124.2 14.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.12 -107.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.8 m -38.44 -59.75 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -1.059 . . . . 0.0 111.368 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.23 -44.4 88.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.988 -1.07 . . . . 0.0 109.609 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 2' ' ' ILE . 25.4 tp -66.22 -63.33 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.693 -0.63 . . . . 0.0 109.873 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' GLY . 42.5 t -40.47 -57.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 122.043 0.925 . . . . 0.0 108.75 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -54.24 -39.09 66.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.71 -35.45 74.54 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.814 HD11 HD13 ' A' ' 2' ' ' ILE . 49.8 mt -75.46 -57.29 3.98 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.452 -1.405 . . . . 0.0 108.741 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -46.12 -30.61 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.53 -45.93 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.0 t -77.38 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 121.716 0.77 . . . . 0.0 109.949 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.63 -47.3 66.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.788 -0.57 . . . . 0.0 111.897 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 -117.91 10.65 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.642 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' B' ' 44' ' ' GLY . 41.5 tt0 -66.14 -41.31 90.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.321 -1.105 . . . . 0.0 111.233 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.1 mtm180 -49.38 -16.27 0.18 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 71.48 -173.79 43.02 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 107.193 -2.363 . . . . 0.0 107.193 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.416 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.0 p90 -169.04 169.59 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 119.996 -1.885 . . . . 0.0 111.434 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.479 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.552 ' O ' ' CB ' ' B' ' 48' ' ' THR . 0.2 OUTLIER -169.92 -64.39 0.02 OUTLIER 'General case' 0 C--N 1.405 2.991 0 O-C-N 119.376 -2.077 . . . . 0.0 109.239 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.552 ' CB ' ' O ' ' B' ' 47' ' ' TYR . 2.7 m 97.0 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 2.5 mtmt -70.38 -43.16 16.87 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.475 -0.765 . . . . 0.0 110.898 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 21.7 Cg_exo -53.53 -63.03 0.25 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.942 1.094 . . . . 0.0 110.537 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.54 179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.954 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.798 HD11 HD11 ' B' ' 32' ' ' LEU . 8.5 tt -49.04 -31.03 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.518 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 7' ' ' CYS . 64.0 t -59.63 -51.52 71.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.861 -1.15 . . . . 0.0 110.736 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -50.92 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.593 -1.317 . . . . 0.0 110.907 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.57 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.7 mp0 -59.68 -41.36 90.51 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.045 -1.034 . . . . 0.0 111.975 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.2 -45.56 11.2 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 0.0 112.047 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.474 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.7 t -82.69 -53.18 6.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.837 -1.165 . . . . 0.0 111.053 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 m -71.43 -27.62 63.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.187 . . . . 0.0 108.945 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.5 m -136.14 173.96 11.14 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.21 130.04 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.61 -1.306 . . . . 0.0 108.851 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.31 -173.08 3.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.212 1.006 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.89 151.85 48.43 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.15 -60.52 1.42 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.286 1.041 . . . . 0.0 109.622 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.71 -45.22 19.38 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.84 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.5 mt-30 -64.4 -32.61 74.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.51 -35.25 65.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.167 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 23.6 mt-10 -64.68 -37.59 88.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.124 0.964 . . . . 0.0 110.367 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -48.86 -36.85 17.92 Favored 'General case' 0 C--N 1.286 -2.196 0 CA-C-O 121.982 0.896 . . . . 0.0 109.982 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.615 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.53 4.33 47.14 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.0 m -76.55 74.27 3.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 119.787 -1.821 . . . . 0.0 109.824 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 18.7 t30 . . . . . 0 C--N 1.294 -1.826 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.547 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.591 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -147.81 165.58 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.591 ' N ' HG22 ' B' ' 23' ' ' VAL . 8.2 m120 -122.69 71.27 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -120.37 169.56 10.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.802 0.811 . . . . 0.0 110.166 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -90.53 92.69 8.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.06 138.82 32.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.677 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' GLY . 56.4 m -140.15 124.04 17.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.363 -0.836 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -108.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' ' 29' ' ' GLY . 10.0 t -39.08 -56.29 1.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.433 -1.039 . . . . 0.0 111.403 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.65 -27.49 65.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.919 -1.113 . . . . 0.0 110.022 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.798 HD11 HD11 ' A' ' 2' ' ' ILE . 19.8 tp -84.23 -61.57 1.77 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.78 . . . . 0.0 109.272 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' B' ' 29' ' ' GLY . 43.2 t -40.97 -57.68 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.828 0.823 . . . . 0.0 109.028 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.08 -36.71 63.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.24 -36.33 79.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 2' ' ' ILE . 52.1 mt -75.06 -56.52 4.66 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.568 -1.333 . . . . 0.0 108.654 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -46.67 -30.72 2.49 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.446 HD23 ' C ' ' B' ' 38' ' ' LEU . 10.0 tt -75.76 -47.9 23.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.98 -60.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.707 0.765 . . . . 0.0 109.819 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' B' ' 36' ' ' LEU . 23.7 m -69.38 -47.29 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.699 -0.626 . . . . 0.0 112.096 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.26 -118.15 11.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.564 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 44' ' ' GLY . 4.7 tp10 -63.83 -43.77 95.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -1.098 . . . . 0.0 111.123 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -49.22 -14.69 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.854 -1.153 . . . . 0.0 110.637 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.21 -173.15 39.91 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.7 p90 -169.31 169.79 8.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.026 -1.867 . . . . 0.0 111.471 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.477 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.58 97.78 0.24 Allowed 'General case' 0 C--N 1.403 2.928 0 O-C-N 119.637 -1.914 . . . . 0.0 108.404 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -64.25 107.93 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.475 -0.766 . . . . 0.0 109.643 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -65.23 116.64 32.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.098 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -53.19 -55.09 3.99 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 CA-C-N 119.102 0.715 . . . . 0.0 110.359 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.49 179.961 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.515 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.974 0 N-CA-C 119.767 2.667 . . . . 0.0 119.767 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 36' ' ' LEU . 8.0 tt -62.35 -29.95 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -1.128 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' CYS . 84.4 t -59.34 -50.43 79.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.893 -1.129 . . . . 0.0 110.909 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -51.1 -62.49 1.58 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.62 -1.3 . . . . 0.0 111.088 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.4 mp0 -60.5 -40.25 90.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 111.945 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.43 -46.03 10.61 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.014 -1.054 . . . . 0.0 112.081 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.9 t -82.7 -53.05 6.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.855 -1.153 . . . . 0.0 111.057 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -71.01 -28.51 64.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.793 -1.192 . . . . 0.0 108.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 6' ' ' CYS . 69.8 m -135.8 174.18 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.63 131.05 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.611 -1.306 . . . . 0.0 108.763 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -93.69 -173.07 3.06 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.26 1.029 . . . . 0.0 109.927 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.459 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -138.11 152.19 48.52 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -42.55 -60.76 1.42 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.267 1.032 . . . . 0.0 109.49 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.52 -45.3 18.43 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.845 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.573 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.7 mt-30 -64.61 -32.47 74.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.6 mp -73.72 -34.98 65.05 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.166 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 mt-10 -64.66 -37.74 88.62 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 122.147 0.975 . . . . 0.0 110.387 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -48.91 -37.01 18.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.983 0.897 . . . . 0.0 110.086 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.609 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.3 m-85 -88.21 3.42 49.45 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.0 m -75.61 74.95 2.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 119.803 -1.811 . . . . 0.0 109.785 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.435 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 12.0 t-20 . . . . . 0 C--N 1.295 -1.785 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.534 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.604 HG22 ' N ' ' B' ' 24' ' ' ASN . 5.0 p -120.92 164.97 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.384 -0.822 . . . . 0.0 109.995 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.604 ' N ' HG22 ' B' ' 23' ' ' VAL . 8.5 m120 -123.56 71.55 1.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -121.61 170.51 9.63 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.853 0.835 . . . . 0.0 110.058 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -89.33 91.72 8.86 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.96 138.23 33.88 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.638 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 54.8 m -139.62 124.09 18.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.604 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.83 -108.99 0.09 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 29' ' ' GLY . 58.5 m -38.85 -58.14 1.13 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.37 -1.076 . . . . 0.0 111.642 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.12 -27.02 66.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 110.11 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 2' ' ' ILE . 19.7 tp -84.15 -61.44 1.81 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.442 -0.786 . . . . 0.0 109.262 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' B' ' 29' ' ' GLY . 39.5 t -41.28 -57.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 121.773 0.797 . . . . 0.0 109.001 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -54.14 -35.95 62.78 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.98 -36.09 80.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.816 HD11 HD13 ' A' ' 2' ' ' ILE . 50.2 mt -74.75 -57.77 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.886 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.408 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.3 t80 -45.58 -31.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.477 HD23 ' C ' ' B' ' 38' ' ' LEU . 9.5 tt -74.91 -47.07 31.73 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.95 -60.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.725 0.774 . . . . 0.0 109.818 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.2 m -68.69 -47.18 67.11 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.773 -0.579 . . . . 0.0 112.055 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.23 -117.86 11.66 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.465 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' B' ' 44' ' ' GLY . 15.8 tp10 -63.46 -43.92 95.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -1.095 . . . . 0.0 111.221 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -49.72 -15.49 0.18 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.869 -1.144 . . . . 0.0 110.631 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.43 -174.88 37.62 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.433 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.9 p90 -167.95 170.69 10.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.116 -1.814 . . . . 0.0 111.194 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.484 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.413 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -175.86 84.11 0.03 OUTLIER 'General case' 0 C--N 1.402 2.86 0 O-C-N 119.68 -1.887 . . . . 0.0 108.11 178.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.454 ' O ' ' O ' ' B' ' 49' ' ' LYS . 26.3 p -147.55 -144.92 0.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.985 . . . . 0.0 109.229 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' B' ' 48' ' ' THR . 10.1 mtmt 58.27 158.0 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -51.75 -59.21 1.2 Allowed 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 120.624 0.883 . . . . 0.0 110.393 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.477 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.951 0 N-CA-C 119.757 2.663 . . . . 0.0 119.757 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.815 HD11 HD11 ' B' ' 32' ' ' LEU . 8.2 tt -48.76 -30.28 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.515 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.0 t -60.26 -51.68 70.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.742 -1.224 . . . . 0.0 110.673 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -50.83 -62.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.62 -1.3 . . . . 0.0 110.888 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.3 mp0 -60.09 -41.15 91.86 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.956 -1.09 . . . . 0.0 112.028 -177.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.583 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.21 -45.51 11.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.032 -1.043 . . . . 0.0 111.975 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 38.3 t -82.67 -53.1 6.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.795 -1.191 . . . . 0.0 111.056 -178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 m -71.47 -27.87 63.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.742 -1.224 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' CYS . 65.2 m -135.76 174.12 10.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.61 130.28 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.651 -1.28 . . . . 0.0 109.039 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.22 -172.97 2.95 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.152 0.977 . . . . 0.0 109.855 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -137.5 154.31 49.9 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -43.83 -60.57 1.76 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.4 1.095 . . . . 0.0 109.414 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -46.43 -44.96 17.73 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.582 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.4 mt-30 -64.99 -32.41 74.12 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.59 -34.86 65.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.909 -1.117 . . . . 0.0 108.128 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.9 mt-10 -65.03 -37.75 88.64 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.122 0.963 . . . . 0.0 110.398 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.9 -37.09 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.907 0.86 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.615 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.0 m-85 -87.77 3.12 49.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.0 m -75.42 75.79 2.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 119.702 -1.874 . . . . 0.0 109.993 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.45 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 26.6 t30 . . . . . 0 C--N 1.295 -1.804 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.646 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.584 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -148.23 165.59 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 109.937 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.584 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.0 m120 -121.85 71.11 0.97 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -119.49 169.65 9.86 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.824 0.821 . . . . 0.0 110.196 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.69 92.02 8.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 mt -83.75 139.71 32.55 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.43 -0.794 . . . . 0.0 110.734 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 m -140.28 124.11 17.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.339 -0.851 . . . . 0.0 109.745 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.42 -109.98 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 41.5 t -38.82 -54.84 1.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.378 -1.072 . . . . 0.0 111.464 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.5 OUTLIER -70.49 -27.8 64.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.98 -1.075 . . . . 0.0 109.889 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 2' ' ' ILE . 19.6 tp -84.23 -61.5 1.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.457 -0.777 . . . . 0.0 109.261 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.3 t -41.15 -57.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.836 0.827 . . . . 0.0 108.948 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -54.31 -36.48 63.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.37 -36.08 79.24 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.795 HD11 HD13 ' A' ' 2' ' ' ILE . 50.8 mt -75.02 -57.24 4.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.644 -1.285 . . . . 0.0 108.765 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -46.2 -31.29 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 tt -74.65 -48.22 27.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -73.93 -60.68 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.789 0.804 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.7 m -68.69 -47.22 66.99 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 112.166 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.67 -120.76 17.96 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.572 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' B' ' 44' ' ' GLY . 21.4 tt0 -63.58 -43.18 97.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.337 -1.096 . . . . 0.0 111.121 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -46.77 -18.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.982 -1.074 . . . . 0.0 110.448 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.04 -176.07 41.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.45 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.4 p90 -167.6 170.11 11.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.164 -1.786 . . . . 0.0 111.201 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.48 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.409 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -175.91 92.12 0.05 Allowed 'General case' 0 C--N 1.401 2.843 0 O-C-N 119.581 -1.949 . . . . 0.0 108.639 178.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.7 OUTLIER -80.95 -117.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 108.843 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.525 ' N ' ' OG1' ' B' ' 48' ' ' THR . 0.3 OUTLIER -93.3 169.49 10.2 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -50.31 -67.22 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.289 1.326 . . . . 0.0 110.497 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.405 HG22 ' H ' ' B' ' 51' ' ' THR . 1.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.421 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.529 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.999 0 N-CA-C 119.719 2.647 . . . . 0.0 119.719 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.821 HD11 HD11 ' B' ' 32' ' ' LEU . 8.0 tt -59.52 -30.95 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -1.142 . . . . 0.0 109.564 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -59.36 -49.7 82.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.881 -1.137 . . . . 0.0 110.821 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -52.2 -62.5 1.6 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.668 -1.27 . . . . 0.0 111.055 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.1 mp0 -60.59 -39.88 89.72 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.936 -1.103 . . . . 0.0 111.836 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 m -86.49 -46.22 10.39 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.068 -1.02 . . . . 0.0 112.164 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' VAL . 37.1 t -82.84 -52.88 6.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.77 -1.206 . . . . 0.0 110.897 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -70.34 -30.61 67.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.758 -1.214 . . . . 0.0 108.849 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 6' ' ' CYS . 66.7 m -133.41 174.22 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.73 129.57 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.627 -1.295 . . . . 0.0 109.077 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.594 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -93.33 -173.07 3.12 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.191 0.996 . . . . 0.0 109.838 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.471 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -137.38 155.46 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.2 tp -44.26 -60.56 1.86 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.355 1.074 . . . . 0.0 109.363 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -46.39 -45.05 17.61 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.889 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.0 mt-30 -64.86 -32.52 74.27 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.67 -35.17 65.18 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.156 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 31.3 mt-10 -64.6 -37.81 88.84 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.154 0.978 . . . . 0.0 110.39 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -49.0 -37.02 19.05 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.913 0.863 . . . . 0.0 110.136 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.627 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.6 m-85 -88.2 2.8 51.41 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.6 m -75.01 73.56 2.19 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 119.848 -1.783 . . . . 0.0 110.111 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 38.7 t-20 . . . . . 0 C--N 1.293 -1.878 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.011 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.576 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.5 p -149.28 165.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.993 -1.067 . . . . 0.0 109.985 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.576 ' N ' HG22 ' B' ' 23' ' ' VAL . 9.9 m120 -121.66 70.99 0.96 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -119.39 169.19 10.23 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.05 92.29 8.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.5 mt -83.7 141.2 31.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.387 -0.82 . . . . 0.0 110.6 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 49.5 m -142.5 124.25 15.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 109.954 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.5 -107.45 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 29' ' ' GLY . 13.1 t -38.65 -59.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.343 -1.092 . . . . 0.0 111.447 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -42.73 93.25 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 2' ' ' ILE . 24.4 tp -68.03 -63.23 1.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.724 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.569 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.8 t -40.52 -56.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 122.018 0.913 . . . . 0.0 108.655 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.39 -40.05 67.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -58.9 -36.03 74.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 2' ' ' ILE . 49.5 mt -74.95 -57.48 3.88 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.518 -1.364 . . . . 0.0 108.736 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -46.09 -30.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.445 HD23 ' C ' ' B' ' 38' ' ' LEU . 10.0 tt -75.92 -47.33 25.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.5 t -74.71 -60.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.784 0.802 . . . . 0.0 109.804 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.7 m -68.24 -47.3 68.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.727 -0.608 . . . . 0.0 112.091 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.1 -117.91 10.41 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.604 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.4 tt0 -65.89 -41.88 90.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 111.354 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -49.45 -15.78 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.868 -1.145 . . . . 0.0 110.327 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.16 -172.77 40.41 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 21.8 p90 -169.76 170.14 8.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.112 -1.817 . . . . 0.0 110.936 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.475 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.407 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -176.39 -84.88 0.0 OUTLIER 'General case' 0 C--N 1.401 2.821 0 O-C-N 119.815 -1.803 . . . . 0.0 107.797 178.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.502 HG22 ' H ' ' B' ' 49' ' ' LYS . 1.6 m 43.67 -140.37 0.22 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.246 -0.909 . . . . 0.0 110.048 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.502 ' H ' HG22 ' B' ' 48' ' ' THR . 50.1 mttm 46.82 72.42 1.26 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 109.874 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -57.2 -54.13 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.736 1.624 . . . . 0.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.327 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.938 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 HD11 ' B' ' 32' ' ' LEU . 9.4 tt -53.06 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 7' ' ' CYS . 93.6 t -68.47 -50.71 54.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.561 -1.337 . . . . 0.0 110.641 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -50.89 -62.58 1.52 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.58 -1.325 . . . . 0.0 111.097 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.576 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 1.9 mp0 -62.69 -40.05 95.9 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.896 -1.127 . . . . 0.0 111.948 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 4.3 m -85.81 -44.96 12.03 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.06 -1.025 . . . . 0.0 112.222 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 3' ' ' VAL . 49.0 t -83.14 -53.07 6.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.536 -1.353 . . . . 0.0 110.906 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -69.9 -31.47 69.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.822 -1.174 . . . . 0.0 108.807 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.9 m -132.09 174.01 10.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.81 136.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.598 -1.314 . . . . 0.0 108.975 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -102.71 -172.92 2.21 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.127 0.965 . . . . 0.0 109.668 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.455 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -137.45 157.08 47.35 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.8 tp -44.34 -60.26 2.01 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.296 1.046 . . . . 0.0 109.452 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.27 -45.13 17.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.948 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.1 mt-30 -64.7 -32.55 74.28 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.9 mp -73.87 -35.35 64.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.28 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 21.8 mt-10 -64.34 -37.73 88.55 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.12 0.962 . . . . 0.0 110.464 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -48.83 -37.17 18.59 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.94 0.876 . . . . 0.0 110.173 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.613 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.9 m-85 -87.71 2.73 50.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.5 m -74.12 74.29 1.75 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 119.806 -1.809 . . . . 0.0 110.045 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 32.3 t30 . . . . . 0 C--N 1.293 -1.861 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.74 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.599 HG22 ' N ' ' B' ' 24' ' ' ASN . 4.0 p -149.16 166.06 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.968 -1.083 . . . . 0.0 109.801 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.599 ' N ' HG22 ' B' ' 23' ' ' VAL . 13.0 m120 -123.47 69.73 1.03 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -118.63 168.24 10.89 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.789 0.804 . . . . 0.0 109.957 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -88.8 91.85 8.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.43 138.91 33.26 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.432 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.401 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.4 m -140.29 124.04 17.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.18 -109.43 0.11 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 29' ' ' GLY . 69.5 m -38.92 -58.18 1.14 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -1.094 . . . . 0.0 111.674 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.73 -27.27 66.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.917 -1.114 . . . . 0.0 110.057 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.82 HD11 HD11 ' A' ' 2' ' ' ILE . 18.9 tp -84.16 -61.47 1.8 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.324 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' B' ' 29' ' ' GLY . 33.1 t -41.28 -57.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.771 0.796 . . . . 0.0 108.992 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.07 -36.17 62.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -61.58 -36.32 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.812 HD11 HD13 ' A' ' 2' ' ' ILE . 48.9 mt -74.44 -57.84 3.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.617 -1.302 . . . . 0.0 108.876 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.7 t80 -45.94 -30.02 1.62 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.53 HD23 ' C ' ' B' ' 38' ' ' LEU . 8.9 tt -76.73 -46.03 27.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 36' ' ' LEU . 25.0 t -75.88 -60.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.757 0.789 . . . . 0.0 109.677 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' LEU . 31.3 m -68.17 -47.06 69.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.704 -0.623 . . . . 0.0 111.942 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -118.4 12.23 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.755 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' B' ' 44' ' ' GLY . 29.7 tt0 -64.75 -43.14 94.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -1.076 . . . . 0.0 111.351 -178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 3.2 mtm180 -48.24 -17.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.912 -1.118 . . . . 0.0 110.415 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 72.68 -175.51 44.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.431 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.6 p90 -168.13 170.93 9.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.203 -1.763 . . . . 0.0 110.905 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.485 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.407 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER 179.48 134.06 0.1 Allowed 'General case' 0 C--N 1.401 2.808 0 O-C-N 119.811 -1.806 . . . . 0.0 108.236 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -82.17 171.28 14.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.22 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -50.65 151.97 3.75 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.139 -0.976 . . . . 0.0 108.709 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -50.38 -71.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 120.514 0.809 . . . . 0.0 110.478 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.124 -179.751 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.98 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.788 HD11 HD11 ' B' ' 32' ' ' LEU . 8.4 tt -54.21 -30.95 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -1.148 . . . . 0.0 109.618 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' CYS . 99.7 t -59.17 -50.1 81.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.813 -1.179 . . . . 0.0 110.814 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.65 -62.45 1.62 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.596 -1.315 . . . . 0.0 111.032 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.55 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 2.6 mp0 -60.24 -40.25 89.58 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.954 -1.091 . . . . 0.0 111.949 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.4 m -86.49 -46.16 10.44 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.038 -1.039 . . . . 0.0 112.008 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.9 t -82.93 -52.95 6.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.797 -1.19 . . . . 0.0 111.023 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.87 -28.32 64.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.731 -1.231 . . . . 0.0 108.889 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.9 m -135.97 174.12 10.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mt -87.22 128.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.616 -1.302 . . . . 0.0 108.981 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -91.32 -173.05 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.259 1.028 . . . . 0.0 109.974 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.11 151.61 49.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.35 -60.56 1.45 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.237 1.017 . . . . 0.0 109.572 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -46.66 -45.13 19.07 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.823 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 27.5 mt-30 -64.35 -32.59 74.25 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.82 -35.37 64.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.268 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 15.2 mt-10 -64.43 -37.61 88.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.088 0.947 . . . . 0.0 110.43 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.79 -37.13 18.28 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.929 0.871 . . . . 0.0 110.088 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.646 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.9 m-85 -88.29 3.81 48.28 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 62.2 m -76.04 75.0 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 119.83 -1.794 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.434 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 14.1 t-20 . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.576 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.591 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -147.81 165.47 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.018 -1.051 . . . . 0.0 109.847 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.591 ' N ' HG22 ' B' ' 23' ' ' VAL . 15.0 m120 -122.93 71.7 1.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -120.94 170.75 9.19 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.804 0.812 . . . . 0.0 110.09 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -90.89 92.63 8.86 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.96 140.25 32.04 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.366 -0.833 . . . . 0.0 110.572 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' B' ' 29' ' ' GLY . 54.4 m -142.38 124.36 15.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 67.1 m -38.53 -60.56 0.79 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.391 -1.064 . . . . 0.0 111.391 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.91 -45.46 89.21 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.014 -1.054 . . . . 0.0 109.636 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 2' ' ' ILE . 25.3 tp -64.84 -63.71 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.663 . . . . 0.0 109.638 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 29' ' ' GLY . 40.9 t -40.85 -57.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -53.97 -39.66 66.17 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.56 -36.65 76.61 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.786 HD11 HD13 ' A' ' 2' ' ' ILE . 52.1 mt -74.29 -57.1 4.17 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.505 -1.372 . . . . 0.0 108.844 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' B' ' 36' ' ' LEU . 40.8 t80 -46.66 -30.57 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.555 HD23 ' C ' ' B' ' 38' ' ' LEU . 8.4 tt -75.96 -47.49 24.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.78 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.747 0.784 . . . . 0.0 109.669 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 24.7 m -67.94 -47.24 69.24 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.777 -0.577 . . . . 0.0 112.037 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.76 -117.84 10.56 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.696 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -39.59 90.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -1.059 . . . . 0.0 111.403 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' B' ' 43' ' ' ARG . 2.6 mtm180 -52.56 -15.68 0.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.78 -173.87 40.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.434 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 22.8 p90 -168.31 170.57 9.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.083 -1.834 . . . . 0.0 111.273 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.489 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' B' ' 48' ' ' THR . 0.2 OUTLIER -172.69 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.403 2.924 0 O-C-N 119.461 -2.024 . . . . 0.0 108.984 178.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 47' ' ' TYR . 60.8 p -41.02 143.63 0.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 110.246 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm 53.09 71.07 1.53 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.857 . . . . 0.0 109.35 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -57.7 -71.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.819 1.679 . . . . 0.0 110.52 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.495 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.515 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.948 0 N-CA-C 119.916 2.727 . . . . 0.0 119.916 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.792 HD11 HD11 ' B' ' 32' ' ' LEU . 7.8 tt -68.32 -30.8 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -1.171 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.0 t -58.98 -49.46 83.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.831 -1.168 . . . . 0.0 110.838 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -52.57 -62.37 1.69 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.591 -1.318 . . . . 0.0 111.042 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.9 mp0 -59.82 -40.48 88.59 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.879 -1.138 . . . . 0.0 111.82 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -86.3 -46.13 10.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.084 -1.01 . . . . 0.0 112.111 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 3' ' ' VAL . 35.2 t -82.98 -53.04 6.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.719 -1.238 . . . . 0.0 110.953 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -70.67 -28.07 64.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.763 -1.211 . . . . 0.0 108.883 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.1 m -136.31 174.22 10.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.63 127.65 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.625 -1.297 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -90.31 -173.08 3.68 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.209 1.005 . . . . 0.0 109.959 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.44 152.51 49.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.4 tp -42.59 -60.59 1.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 122.369 1.08 . . . . 0.0 109.651 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -46.52 -45.19 18.39 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.874 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 26.3 mt-30 -64.26 -32.53 74.15 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -74.03 -35.1 64.33 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.256 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 18.5 mt-10 -64.37 -37.74 88.57 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.126 0.965 . . . . 0.0 110.393 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -49.04 -37.36 20.62 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.972 0.892 . . . . 0.0 110.217 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.632 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.5 m-85 -87.7 2.66 50.49 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.3 m -75.71 75.03 2.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 119.886 -1.759 . . . . 0.0 110.069 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.432 ' OXT' ' O ' ' A' ' 20' ' ' CYS . 27.1 t-20 . . . . . 0 C--N 1.293 -1.877 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.053 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.586 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.7 p -148.38 165.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.076 -1.015 . . . . 0.0 109.817 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.586 ' N ' HG22 ' B' ' 23' ' ' VAL . 8.5 m120 -123.18 71.22 1.05 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -119.87 170.06 9.59 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.752 0.787 . . . . 0.0 109.994 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -90.9 94.22 9.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -85.48 140.78 30.41 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 110.488 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.412 ' O ' ' C ' ' B' ' 29' ' ' GLY . 52.0 m -142.53 124.25 15.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.32 -107.17 0.06 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 29' ' ' GLY . 11.1 t -38.58 -59.98 0.86 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -1.109 . . . . 0.0 111.344 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.77 -43.63 92.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.977 -1.077 . . . . 0.0 109.689 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 2' ' ' ILE . 23.9 tp -66.9 -63.26 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.647 -0.658 . . . . 0.0 109.642 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.7 t -40.6 -57.16 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.021 0.915 . . . . 0.0 108.709 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -53.86 -39.65 65.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.43 -36.21 75.46 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.791 HD11 HD13 ' A' ' 2' ' ' ILE . 49.1 mt -74.68 -57.33 3.99 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.527 -1.358 . . . . 0.0 108.825 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.41 ' C ' ' O ' ' B' ' 36' ' ' LEU . 38.4 t80 -46.04 -31.23 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.435 HD23 ' C ' ' B' ' 38' ' ' LEU . 9.8 tt -74.76 -47.82 28.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' B' ' 36' ' ' LEU . 26.3 t -74.16 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.71 0.767 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.535 ' N ' ' O ' ' B' ' 36' ' ' LEU . 22.2 m -67.98 -47.19 69.24 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.748 -0.595 . . . . 0.0 112.058 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.7 11.6 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.539 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' B' ' 44' ' ' GLY . 52.2 tp10 -62.58 -44.07 97.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.318 -1.107 . . . . 0.0 111.446 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -50.72 -14.0 0.17 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.918 -1.114 . . . . 0.0 110.667 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 68.53 -173.44 33.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -169.38 169.48 8.99 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.138 -1.801 . . . . 0.0 110.841 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.492 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' B' ' 48' ' ' THR . 0.1 OUTLIER -178.6 140.74 0.2 Allowed 'General case' 0 C--N 1.401 2.807 0 O-C-N 119.689 -1.882 . . . . 0.0 108.534 178.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.43 ' O ' ' O ' ' B' ' 47' ' ' TYR . 16.9 m 52.98 101.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.391 -0.818 . . . . 0.0 109.861 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.59 ' CD ' ' H ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -82.25 160.5 62.45 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -49.75 -72.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.407 1.405 . . . . 0.0 110.695 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.457 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.531 4.999 0 N-CA-C 119.817 2.687 . . . . 0.0 119.817 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.821 HD11 HD11 ' B' ' 32' ' ' LEU . 8.0 tt -65.54 -29.81 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.502 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 7' ' ' CYS . 85.0 t -59.84 -50.3 80.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.889 -1.132 . . . . 0.0 110.809 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.32 -62.44 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.7 -1.25 . . . . 0.0 111.041 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 3.0 mp0 -60.76 -40.36 92.18 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 111.889 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.5 m -86.29 -46.03 10.7 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.047 -1.033 . . . . 0.0 112.164 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' VAL . 36.8 t -82.83 -52.97 6.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.719 -1.238 . . . . 0.0 111.027 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -70.99 -28.25 64.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.793 -1.192 . . . . 0.0 108.919 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 64.6 m -135.99 174.17 10.9 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mt -87.09 130.86 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.587 -1.321 . . . . 0.0 109.051 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.3 m -94.67 -173.19 2.94 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.223 1.011 . . . . 0.0 109.845 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -136.96 155.43 49.74 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' LEU . 10.7 tp -44.97 -60.69 1.94 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.303 1.049 . . . . 0.0 109.239 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -46.2 -45.07 16.66 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.847 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.586 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 28.6 mt-30 -64.86 -32.73 74.57 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.8 mp -73.6 -35.19 65.34 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.159 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 29.2 mt-10 -64.59 -37.76 88.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.134 0.969 . . . . 0.0 110.37 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.92 -36.99 18.55 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 121.871 0.843 . . . . 0.0 110.066 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 2' ' ' ILE . 29.4 m-85 -88.29 2.93 51.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 61.8 m -74.32 74.41 1.85 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.8 -1.812 . . . . 0.0 109.892 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.446 ' H ' ' HA ' ' B' ' 45' ' ' PHE . 21.4 t-20 . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.668 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.574 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.6 p -149.72 165.53 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.054 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.574 ' N ' HG22 ' B' ' 23' ' ' VAL . 11.8 m120 -121.31 71.27 0.95 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -120.22 169.84 9.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.832 0.825 . . . . 0.0 110.179 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -91.13 92.75 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.36 140.65 31.44 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 110.514 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -142.05 124.26 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 38.66 -107.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 29' ' ' GLY . 66.8 m -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.381 -1.07 . . . . 0.0 111.358 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.35 -42.9 95.99 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.962 -1.086 . . . . 0.0 109.695 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 2' ' ' ILE . 25.2 tp -68.17 -63.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.81 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 29' ' ' GLY . 37.4 t -40.66 -57.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -53.79 -39.29 65.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 32' ' ' LEU . . . -59.68 -36.46 76.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.8 HD11 HD13 ' A' ' 2' ' ' ILE . 50.7 mt -74.49 -56.74 4.5 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.55 -1.344 . . . . 0.0 108.703 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -46.45 -30.71 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.616 HD23 ' C ' ' B' ' 38' ' ' LEU . 7.3 tt -75.98 -46.52 29.18 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.03 -61.17 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.82 0.819 . . . . 0.0 109.73 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 28.5 m -68.05 -47.23 68.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.772 -0.58 . . . . 0.0 111.993 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.22 -117.87 11.02 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.665 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.37 -42.46 92.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -1.06 . . . . 0.0 111.309 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -48.99 -17.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.853 -1.155 . . . . 0.0 110.506 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.7 -175.03 44.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.446 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 23.3 p90 -167.98 170.66 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.088 -1.831 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.472 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.416 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -177.04 87.79 0.03 OUTLIER 'General case' 0 C--N 1.4 2.779 0 O-C-N 119.826 -1.796 . . . . 0.0 107.654 178.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -86.78 -19.31 29.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.17 -0.956 . . . . 0.0 110.204 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.45 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 7.6 mtmp? 53.42 75.8 0.59 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.08 -1.013 . . . . 0.0 109.436 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -55.6 -72.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.494 1.463 . . . . 0.0 110.555 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.565 179.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.95 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.804 HD11 HD11 ' B' ' 32' ' ' LEU . 8.8 tt -62.32 -28.92 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -1.118 . . . . 0.0 109.716 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' CYS . 95.2 t -61.75 -49.34 84.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.78 -1.2 . . . . 0.0 111.01 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -51.95 -62.54 1.57 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.24 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 1' ' ' GLY . 2.6 mp0 -62.38 -38.8 90.99 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.845 -1.159 . . . . 0.0 111.872 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 2' ' ' ILE . 3.8 m -86.33 -46.13 10.58 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.976 -1.078 . . . . 0.0 112.101 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' VAL . 39.0 t -83.31 -53.0 6.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.649 -1.282 . . . . 0.0 110.945 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -69.91 -29.73 66.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.725 -1.234 . . . . 0.0 108.857 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 6' ' ' CYS . 67.3 m -134.83 174.19 10.86 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mt -86.41 134.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.587 -1.321 . . . . 0.0 108.951 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 1.2 m -98.82 -172.96 2.4 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.203 1.001 . . . . 0.0 109.838 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -137.28 152.46 49.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 16' ' ' LEU . 11.0 tp -42.16 -60.32 1.49 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.229 1.014 . . . . 0.0 109.617 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -46.91 -45.24 20.45 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.824 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.579 ' O ' ' CE2' ' A' ' 19' ' ' TYR . 25.8 mt-30 -64.19 -32.56 74.18 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LEU . 3.7 mp -73.64 -35.72 65.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.267 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.453 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 25.8 mt-10 -64.2 -37.64 88.2 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.128 0.965 . . . . 0.0 110.462 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -48.78 -37.21 18.46 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.885 0.85 . . . . 0.0 110.063 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.63 ' CD2' HD12 ' A' ' 2' ' ' ILE . 30.4 m-85 -88.01 2.81 50.9 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 17' ' ' GLU . 60.4 m -75.41 74.51 2.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 119.84 -1.788 . . . . 0.0 110.189 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' CYS . 37.2 t-20 . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.988 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.584 HG22 ' N ' ' B' ' 24' ' ' ASN . 3.4 p -150.21 165.91 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 109.841 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.584 ' N ' HG22 ' B' ' 23' ' ' VAL . 7.5 m120 -123.49 71.69 1.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -120.42 169.74 10.03 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.752 0.786 . . . . 0.0 110.057 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -90.06 92.02 8.8 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.54 141.26 31.73 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 110.438 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' B' ' 29' ' ' GLY . 46.3 m -143.17 124.33 14.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.956 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' B' ' 33' ' ' VAL . . . 39.04 -107.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 29' ' ' GLY . 26.4 t -38.73 -60.75 0.79 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -1.085 . . . . 0.0 111.46 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -43.57 95.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.934 -1.104 . . . . 0.0 109.72 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.804 HD11 HD11 ' A' ' 2' ' ' ILE . 24.4 tp -67.24 -63.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.654 -0.654 . . . . 0.0 109.732 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' B' ' 29' ' ' GLY . 38.1 t -40.62 -57.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.033 0.92 . . . . 0.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -53.65 -39.53 65.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' B' ' 32' ' ' LEU . . . -59.46 -36.63 76.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.789 HD11 HD13 ' A' ' 2' ' ' ILE . 49.8 mt -74.44 -56.67 4.59 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.553 -1.342 . . . . 0.0 108.722 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -46.33 -30.67 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.595 HD23 ' C ' ' B' ' 38' ' ' LEU . 7.7 tt -76.39 -48.23 20.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.83 -60.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.828 0.823 . . . . 0.0 109.687 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' LEU . 27.9 m -68.38 -47.17 68.07 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.802 -0.561 . . . . 0.0 112.152 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 -121.72 22.44 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.353 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' B' ' 44' ' ' GLY . 8.3 tp10 -61.26 -44.14 97.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -1.096 . . . . 0.0 110.979 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -16.68 0.07 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.999 -1.063 . . . . 0.0 110.622 -177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 42' ' ' GLU . . . 70.45 -174.62 38.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.404 ' HA ' ' H ' ' A' ' 21' ' ' ASN . 25.1 p90 -169.24 169.92 8.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.185 -1.773 . . . . 0.0 110.917 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' 23F . . . . . 0.482 ' N ' ' HD1' ' B' ' 46' ' ' 23F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.411 ' CD2' HG22 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -178.11 114.31 0.08 Allowed 'General case' 0 C--N 1.402 2.861 0 O-C-N 119.573 -1.954 . . . . 0.0 108.535 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.3 t -89.02 -173.07 3.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.269 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.544 ' H ' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -149.45 -62.81 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.309 -0.87 . . . . 0.0 109.677 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.544 ' HD2' ' H ' ' B' ' 49' ' ' LYS . 24.7 Cg_exo -41.59 -54.42 2.76 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.995 1.13 . . . . 0.0 110.769 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.768 179.998 . . . . . . . . 0 0 . 1 stop_ save_